Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 180
Encontrada(s) 2 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Soluble oligomers of amyloid-beta peptide disrupt membrane trafficking of alpha-amino-3-hydroxy-5-methylisoxazole-4 propionic acid receptor (AMPAR) contributing to early synapse dysfunction

  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
  • España Agustí, Judit
  • Martín, Elsa
  • Barneda Zahonero, Bruna|||0000-0002-6557-5222
  • Fadó, Rut|||0000-0002-3293-2342
  • Solé Piñol, Montserrat|||0000-0003-4240-6562
  • Trullas i Oliva, Ramon
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
β-Amyloid (Aβ), a peptide generated from the amyloid precursor protein, is widely believed to underlie the pathophysiology of Alzheimer disease (AD). Emerging evidences suggest that soluble Aβ oligomers adversely affect synaptic function, leading to cognitive failure associated with AD. The Aβ-induced synaptic dysfunction has been attributed to the synaptic removal of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors (AMPARs). However, the molecular mechanisms underlying the loss of AMPAR induced by Aβ at synapses are largely unknown. In this study we have examined the effect of Aβ oligomers on phosphorylated GluA1 at serine 845, a residue that plays an essential role in the trafficking of AMPARs toward extrasynaptic sites and the subsequent delivery to synapses during synaptic plasticity events. We found that Aβ oligomers reduce basal levels of Ser-845 phosphorylation and surface expression of AMPARs affecting AMPAR subunit composition. Aβ-induced GluA1 dephosphorylation and reduced receptor surface levels are mediated by an increase in calcium influx into neurons through ionotropic glutamate receptors and activation of the calcium-dependent phosphatase calcineurin. Moreover, Aβ oligomers block the extrasynaptic delivery of AMPARs induced by chemical synaptic potentiation. In addition, reduced levels of total and phosphorylated GluA1 are associated with initial spatial memory deficits in a transgenic mouse model of AD. These findings indicate that Aβ oligomers could act as a synaptic depressor affecting the mechanisms involved in the targeting of AMPARs to the synapses during early stages of the disease.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

p73 Plays a Role in Erythroid Differentiation through GATA1 Induction

  • Marqués García, Fernando
  • Ferrándiz Diaz, Nuria
  • Fernández Alonso, Rosalía
  • González Cano, Laura
  • Herreros Villanueva, Marta
  • Rosa Garrido, Manuel
  • Fernández García, Belén
  • Vaqué Díez, José Pedro
  • Marqués Martínez, Margarita
  • Alonso, María Eugenia
  • Segovia Sanz, Jose Carlos
  • León Serrano, Javier
  • Marín Vieira, María Carmen
Palabras clave extraídas del título y del contenido, [EN] The TP73 gene gives rise to transactivation domain-p73 isoforms (TAp73) as well as ΔNp73 variants with a truncated N terminus. Although TAp73α and -β proteins are capable of inducing cell cycle arrest, apoptosis, and differentiation, ΔNp73 acts in many cell types as a dominant-negative repressor of p53 and TAp73. It has been proposed that p73 is involved in myeloid differentiation, and its altered expression is involved in leukemic degeneration. However, there is little evidence as to which p73 variants (TA or ΔN) are expressed during differentiation and whether specific p73 isoforms have the capacity to induce, or hinder, this differentiation in leukemia cells. In this study we identify GATA1 as a direct transcriptional target of TAp73α. Furthermore, TAp73α induces GATA1 activity, and it is required for erythroid differentiation. Additionally, we describe a functional cooperation between TAp73 and ΔNp73 in the context of erythroid differentiation in human myeloid cells, K562 and UT-7. Moreover, the impaired expression of GATA1 and suggests a physiological role for TP73 in erythropoiesis, SI, This work was supported by Grants SAF2006-10756, SAF2005-00461, SAF2008-1883, and RETIC-RD06/0020 from Spanish Ministerio de Educación y Ciencia (to M. C. M., J. L. S., and J. C. S.) and Grant LE030A07 from the Junta de Castilla y León (to M. M. M.).
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Effect of dietary phenolic compounds intake on mortality in the “Seguimiento Universidad De Navarra” (SUN) Mediterranean cohort

  • Vázquez Ruiz, Zenaida
  • Toledo, Estefanía
  • Vitelli Storelli, Facundo Ezequiel
  • Bes Rastrollo, Maira
  • Martínez González, Miguel Ángel
[EN] Plant-based dietary patterns have been demonstrated to reduce the risk of non-communicable disease (NCD), including cardiovascular disease (CVD), type 2 diabetes, cancer, and all-cause mortality. Phenolic compounds (PC), abundant in plant-based foods, have been considered as instrumental in this attenuation of NCD risk. We evaluated the association between dietary intake of PC and the risk of all-cause mortality in a relatively young Mediterranean cohort of 18,173 Spanish participants in the “Seguimiento Universidad de Navarra” (SUN) project, after a median follow-up of 12.7 years. Intake of PC was estimated at baseline and repeatedly after 10-year follow-up using a 136-item validated food frequency questionnaire and the Phenol-Explorer database. During 236,329 person-years, 544 deaths were confirmed. Cox regression models compared low intake (lowest quintile) vs. high intake (the four upper quintiles merged, as a reference category) of total energy-adjusted PC intake. Adjusted hazard ratios (HR) for low PC intake among those participants aged over 45 years during follow-up were 1.32; 95% CI 1.02–1.71 for all-cause mortality, HR:1.44; 95% CI 1.02–2.02 for cancer mortality; HR: 0.88; 95% CI 0.47–1.66 for CVD mortality and HR: 1.69 95% CI 1.04–2.74 for causes of death other than cancer or CVD. In conclusion, a low intake of total PC was associated with a significantly higher risk of all-cause mortality, and, specifically, a higher risk for cancer in a relatively young cohort. Among PC classes a low intake of flavonoids and phenolic acids showed significant effects for non-cancer/non-CVD mortality. Cherries, chocolate, apples and pears, olives, and coffee, were the major sources of between-person variability for total PC intake in our Mediterranean cohort, SI, Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The project SUN has received funding from the Spanish Government - Instituto de Salud Carlos III, and the European Regional Develop- ment Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, PI20/00564 and G03/140), the Government of Navarra (27/2011, 45/2011, 122/2014), the National Plan on Drugs (2020 / 021) as well as the University of Navarra
Docta Complutense
Publication Artículo científico (JournalArticle)

3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization

  • Santamaría, Beatriz
  • Ucero Herrería, Álvaro Conrado
  • Reyero, Ana
  • Selgas, Rafael
  • Ruíz Ortega, Marta
  • Catalan, Marina
  • Egido, Jesús
  • Ortiz, Alberto
Background: The mesothelium contributes significantly to the functional, structural and homeostatic properties of the peritoneum. Bioincompatible peritoneal dialysis solutions contribute to mesothelial cell loss during chronic peritoneal dialysis. Cell death has been implicated in mesothelial cell loss, but the molecular mechanisms have not been adequately characterized. We now report the modulation of mesothelial cell death by the glucose degradation product 3,4-dideoxyglucosone-3-ene (3,4-DGE). Methods: Human mesothelial cells were cultured from the effluents of stable dialysis patients. Apoptosis was quantified in cultured mesothelial cells and in peritoneal effluents. Confocal microscopy and inhibitors were used to assess molecular mechanisms. Results: Peritoneal dialysis solutions with a high content of both glucose and glucose degradation products, but not those with low glucose degradation product content, induced mesothelial cell apoptosis and loss of cell viability in culture and in vivo. 3,4-DGE also induced mesothelial cell apoptosis. Apoptosis induced by peritoneal dialysis solutions and 3,4-DGE was associated with oligomerization of Bax at mitochondria and caspase activation. Bax antagonism prevented caspase activation, apoptosis and cell death. The pancaspase inhibitor zVAD was also protective. Conclusion: 3,4-DGE and peritoneal dialysis solutions with a high content in glucose degradation products induce mesothelial cell apoptosis by a Bax-dependent mechanism. This could contribute to chronic demesothelization in peritoneal dialysis.
Docta Complutense
Publication Artículo científico (JournalArticle)

Proteomic characterization of human proinflammatory M1 and anti-inflammatory M2 macrophages and their response to Candida albicans

  • Reales Calderón, José Antonio
  • Aguilera Montilla, Noemí
  • Corbí, Ángel L.
  • Molero Martín-Portugués, María Gloria
  • Gil , Concha
In response to different stimuli, macrophages can differentiate into either a pro-inflammatory subtype (M1, classically activated macrophages) or acquire an anti-inflammatory phenotype (M2, alternatively activated macrophages). Candida albicans is the most important opportunistic fungus in nosocomial infections, and it is contended by neutrophils and macrophages during the first steps of the invasive infection. Murine macrophages responses to C. albicans have been widely studied, whereas the responses of human-polarized macrophages remain less characterized. In this study, we have characterized the proteomic differences between human M1- and M2-polarized macrophages, both in basal conditions and in response to C. albicans, by quantitative proteomics (2DE). This proteomic approach allowed us to identify metabolic routes and cytoskeletal rearrangement components that are the most relevant differences between M1 and M2 macrophages. The analysis has revealed fructose-1,6-bisphosphatase 1, a critical enzyme in gluconeogenesis, up-regulated in M1, as a novel protein marker for macrophage polarization. Regarding the response to C. albicans, an M1-to-M2 switch in polarization was observed. This M1-to-M2 switch might contribute to Candida pathogenicity by decreasing the generation of specific immune responses, thus enhancing fungal survival and colonization, or instead, may be part of the host attempt to reduce the inflammation and limit the damage of the infection.
Docta Complutense
Publication Artículo científico (JournalArticle)

β-adrenergic receptors activate exchange protein directly activated by camp (epac), translocate munc13-1, and enhance the rab3a-rim1α interaction to potentiate glutamate release at cerebrocortical nerve terminals

  • Ferrero, José Javier
  • Alvarez, Ana Maria
  • Ramírez-Franco, Jorge
  • Godino, Maria del Carmen
  • Bartolomé-Martín, David
  • Aguado, Carolina
  • Torres Molina, Magdalena Isabel
  • Luján, Rafael
  • Ciruela, Francisco
  • Sánchez-Prieto Borja, José
The adenylyl cyclase activator forskolin facilitates synaptic transmission presynaptically via cAMP-dependent protein kinase (PKA). In addition, cAMP also increases glutamate release via PKA-independent mechanisms, although the downstream presynaptic targets remain largely unknown. Here, we describe the isolation of a PKA-independent component of glutamate release in cerebrocortical nerve terminals after blocking Na+ channels with tetrodotoxin. We found that 8-pCPT-2′-O-Me-cAMP, a specific activator of the exchange protein directly activated by cAMP (Epac), mimicked and occluded forskolin-induced potentiation of glutamate release. This Epac-mediated increase in glutamate release was dependent on phospholipase C, and it increased the hydrolysis of phosphatidylinositol 4,5-bisphosphate. Moreover, the potentiation of glutamate release by Epac was independent of protein kinase C, although it was attenuated by the diacylglycerol-binding site antagonist calphostin C. Epac activation translocated the active zone protein Munc13-1 from soluble to particulate fractions; it increased the association between Rab3A and RIM1α and redistributed synaptic vesicles closer to the presynaptic membrane. Furthermore, these responses were mimicked by the β-adrenergic receptor (βAR) agonist isoproterenol, consistent with the immunoelectron microscopy and immunocytochemical data demonstrating presynaptic expression of βARs in a subset of glutamatergic synapses in the cerebral cortex. Based on these findings, we conclude that βARs couple to a cAMP/Epac/PLC/Munc13/Rab3/RIM-dependent pathway to enhance glutamate release at cerebrocortical nerve terminals. Background: G protein-coupled receptors generating cAMP at nerve terminals modulate neurotransmitter release. Results: β-Adrenergic receptor enhances glutamate release via Epac protein activation and Munc13-1 translocation at cerebrocortical nerve terminals. Conclusion: Protein kinase A-independent signaling pathways triggered by β-adrenergic receptors control presynaptic function. Significance: β-Adrenergic receptors target presynaptic release machinery.
Docta Complutense
Publication Artículo científico (JournalArticle)

Non-additive potentiation of glutamate release by phorbol esters and metabotropic mGlu7 receptor in cerebrocortical nerve terminals

  • Martín Herranz, Ricardo
  • Bartolomé-Martín, David
  • Torres Molina, Magdalena Isabel
  • Sánchez-Prieto Borja, José
We recently showed that prolonged activation of metabotropic glutamate receptor 7 (mGlu7) potentiates glutamate release. This signalling involves phospholipase C activation via a pertussis toxin insensitive G protein and the subsequent hydrolysis of phosphatidylinositol (4,5)-bisphosphate. Release potentiation is independent of protein kinase C activation but it is dependent on the downstream release machinery, as reflected by the concomitant translocation of active zone Munc13-1 protein from the soluble to particulate fractions. Here we show that phorbol ester and mGlu7 receptor-dependent facilitation of neurotransmitter release is not additive, suggesting they share a common signalling mechanism. However, release potentiation is restricted to release sites that express N-type Ca2+ channels, because phorbol ester and mGlu7 receptor-mediated release potentiation are absent in nerve terminals from mice lacking N-type Ca2+ channels. In addition, phorbol esters but not mGlu7 receptors potentiate release at nerve terminals with P/Q-type Ca2+ channels, although only under restricted conditions of Ca2+ influx. The differential effect of phorbol esters at nerve terminals with either N- or P/Q-type Ca2+ channels seems to be unrelated to the type Munc13 isoform expressed, and it is more likely dependent on other properties of the release machinery.
Docta Complutense
Publication Artículo científico (JournalArticle)

Efficient synaptic vesicle recycling after intense exocytosis concomitant with the accumulation of non-releasable endosomes at early developmental stages

  • Bartolomé-Martín, David
  • Ramírez-Franco, Jorge
  • Castro López-Tarruella, Enrique
  • Sánchez-Prieto Borja, José
  • Torres Molina, Magdalena Isabel
Following the exocytosis of neurotransmitter-containing synaptic vesicles, endocytosis is fundamental to re-establishing conditions for synaptic transmission. As there are distinct endocytotic pathways that each differ in their efficiency to generate releasable synaptic vesicles, we used the dye FM1-43 to track vesicle recycling, and to determine whether nerve terminals use multiple pathways of endocytosis. We identified two types of synaptic boutons in cultured cerebellar granule cells that were characterized by weak or strong FM1-43-unloading profiles. Decreasing the extent of exocytosis dramatically increased the proportion of synaptic boutons that exhibited strong FM1-43-unloading and dramatically reduced the number of endosome-like structures. Hence, we concluded that efficient recycling of synaptic vesicles is concomitant with the formation of non-releasable endosomes in both types of synaptic boutons, although to different extents. Furthermore, cell maturation in culture increased the proportion of synaptic boutons that were capable of an intense release response, whereas the chronic blockage of synaptic activity diminished the capacity of boutons to release dye.
Docta Complutense
Publication Artículo científico (JournalArticle)

Inflammation determines the pro-adhesive properties of high extracellular D-glucose in human endothelial cells in vitro and rat microvessels in vivo.

  • Azcutia Criado, Verónica
  • Abu-Taha, May
  • Romacho, Tania
  • Vázquez-Bella, Marta
  • Matesanz, Nuria
  • Luscinskas, Francis
  • Rodríguez-Mañas, Leocadio
  • Sanz, María Jesús
  • Sánchez-Ferrer, Carlos
  • Peiró, Concepción
Background: Hyperglycemia is acknowledged as an independent risk factor for developing diabetes-associated atherosclerosis. At present, most therapeutic approaches are targeted at a tight glycemic control in diabetic patients, although this fails to prevent macrovascular complications of the disease. Indeed, it remains highly controversial whether or not the mere elevation of extracellular D-glucose can directly promote vascular inflammation, which favors early proatherosclerotic events. Methods and Findings: In the present work, increasing extracellular D-glucose from 5.5 to 22 mmol/L was neither sufficient to induce intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression, analyzed by flow cytometry, nor to promote leukocyte adhesion to human umbilical vein endothelial cells (HUVEC) in vitro, measuredby flow chamber assays. Interestingly, the elevation of D-glucose levels potentiated ICAM-1 and VCAM-1 expression and leukocyte adhesion induced by a pro-inflammatory stimulus, such as interleukin (IL)-1b (5 ng/mL). In HUVEC, high D-glucose augmented the activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) and nuclear transcription factor-kB (NF-kB) elicited by IL-1b, measured by Western blot and electromobility shift assay (EMSA), respectively, but had no effect by itself. Both ERK 1/2 and NF-kB were necessary for VCAM-1 expression, but not for ICAM-1 expression. In vivo, leukocyte trafficking was evaluated in the rat mesenteric microcirculation by intravital microscopy. In accordance with the in vitro data, the acute intraperitoneal injection of D-glucose increased leukocyte rolling flux, adhesion and migration, but only when IL-1b was coadministered. Conclusions: These results indicate that the elevation of extracellular D-glucose levels is not sufficient to promote vascular inflammation, and they highlight the pivotal role of a pro-inflammatory environment in diabetes, as a critical factor conditioning the early pro-atherosclerotic actions of hyperglycemia.
Docta Complutense
Publication Artículo científico (JournalArticle)

Analysis of Candida albicans plasma membrane proteome

  • Cabezón, Virginia
  • Llama Palacios, María Arantxazu
  • Nombela Cano, César
  • Monteoliva Díaz, Lucía
  • Gil García, Concepción
The opportunistic human fungal pathogen Candida albicans causes a wide variety of infections including deep systemic syndromes. The C. albicans plasma membrane is an important interface in the host–pathogen relationship. The plasma membrane proteins mediate a variety of functions, including sensing and signalling to the external environment, in which the glycosylphosphatidylinositol (GPI)-anchored membrane proteins play a crucial role. A subproteomic approach to obtain a global picture of the protein composition of the C. albicans plasma membrane was developed, and different strategies were tested in order to extract the largest number of yeast plasma membrane proteins and GPI-anchored membrane proteins. These methods involved: (i) protoplast generation, (ii) mechanical disruption, (iii) ultracentrifugation in sucrose gradients, and (iv) Na2CO3 treatments. To isolate GPI-anchored proteins two additional steps were performed: two-phase separation and phosphatidylinositolphospholipase C treatment. After LC-MS/MS analysis using both a MALDI-TOF/TOF and a linear ion trap quadrupole, a total of 214 membrane proteins were identified, including 41 already described as plasma membrane proteins, 20 plasma membrane associated proteins, and 22 proteins with unknown membrane localisation. Bioinformatic analysis revealed that this set of C. albicans membrane proteins is highly enriched in proteins involved in biopolymer biosynthesis or transport processes. Furthermore, after phosphatidylinositol-phospholipase C treatment, 12 GPI-anchored membrane proteins were released and identified; most of them are associated with cell wall β-glucan synthesis and maintenance or are virulence factors, such as phospholipases or aspartyl proteinases.
Docta Complutense
Publication Artículo científico (JournalArticle)

HIV medical care interruption among people living with HIV in Spain, 2004-2020

  • Izquierdo, Rebeca
  • Rava, Marta
  • Moreno García, Estela
  • Blanco, José Ramón
  • Asensi, Víctor
  • Cervero, Miguel
  • Curran, Adrian
  • Rubio García, Rafael
  • Iribarren, José Antonio
  • Jarrín, Inmaculada
Objective: We estimated the incidence rate of HIV medical care interruption (MCI) and its evolution over a 16-year-period, and identified associated risk factors among HIV-positive individuals from the Cohort of the Spanish AIDS Research Network in 2004-2020. Design: We included antiretroviral-naive individuals aged at least 18 years at enrolment, recruited between January 1, 2004, and August 30, 2019, and followed-up until November 30, 2020. Methods: Individuals with any time interval of at least 15 months between two visits were defined as having a MCI. We calculated the incidence rate (IR) of having at least one MCI and used multivariable Poisson regression models to identify associated risk factors. Results: Of 15 274 individuals, 5481 (35.9%) had at least one MCI. Of those, 2536 (46.3%) returned to HIV care after MCI and 3753 (68.5%) were lost to follow-up at the end of the study period. The incidence rate (IR) of MCI was 7.2/100 person-years (py) [95% confidence interval (CI): 7.0-7.4]. The annual IR gradually decreased from 20.5/100 py (95% CI: 16.4-25.6) in 2004 to 4.9/100 py (95% CI: 4.4-5.5) in 2014, a slight increase was observed between 2015 and 2018, reaching 9.3/100 py (95% CI: 8.6-10.2) in 2019. Risk factors for MCI included younger age, lower educational level, having contracted HIV infection through injecting drug use or heterosexual intercourse, having been born outside of Spain, and CD4 + cell count >200 cell/μl, viral load <100 000 and co-infection with hepatitis C virus at enrolment. Conclusions: Around a third of individuals had at least one MCI during the follow-up. Identified predictors of MCI can help health workers to target and support most vulnerable individuals.
Docta Complutense
Publication Artículo científico (JournalArticle)

Spatially restricted JAG1-Notch signaling in human thymus provides suitable DC developmental niches

  • Martín Gayo, Enrique
  • González García, Sara
  • García León, María J.
  • Murcia Ceballos, Alba
  • Alcain, Juan
  • García Peydró, Marina
  • Allende Martínez, Luis Miguel
  • De Andrés, Belén
  • Gaspar, María L.
  • Toribio, María L.
A key unsolved question regarding the developmental origin of conventional and plasmacytoid dendritic cells (cdcs and pdcs, respectively) resident in the steady-state thymus is whether early thymic progenitors (EtPs) could escape t cell fate constraints imposed normally by a notch-inductive microenvironment and undergo dc development. By modeling dc generation in bulk and clonal cultures, we show here that Jagged1 (JAG1)-mediated notch signaling allows human EtPs to undertake a myeloid transcriptional program, resulting in GAtA2-dependent generation of cd34+ cd123+ progenitors with restricted pdc, cdc, and monocyte potential, whereas delta-like1 signaling down-regulates GAtA2 and impairs myeloid development. Progressive commitment to the dc lineage also occurs intrathymically, as myeloid-primed cd123+ monocyte/dc and common dc progenitors, equivalent to those previously identified in the bone marrow, are resident in the normal human thymus. the identification of a discrete JAG1+ thymic medullary niche enriched for dc-lineage cells expressing notch receptors further validates the human thymus as a dc-poietic organ, which provides selective microenvironments permissive for dc development.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of the Spanish smoke-free legislation on adult, non-smoker exposure to secondhand smoke, Cross-sectional surveys before (2004) and after (2012) legislation

  • Sureda, Xisca|||0000-0002-6262-2257
  • Martínez-Sánchez, José M.|||0000-0002-9632-5701
  • Fu, Marcela|||0000-0002-4962-0927
  • Pérez Ortuño, Raúl|||0000-0002-1837-5447
  • Martínez, Cristina|||0000-0002-9368-1356
  • Carabasa, Esther
  • López Medina, María José|||0000-0003-4402-2239
  • Saltó, Esteve|||0000-0002-6739-8936
  • Pascual, José A.|||0000-0003-0837-4026
  • Fernández, Esteve|||0000-0003-4239-723X
Background: In 2006, Spain implemented a national smoke-free legislation that prohibited smoking in enclosed public places and workplaces (except in hospitality venues). In 2011, it was extended to all hospitality venues and selected outdoor areas (hospital campuses, educational centers, and playgrounds). The objective of the study is to evaluate changes in exposure to secondhand smoke among the adult non-smoking population before the first law (2004-05) and after the second law (2011-12). Methods: Repeated cross-sectional survey (2004-2005 and 2011-2012) of a representative sample of the adult (≥16 years) non-smoking population in Barcelona, Spain. We assess self-reported exposure to secondhand smoke (at home, the workplace, during leisure time, and in public/private transportation vehicles) and salivary cotinine concentration. Results: Overall, the self-reported exposure to secondhand smoke fell from 75.7% (95%CI: 72.6 to 78.8) in 2004-05 to 56.7% (95%CI: 53.4 to 60.0) in 2011-12. Self-reported exposure decreased from 32.5% to 27.6% (215.1%, p<0.05) in the home, from 42.9% to 37.5% (212.6%, p = 0.11) at work/education venues, from 61.3% to 38.9% (236.5%, p<0.001) during leisure time, and from 12.3% to 3.7% (269.9%, p<0.001) in public transportation vehicles. Overall, the geometric mean of the salivary cotinine concentration in adult non-smokers fell by 87.2%, from 0.93 ng/mL at baseline to 0.12 ng/mL after legislation (p<0.001). Conclusions: Secondhand smoke exposure among non-smokers, assessed both by self-reported exposure and salivary cotinine concentration, decreased after the implementation of a stepwise, comprehensive smoke-free legislation. There was a high reduction in secondhand smoke exposure during leisure time and no displacement of secondhand smoke exposure at home. © 2014 Sureda et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells

  • Grotsky, David A.
  • Gonzalez-Suarez, Ignacio
  • Novell, Anna|||0000-0001-6619-8062
  • Neumann, Martin A.
  • Yaddanapudi, Sree C. S.
  • Croke, Monica R.
  • Martinez-Alonso, Montserrat|||0000-0003-1504-8552
  • Redwood, Abena B.
  • Ortega-Martinez, Sylvia
  • Feng, Zhihui
  • Lerma Puertas, Enrique|||0000-0001-7908-2747
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Zhang, Junran
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Dusso, Ariadna S.
  • Gonzalo, Susana
Loss of 53BP1 rescues BRCA1 deficiency and is associated with BRCA1-deficient and triple-negative breast cancers (TNBC) and with resistance to genotoxic drugs. The mechanisms responsible for decreased 53BP1 transcript and protein levels in tumors remain unknown. Here, we demonstrate that BRCA1 loss activates cathepsin L (CTSL)-mediated degradation of 53BP1. Activation of this pathway rescued homologous recombination repair and allowed BRCA1-deficient cells to bypass growth arrest. Importantly, depletion or inhibition of CTSL with vitamin D or specific inhibitors stabilized 53BP1 and increased genomic instability in response to radiation and poly(adenosine diphosphate-ribose) polymerase inhibitors, compromising proliferation. Analysis of human breast tumors identified nuclear CTSL as a positive biomarker for TNBC, which correlated inversely with 53BP1. Importantly, nuclear levels of CTSL, vitamin D receptor, and 53BP1 emerged as a novel triple biomarker signature for stratification of patients with BRCA1-mutated tumors and TNBC, with potential predictive valuefor drug response. We identify here a novel pathway with prospective relevance for diagnosis and customization of breast cancer therapy. © 2013 Grotsky et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Driving and legal status of Spanish opioid-dependent patients

  • Roncero, Carlos|||0000-0003-1421-7385
  • Álvarez, F.Javier
  • Barral, Carmen|||0000-0001-9963-6153
  • Gómez-Baeza, Susana
  • Gonzalvo, Begoña
  • Rodríguez-Cintas, Laia|||0000-0003-2703-6225
  • Brugal, María Teresa|||0000-0003-0580-676X
  • Jacas, Carlos|||0000-0002-7023-3657
  • Romaguera, Anna
  • Casas Brugué, Miquel|||0000-0003-3496-8522
Background: Opioid dependent patients have legal problems, driving violations and accidents more frequently than the general population. We have hypothesized that those patients currently driving may have better legal outcomes than those who do not possess a valid driving license. With this aim we have analyzed the information gathered in the PROTEUS study regarding the legal and driving statuses and assessed the possible association between them. The PROTEUS study was an observational, cross-sectional, descriptive, multicenter nationwide representative study, conducted in Spanish healthcare centers for opioid dependent patients.Findings: The driving and legal statuses of a population of opioid dependent patients ≥18 years and enrolled in Opioid Agonist Therapy treatment centers in Spain, were assessed using a short specific questionnaire and the EuropASI questionnaire to highlight distinct individual clinical needs. 621 patients were evaluable (84% men, 24.5% active workers). 321 patients (52%) drove on a regular basis. Nineteen percent of patients had some problem with the criminal justice system. There was a significant difference (p = 0.0433) in status, according to the criminal justice system, between patients who drove on a regular basis and those who did not, with a higher percentage of patients with non-pending charges among usual drivers.Conclusions: Regular drivers showed fewer legal problems than non-regular drivers, with the exception of those related to driving (driving violations and drunk driving). Driving is a good prognostic factor for the social integration of the patients and policies should be implemented to enable these patients to drive safely under medical authorization. The legal description will be useful to assess treatment efficacy. © 2013 Roncero et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

  • Couch, Ferguson J.
  • Wang, Xianshu
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Lee, Andrew J.
  • Olswold, Curtis L.
  • Kuchenbaecker, Karoline|||0000-0001-9726-603X
  • Soucy, Penny
  • Fredericksen, Z.
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Dennis, Joe G.
  • Gaudet, Mia M.
  • Dicks, Ed M.
  • Kosel, Matthew L.
  • Healey, Sue C.
  • Sinilnikova, Olga M.
  • Lee, Adam M.
  • Bacot, François
  • Vincent, Daniel
  • Hogervorst, Frans B. L.
  • Peock, Susan
  • Stoppa-Lyonnet, Dominique
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Radice, Paolo|||0000-0001-6298-4111
  • Schmutzler, Rita Katharina
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Piedmonte, Marion R.
  • Singer, Christian Fridolin
  • Friedman, Eitan A.
  • Thomassen, Mads
  • Hansen, Thomas Van Overeem
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Szabo, Csilla I.
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Greene, Mark H.|||0000-0003-1852-9239
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Garber, Judy Ellen
  • Phelan, Catherine M.
  • Weitzel, Jeffrey|||0000-0001-6714-092X
  • Montagna, Marco
  • Olah, Edith
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Yannoukakos, Drakoulis
  • Goldgar, David E.
  • Caldes, Trinidad
  • Nevanlinna, Heli A.
  • Osorio, Ana|||0000-0001-8124-3984
  • Terry, Mary Beth Eth
  • Daly, Mary Beryl
  • van Rensburg, Elizabeth J.|||0000-0003-2077-230X
  • Hamann, Ute|||0000-0001-6705-7624
  • Ramus, Susan J.|||0000-0003-0005-7798
  • Ewart Toland, Amanda
  • Caligo, Maria|||0000-0003-0589-1829
  • Olopade, Olufunmilayo Ibironke
  • Tung, Nadine M.
  • Claes, Kathleen|||0000-0003-0841-7372
  • Beattie, Mary Spanos
  • Southey, Melissa C.|||0000-0002-6313-9005
  • Imyanitov, Evgeny N.
  • Tischkowitz, Marc D.
  • Janavicius, Ramunas
  • John, Esther M.
  • Kwong, Ava
  • Diez, Orland|||0000-0001-7339-0570
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Barkardottir, Rósa Björk
  • Arun, Banu K.
  • Rennert, Gad|||0000-0002-8512-068X
  • Teo, Soo|||0000-0002-0444-590X
  • Ganz, Patricia|||0000-0002-1841-4143
  • Campbell, Ian|||0000-0002-7773-4155
  • van der Hout, Annemarie H.
  • van Deurzen, Carolien H. M.
  • Seynaeve, Caroline M.
  • Gómez Garcia, Encarna B.
  • van Leeuwen, Flora Elizabeth
  • Meijers-Heijboer, Hanne E. J.
  • Gille, Johan|||0000-0003-4526-298X
  • Ausems, Margreet G. E. M.
  • Blok, Marinus J.|||0000-0002-7935-5933
  • Ligtenberg, Marjolijn J. L.
  • Rookus, Matti A.
  • Devilee, Peter P.
  • Verhoef, Senno
  • van Os, Theo A. M.
  • Wijnen, Juul Th
  • Frost, Debra
  • Ellis, Steve D.
  • Fineberg, Elena
  • Platte, Radka
  • Evans, Gareth|||0000-0002-8482-5784
  • Izatt, Louise|||0000-0003-1258-4843
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Adlard, Julian|||0000-0002-1693-0435
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Cook, Jacqueline A.
  • Brewer, Carole M.
  • Douglas, Fiona S.
  • Hodgson, Shirley Victoria
  • Morrison, Pattrick|||0000-0002-2823-1762
  • Side, Lucy E.
  • Donaldson, Alan|||0000-0001-9193-4172
  • Houghton, Catherine
  • Rogers, Mark T.
  • Dorkins, Huw R.
  • Eason, Jacqueline
  • Gregory, Helen
  • McCann, Emma
  • Murray, Alex J.
  • Calender, Alain
  • Hardouin, Agnès
  • Berthet, Pascaline
  • Delnatte, Capucine
  • Nogues, Catherine
  • Lasset, Christine
  • Houdayer, Claude
  • Leroux, Dominique
  • Rouleau, Étienne L.
  • Prieur, Fabienne
  • Damiola, F.
  • Sobol, H.
  • Coupier, I.
  • Venat-Bouvet, L.
  • Castera, L.
  • Gauthier-Villars, M.
  • Léoné, M.
  • Pujol, P.
  • Mazoyer, S.
  • Bignon, Y.J.
  • Złowocka-Perłowska, E.
  • Gronwald, J.
  • Lubinski, J.
  • Durda, K.
  • Jaworska, K.
  • Huzarski, T.
  • Spurdle, A.B.
  • Peissel, B.
  • Bonanni, B.
  • Melloni, G.
  • Ottini, L.
  • Papi, L.
  • Varesco, L.
  • Tibiletti, M.G.
  • Peterlongo, P.
  • Volorio, S.
  • Manoukian, S.
  • Pensotti, V.
  • Arnold, N.
  • Engel, C.
  • Deissler, H.
  • Gadzicki, D.
  • Gehrig, A.
  • Kast, K.
  • Rhiem, K.
  • Meindl, A.
  • Niederacher, D.
  • Ditsch, N.
  • Plendl, H.
  • Preisler-Adams, S.
  • Engert, S.
  • Sutter, C.
  • Varon-Mateeva, Raymonda
  • Wappenschmidt, B.
  • Weber, B.H.F.
  • Arver, B.
  • Stenmark-Askmalm, M.
  • Loman, N.
  • Rosenquist, R.
  • Einbeigi, Z.
  • Nathanson, K.L.
  • Rebbeck, T.R.
  • Blank, S.V.
  • Cohn, D.E.
  • Rodriguez, G.C.
  • Small, L.
  • Friedländer, Marc R.
  • Bae-Jump, V.L.
  • Fink-Retter, A.
  • Rappaport, C.
  • Gschwantler-Kaulich, D.
  • Pfeiler, G.
  • Tea, M.K.
  • Lindor, N.M.
  • Kaufman, B.
  • Shimon Paluch, S.
  • Laitman, Y.
  • Skytte, A.B.
  • Gerdes, A.M.
  • Pedersen, I.S.
  • Moeller, S.T.
  • Kruse, T.A.
  • Jensen, U.B.
  • Vijai, J.
  • Sarrel, K.
  • Robson, M.
  • Kauff, N.
  • Mulligan, A.M.
  • Glendon, G.
  • Ozcelik, H.
  • Ejlertsen, B.
  • Nielsen, F.C.
  • Jønson, L.
  • Andersen, M.K.
  • Ding, Y.C.
  • Steele, L.
  • Foretova, L.
  • Teule, Alex|||0000-0003-0028-7200
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Brunet, Joan|||0000-0003-1945-3512
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Mai, P.L.
  • Loud, J.T.
  • Walsh, C.
  • Lester, J.
  • Orsulic, S.
  • Narod, Steven A.
  • Herzog, J.
  • Sand, S.R.
  • Tognazzo, S.
  • Agata, Simona
  • Vaszkó, Tibor
  • Weaver, J.
  • Stavropoulou, A.V.
  • Buys, S.S.
  • Romero, A.
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • Aittomäki, K.
  • Muranen, T.A.
  • Durán, Mercedes|||0000-0002-6301-9732
  • Chung, W.K.
  • Lasa, Adriana|||0000-0001-9957-9646
  • Dorfling, C.M.
  • Miron, A.
  • Benitez, J.
  • Senter, L.
  • Huo, D.
  • Chan, S.B.
  • Sokolenko, A.P.
  • Chiquette, J.
  • Tihomirova, L.
  • Friebel, T.M.
  • Agnarsson, Bjarni A.
  • Lu, K.H.
  • Lejbkowicz, F.
  • James, Paul|||0000-0002-4361-4657
  • Hall, P.
  • Dunning, A.M.
  • Tessier, Daniel C.
  • Cunningham, Julie M.
  • Slager, S.L.
  • Wang, C.
  • Hart, S.
  • Stevens, Kristen
  • Simard, J.
  • Pastinen, T.
  • Pankratz, V.S.
  • Offit, K.
  • Easton, D.F.
  • Chenevix-Trench, G.
  • Antoniou, A.C.
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a multi-stage GWAS of 11,705 BRCA1 carriers (of whom 5,920 were diagnosed with breast and 1,839 were diagnosed with ovarian cancer), with a further replication in an additional sample of 2,646 BRCA1 carriers. We identified a novel breast cancer risk modifier locus at 1q32 for BRCA1 carriers (rs2290854, P = 2.7×10, HR = 1.14, 95% CI: 1.09-1.20). In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4×10, HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4×10, HR = 1.20, 95% CI: 1.17-1.38). The 4q32.3 locus was not associated with ovarian cancer risk in the general population or BRCA2 carriers, suggesting a BRCA1-specific association. The 17q21.31 locus was also associated with ovarian cancer risk in 8,211 BRCA2 carriers (P = 2×10). These loci may lead to an improved understanding of the etiology of breast and ovarian tumors in BRCA1 carriers. Based on the joint distribution of the known BRCA1 breast cancer risk-modifying loci, we estimated that the breast cancer lifetime risks for the 5% of BRCA1 carriers at lowest risk are 28%-50% compared to 81%-100% for the 5% at highest risk. Similarly, based on the known ovarian cancer risk-modifying loci, the 5% of BRCA1 carriers at lowest risk have an estimated lifetime risk of developing ovarian cancer of 28% or lower, whereas the 5% at highest risk will have a risk of 63% or higher. Such differences in risk may have important implications for risk prediction and clinical management for BRCA1 carriers. © 2013 Couch et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of Antithrombin-Modulating Genes. Role of LARGE, a Gene Encoding a Bifunctional Glycosyltransferase, in the Secretion of Proteins?

  • de la Morena-Barrio, María Eugenia
  • Buil, Alfonso|||0000-0002-3097-1014
  • Antón, Ana Isabel
  • Martínez-Martínez, Irene
  • Miñano, Antonia
  • Gutiérrez-Gallego, Ricardo
  • Navarro-Fernández, José
  • Aguila, Sonia
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Vicente, Vicente
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Corral de la Calle, Javier
The haemostatic relevance of antithrombin together with the low genetic variability of SERPINC1, and the high heritability of plasma levels encourage the search for modulating genes. We used a hypothesis-free approach to identify these genes, evaluating associations between plasma antithrombin and 307,984 polymorphisms in the GAIT study (352 individuals from 21 Spanish families). Despite no SNP reaching the genome wide significance threshold, we verified milder positive associations in 307 blood donors from a different cohort. This validation study suggested LARGE, a gene encoding a protein with xylosyltransferase and glucuronyltransferase activities that forms heparin-like linear polysaccharides, as a potential modulator of antithrombin based on the significant association of one SNPs, rs762057, with anti-FXa activity, particularly after adjustment for age, sex and SERPINC1 rs2227589 genotype, all factors influencing antithrombin levels (p = 0.02). Additional results sustained this association. LARGE silencing inHepG2 and HEK-EBNA cells did not affect SERPINC1 mRNA levels but significantly reduced the secretion of antithrombin with moderate intracellular retention. Milder effects were observed on α1-antitrypsin, prothrombin and transferrin. Our study suggests LARGE as the first known modifier of plasma antithrombin, and proposes a new role for LARGE in modulating extracellular secretion of certain glycoproteins. © 2013 de la Morena-Barrio et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low density lipoprotein receptor-related protein 1 expression correlates with cholesteryl ester accumulation in the myocardium of ischemic cardiomyopathy patients

  • Cal, Roi
  • Juan-Babot, Oriol|||0000-0002-4328-0335
  • Brossa, Vicenç
  • Roura, Santiago|||0000-0003-4063-9661
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Portoles, Manolo
  • Rivera, Miguel
  • Cinca, Juan|||0000-0003-4819-4265
  • Badimon, Lina|||0000-0002-9162-2459
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Our hypothesis was that overexpression of certain lipoprotein receptors might be related to lipid accumulation in the human ischemic myocardium. Intramyocardial lipid overload contributes to contractile dysfunction and arrhythmias in cardiomyopathy. Thus, the purpose of this study was to assess the effect of hypercholesterolemic LDL and hypertrigliceridemic VLDL dose on LRP1 expression in cardiomyocytes, as well as the potential correlation between LRP1 expression and neutral lipid accumulation in the left ventricle tissue from ischemic cardiomyopathy patients. Cell culture experiments include control and LRP1-deficient cardiomyocytes exposed to lipoproteins under normoxic and hypoxic conditions. Explanted hearts from 18 ICM patients and eight non-diseased hearts (CNT) were included. Low density lipoprotein receptor-related protein 1 (LRP1), very low density lipoprotein receptor (VLDLR) and low density lipoprotein receptor (LDLR) expression was analyzed by real time PCR and Western blotting. Cholesteryl ester (CE), triglyceride (TG) and free cholesterol (FC) content was assess by thin layer chromatography following lipid extraction. Western blotting experiments showed that protein levels of LRP1, VLDLR and HIF-1α were significantly upregulated in ischemic hearts. Immunohistochemistry and confocal microscopy analysis showed that LRP1 and HIF-1α were upregulated in cardiomyocytes of ICM patients. In vitro studies showed that VLDL, LDL and hypoxia exerted an upregulatory effect on LRP1 expression and that LRP1 played a major role in cholesteryl ester accumulation from lipoproteins in cardiomyocytes. Myocardial CE accumulation strongly correlated with LRP1 levels in ischemic hearts. Taken together, our results suggest that LRP1 upregulation is key for myocardial cholesterol ester accumulation in ischemic human hearts and that LRP1 may be a target to prevent the deleterious effects of myocardial cholesterol accumulation in ischemic cardiomyopathy. © 2012 Cal et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Decreased pre-surgical CD34 +/CD144 + cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients

  • Redondo, Santiago
  • González-Rocafort, Álvaro
  • Navarro-Dorado, Jorge
  • Ramajo, Marta
  • Hristov, Mihail
  • Gordillo-Moscoso, Antonio
  • Reguillo, Fernando
  • Carnero-Alcázar, Manuel|||0000-0001-5045-5765
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Enrique
  • Weber, Christian
  • Tejerina, Teresa
Background: Cardiovascular disease has been linked to endothelial progenitor cell (EPC) depletion and functional impairment in atherosclerosis and aortic stenosis. EPCs may play a pivotal role in vascular grafting. However, the EPC depletion in coronary artery bypass grafting (CABG) patients has not been compared to coronary artery disease-free valvular replacement patients with aortic stenosis.Methods: We aimed to assess the basal number of CD34 /KDR and CD34 /CD144 cells in CABG patients, compared to aortic stenosis valvular replacement patients. 100 patients (51 CABG and 49 valvular surgery ones) were included in the present study. All CABG or valvular patients had angiographic demonstration of the presence or the absence of coronary artery disease, respectively. Numbers of CD34 /KDR and CD34 /CD144 were assessed by flow cytometry of pre-surgical blood samples.Results: We found a lower number of CD34 /CD144 cells in CABG patients compared to valvular patients (0.21 ± 0.03% vs. 0.47 ± 0.08%), and this difference remained statistically significant after the P was adjusted for multiple comparisons (P = 0.01428). Both groups had more EPCs than healthy controls.Conclusions: Pre-surgical CD34 /CD144 numbers are decreased in CABG patients, compared to valvular patients with absence of coronary disease. © 2012 Redondo et al; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-faecalis and Non-faecium Enterococcal Isolates With/Without VanC Phenotype, Clinical Implications for Infective Endocarditis

  • García-González, Javier
  • Cañas, María Alexandra|||0000-0002-0521-7204
  • Cuervo, Guillermo|||0000-0002-7075-943X
  • Hernández Meneses, Marta|||0000-0001-9991-1127
  • Verdejo, Miguel Ángel|||0000-0001-7870-0515
  • Bodro, Marta|||0000-0002-0520-8279
  • Díez de los Ríos, Javier
  • Gasch, Oriol|||0000-0001-8518-458X
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Falces, Carles|||0000-0002-3483-3786
  • Perissinotti, Andrés|||0000-0003-4190-2425
  • Vidal, Bárbara
  • Quintana, Eduard|||0000-0002-5386-7463
  • Moreno Camacho, Asunción|||0000-0001-6382-0039
  • Piquet, Maria
  • Roca, Ignasi|||0000-0002-1800-1576
  • Fernandez-Pittol, Mariana|||0000-0002-1685-7127
  • San José-Villar, Sol M.
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Miró, José M.|||0000-0001-8057-7755
(1) Background: Alternative antibiotics are needed to treat infective endocarditis (IE) caused by non-faecalis/non-faecium enterococci; we aimed to assess the in vitro activity of ampicillin plus ceftriaxone (AMP + CTR) against these enterococci and to describe its clinical efficacy in IE cases. (2) Methods: Time-kill curves with standard (ISI) and high (IHI) inocula were performed to test VanC isolates [3 E. casseliflavus (ECAS) and 1 E. gallinarum (EGALL)] and non-VanC isolates [1 E. durans (EDUR), 1 E. hirae (EHIR) and 1 E. raffinosus (ERAF)]. The narrative literature review of IE cases treated with AMP + CTR was analyzed alongside three study cases. Clinical outcomes were relapse and death. (3) Results: Ampicillin plus gentamicin (AMP + GEN) showed synergistic and bactericidal activity against most isolates. AMP + CTR was synergistic at ISI for EGALL, EDUR, and EHIR and bactericidal against EHIR. At IHI, indifferent activity was observed for all isolates. In IE cases treated with AMP + CTR, it was only effective for EDUR and EHIR. Clinical information for EGALL IE is lacking. For IE caused by ECAS and ERAF, AMP + CTR seems suboptimal or ineffective, respectively. (4) AMP + CTR cannot be recommended for treating IE due to ECAS/ERAF. In contrast, this combination was effective in IE caused by EDUR/EHIR and could be recommended.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

  • Maxwell, Christopher|||0000-0002-0713-7136
  • Benítez, Javier J.
  • Gómez-Baldó, Laia
  • Osorio, Ana|||0000-0001-8124-3984
  • Bonifaci, Núria|||0000-0002-8193-6825
  • Fernández-Ramires, Ricardo|||0000-0002-6974-2593
  • Costes, Sylvain|||0000-0002-8542-2389
  • Guinó, Elisabet|||0000-0003-0093-2652
  • Chen, Helen
  • Evans, Gareth|||0000-0002-8482-5784
  • Mohan, Pooja
  • Català, Isabel
  • Petit Montserrat, Anna|||0000-0002-9284-095X
  • Aguilar, Helena
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Aytes, Alvaro|||0000-0003-0725-5340
  • Serra-Musach, Jordi
  • Rennert, Gad|||0000-0002-8512-068X
  • Lejbkowicz, Flavio|||0000-0001-5718-0418
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Manoukian, Siranoush
  • Peissel, Bernard|||0000-0001-9233-3571
  • Ripamonti, Carla Barbara|||0000-0002-2892-8164
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Viel, Alessandra|||0000-0003-2804-0840
  • Allavena, Anna
  • Bernard, Loris
  • Radice, Paolo|||0000-0001-6298-4111
  • Friedman, Eitan|||0000-0002-6745-1733
  • Kaufman, Bella
  • Laitman, Yael
  • Dubrovsky, Maya
  • Milgrom, Roni
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Cybulski, Cezary|||0000-0002-2819-3057
  • Gorski, Bohdan
  • Jaworska, Katarzyna
  • Durda, Katarzyna
  • Sukiennicki, Grzegorz
  • Lubinski, Jan|||0000-0003-2931-3003
  • Shugart, Yin Yao
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Letrero, Richard
  • Weber, Barbara L.
  • Hogervorst, Frans B. L.
  • Rookus, Matti A.
  • Collee, J. Magriet
  • Devilee, Peter|||0000-0002-8023-2009
  • Ligtenberg, Marjolijn J.
  • van der Luijt, Rob|||0000-0002-0018-1089
  • Aalfs, Cora M.
  • Waisfisz, Quinten|||0000-0002-7384-9182
  • Wijnen, Juul
  • van Roozendaal, Cornelis E. P.
  • HEBON, None
  • EMBRACE, None
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Peock, Susan
  • Cook, Margaret
  • Oliver, Clare
  • Frost, Debra
  • Harrington, Patricia
  • Lalloo, Fiona
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Izatt, Louise|||0000-0003-1258-4843
  • Chu, Carol
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Douglas, Fiona
  • Brewer, Carole
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Heikkinen, Tuomas|||0000-0003-1154-6204
  • Couch, Fergus J.
  • Wang, Xianshu
  • Lindor, Noralane M.
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Caligo, Maria|||0000-0003-0589-1829
  • Lombardi, Grazia
  • Loman, Niklas
  • Karlsson, Per
  • Ehrencrona, Hans|||0000-0002-5589-3622
  • von Wachenfeldt, Anna
  • SWE-BRCA, None
  • Barkardottir, Rosa
  • Hamann, Ute|||0000-0001-6705-7624
  • Rashid, Muhammad U.|||0000-0002-7684-3122
  • Lasa, Adriana|||0000-0001-9957-9646
  • Caldes, Trinidad
  • Andrés Conejero, Raquel
  • Schmitt, Michael
  • Assmann, Volker
  • Stevens, Kristen
  • Offit, Kenneth
  • Curado, João
  • Tilgner, Hagen U.|||0000-0002-7058-3606
  • Guigó, Roderic|||0000-0002-5738-4477
  • Aiza, Gemma|||0000-0001-8654-3724
  • Brunet, Joan|||0000-0003-1945-3512
  • Castellsagué, Joan|||0000-0002-2579-3137
  • Martrat, Griselda
  • Urruticoechea, Ander|||0000-0003-0359-3641
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Tihomirova, L.
  • Goldgar, D. E.
  • Buys, S.
  • John, Esther M.
  • Miron, A.
  • Southey, M.
  • Daly, M.B.
  • BCFR, None
  • Schmutzler, R.K.
  • Wappenschmidt, B.
  • Meindl, A.
  • Arnold, N.
  • Deissler, H.
  • Varon-Mateeva, Raymonda
  • Sutter, C.
  • Niederacher, D.
  • Imyamitov, E.
  • Sinilnikova, O.M.
  • Stoppa-Lyonne, D.
  • Mazoyer, S.
  • Verny-Pierre, C.
  • Castera, L.
  • de Pauw, A.
  • Bignon, Y.J.
  • Uhrhammer, N.
  • Peyrat, J.P.
  • Vennin, P.
  • Ferrer, S.
  • Collonge-Rame, M.A.
  • Mortemousque, I.
  • GEMO Study Collaborators, None
  • Spurdle, A.B.
  • Beesley, J.
  • Chen, X.
  • Healey, S.
  • Barcellos-Hoff, M.H.
  • Gruber, S.B.
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Capella, Gabriel|||0000-0002-4669-7320
  • McGuffog, L.
  • Antoniou, A.C.
  • Chenevix-Trench, G.
  • Fleisch, M.C.
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Pujana, Miguel Angel|||0000-0003-3222-4044
Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio (<inf.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Emerging therapeutic strategies to enhance HDL function

  • Redondo, Santiago
  • Martínez-González, José|||0000-0002-3894-7166
  • Urraca, C.
  • Tejerina, T.
Abstract. Epidemiologic studies indicate a strong inverse correlation between plasma levels of high-density lipoproteins (HDL) and cardiovascular disease (CVD). The most relevant cardioprotective mechanism mediated by HDL is thought to be reverse cholesterol transport (RCT). New insights in HDL biology and RCT have allowed the development of promising agents aimed to increase HDL function and promote atherosclerosis regression. In this regard, apo-AI analogs and CETP inhibitors dalcetrapib and anacetrapib have aroused a great interest and opened new expectations in the treatment of CVD. © 2011 Redondo et al; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Premature Neuroimmune and Redox-Inflammatory Breakdown at the Prodromal Stage in Male and Female Triple-Transgenic Alzheimer's Disease Mice

  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • Vida, Carmen|||0000-0002-0942-8076
  • Félix, Judith|||0000-0003-3319-7623
  • Quer-Palomas, Silvia|||0000-0002-4007-8617
  • Fuente, Monica de la|||0000-0002-5969-097X
  • Manassra, Rashed
Background/Objectives: Homeostatic (nervous, immune and endocrine) systems and their communications network are crucial for health and aging rate. We previously reported behavioral and peritoneal leukocyte function alterations and oxidative-inflammatory stress in young female triple-transgenic (3xTg) mice for Alzheimer's disease (AD). Here, the deterioration of the homeostatic systems and their interplay was investigated, in an integrated way, at prodromal stages and in both sexes of 3xTg-AD mice. Methods: An integrative analysis of the behavioral profile, peripheral immune splenic and thymic leukocyte functions, splenic oxidative-inflammatory state, and plasmatic corticosterone in both sexes of 3xTg-AD mice at 4 months of age was compared to that of age- and sex-matched NTg counterparts. Results: The prodromal stage of 3xTg-AD, characterized by anxiety-like behaviors and disrupted exploration, was aligned with reduced chemotaxis, natural killer activity, and lymphoproliferation-especially in the spleen. In addition, 3xTg-AD mice exhibited lower anti-inflammatory (IL-10) and higher pro-inflammatory (IL-2, IL-1β, and TNF-α) cytokine concentrations and oxidative stress (higher oxidants and lower antioxidants). Several of these alterations displayed sex-dependent differences (worse in males). However, no differences in corticosterone were found. Conclusions: These findings suggest that neuroimmune and redox-inflammatory dysfunctions, indicative of premature aging, emerge at the prodromal stage of AD, preceding corticosterone changes, unveiling a time lag in the neuroimmunoendocrine alterations in these animals. They may act as early indicators of premature aging in AD pathology and provide potential targets for sex-specific prodromal intervention.
Repisalud
Publication Artículo científico (JournalArticle)

Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings

  • Trickey, Adam
  • van Sighem, Ard
  • Stover, John
  • Abgrall, Sophie
  • Grabar, Sophie
  • Bonnet, Fabrice
  • Berenguer, Juan
  • Wyen, Christoph
  • Casabona, Jordi
  • d'Arminio Monforte, Antonella
  • Cavassini, Matthias
  • Amo, Julia del
  • Zangerle, Robert
  • Gill, M John
  • Obel, Niels
  • Sterne, Jonathan A C
  • May, Margaret T
Introduction: HIV cohort data from high-income European countries were compared with the UNAIDS Spectrum modelling parameters for these same countries to validate mortality rates and excess mortality estimates for people living with HIV (PLHIV) on antiretroviral therapy (ART). Methods: Data from 2000 to 2015 were analysed from the Antiretroviral Therapy Cohort Collaboration (ART-CC) for Austria, Denmark, France, Italy, the Netherlands, Spain, and Switzerland. Flexible parametric models were used to compare all-cause mortality rates in the ART-CC and Spectrum. The percentage of AIDS-related deaths and excess mortality (both are the same within Spectrum) were compared, with excess mortality defined as that in excess of the general population mortality. Results: Analyses included 94 026 PLHIV with 585 784 person-years of follow-up, from which there were 5515 deaths. All-cause annual mortality rates in Spectrum for 2000-2003 were 0.0121, reducing to 0.0078 in 2012-2015, whilst the ART-CC's corresponding annual mortality rates were 0.0151 [95% confidence interval (95% CI): 0.0130-0.0171] reducing to 0.0049 (95% CI: 0.0039-0.0060). The percentage of AIDS-related deaths in Spectrum was 74.7% in 2000-2003, dropping to 43.6% in 2012-2015. In the ART-CC, AIDS-related mortality constitutes 45.3% (95% CI: 38.4-52.9%) of mortality in 2000-2003 and 26.7% (95% CI: 19-46%) between 2012 and 2015. Excess mortality in the ART-CC was broadly similar to the Spectrum estimates, dropping from 75.3% (95% CI: 60.3-95.2%) in 2000-2003 to 30.7% (95% CI: 25.5-63.7%) in 2012-2015. Conclusion: All-cause mortality assumptions for PLHIV on ART in high-income European settings should be adjusted in Spectrum to be higher in 2000-2003 and decline more quickly to levels currently captured for recent years.
Repisalud
Publication Artículo científico (JournalArticle)

Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.

  • Hernando Sebastian, Victoria
  • Cuevas, Maria Teresa
  • Perez-Olmeda, Mayte
  • Tasias, Maria
  • Vera, Mar
  • Jaen, Angels
  • Mena, Alvaro
  • Jarrin Vera, Inmaculada
  • Diaz Franco, Asuncion
  • CoRIS-HIV Biobank
Background: To estimate the prevalence of recent infection (RI) among people newly diagnosed with HIV in Spain using a representative sample collected by the AIDS Research Network cohort (CoRIS) during 2015-2016. Methods: Stratified sampling of CoRIS data was used with proportional allocation by mode of transmission of new HIV diagnoses notified to National Surveillance System. Samples used were from patients in the CoRIS cohort with available stored plasma collected within 6 months after diagnosis. Weighted methods were used to estimate the prevalence of RI and multivariate logistic regression models were used to determine associated factors. Results: Of the 669 individuals included, 55.1% were men who had sex with men (MSM), 24.6% were heterosexual, and 20.3% were non-MSM non-heterosexual. The weighted prevalence of RI was 11.8% (95% Confidence interval [CI] 9.4-14.8%) overall, 15.5% (12.2-19.4%) among MSM, 6.3% (3.9-10.0%) among heterosexual, and 8.6% (3.2-20.9%) in non-MSM non-heterosexual persons. Factors associated with prevalence of RI were: MSM (OR 2.05; 95% CI 1.02-4.14) vs. heterosexual, being Spanish (OR 2.92; 1.36-6.26) or European (OR 3.42; 1.28-9.13) vs. Latin American, having a secondary or higher education level (OR 3.08; 0.95-1.00) vs. primary, and having a CD4 count of 350-499 (OR 3.26; 1.46-7.30) or >500 (OR 6.26; 2.92-13.39) vs. <350 cells/mm3. Conclusions: In the absence of direct data from surveillance systems, the use of cohort data is a very valuable option for identifying the prevalence of RI at national level. This is the first nationwide study carried out in Spain to determine the prevalence of RI using an avidity assay.
Repisalud
Publication Artículo científico (JournalArticle)

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

  • Mateo, F
  • Arenas, E J
  • Aguilar, H
  • Serra-Musach, J
  • de Garibay, G Ruiz
  • Boni, J
  • Maicas, M
  • Du, S
  • Iorio, F
  • Herranz-Ors, C
  • Islam, A
  • Prado, X
  • Llorente, A
  • Petit, A
  • Vidal, A
  • Català, I
  • Soler, T
  • Venturas, G
  • Rojo-Sebastian, A
  • Serra, H
  • Cuadras, D
  • Blanco, I
  • Lozano, J
  • Canals, F
  • Sieuwerts, A M
  • de Weerd, V
  • Look, M P
  • Puertas, S
  • García, N
  • Perkins, A S
  • Bonifaci, N
  • Skowron, M
  • Gómez-Baldó, L
  • Hernández, V
  • Martínez-Aranda, A
  • Martínez-Iniesta, M
  • Serrat, X
  • Cerón, J
  • Brunet, J
  • Barretina, M P
  • Gil, M
  • Falo, C
  • Fernández, A
  • Morilla, I
  • Pernas, S
  • Plà, M J
  • Andreu, X
  • Seguí, M A
  • Ballester, R
  • Castellà, E
  • Nellist, M
  • Morales, S
  • Valls, J
  • Velasco, A
  • Matias-Guiu, X
  • Figueras, A
  • Sánchez-Mut, J V
  • Sánchez-Céspedes, M
  • Cordero, A
  • Gómez-Miragaya, J
  • Palomero, L
  • Gómez, A
  • Gajewski, T F
  • Cohen, E E W
  • Jesiotr, M
  • Bodnar, L
  • Quintela-Fandino, M
  • López-Bigas, N
  • Valdés-Mas, R
  • Puente, X S
  • Viñals, F
  • Casanovas, O
  • Graupera, M
  • Hernández-Losa, J
  • Ramón Y Cajal, S
  • García-Alonso, L
  • Saez-Rodriguez, J
  • Esteller, M
  • Sierra, A
  • Martín-Martín, N
  • Matheu, A
  • Carracedo, A
  • González-Suárez, E
  • Nanjundan, M
  • Cortés, J
  • Lázaro, C
  • Odero, M D
  • Martens, J W M
  • Moreno-Bueno, G
  • Barcellos-Hoff, M H
  • Villanueva, A
  • Gomis, R R
  • Pujana, M A
Inhibitors of the mechanistic target of rapamycin (mTOR) are currently used to treat advanced metastatic breast cancer. However, whether an aggressive phenotype is sustained through adaptation or resistance to mTOR inhibition remains unknown. Here, complementary studies in human tumors, cancer models and cell lines reveal transcriptional reprogramming that supports metastasis in response to mTOR inhibition. This cancer feature is driven by EVI1 and SOX9. EVI1 functionally cooperates with and positively regulates SOX9, and promotes the transcriptional upregulation of key mTOR pathway components (REHB and RAPTOR) and of lung metastasis mediators (FSCN1 and SPARC). The expression of EVI1 and SOX9 is associated with stem cell-like and metastasis signatures, and their depletion impairs the metastatic potential of breast cancer cells. These results establish the mechanistic link between resistance to mTOR inhibition and cancer metastatic potential, thus enhancing our understanding of mTOR targeting failure.
Repisalud
Publication Carta al director (LetterToTheEditor)

PorB2/3 protein hybrid in Neisseria meningitidis

Repisalud
Publication Artículo científico (JournalArticle)

Essential role of p18Hamlet/SRCAP-mediated histone H2A.Z chromatin incorporation in muscle differentiation.

  • Cuadrado Garcia, Ana
  • Corrado, Nadia
  • Perdiguero, Eusebio
  • Lafarga, Vanesa
  • Muñoz-Canoves, Pura
  • Nebreda, Angel R
The chromatin-remodelling complex SNF2-related CBP activator protein (SRCAP) regulates chromatin structure in yeast by modulating the exchange of histone H2A for the H2A.Z variant. Here, we have investigated the contribution of H2A.Z-mediated chromatin remodelling to mammalian cell differentiation reprogramming. We show that the SRCAP subunit named ZNHIT1 or p18(Hamlet), which is a substrate of p38 MAPK, is recruited to the myogenin promoter at the onset of muscle differentiation, in a p38 MAPK-dependent manner. We also show that p18(Hamlet) is required for H2A.Z accumulation into this genomic region and for subsequent muscle gene transcriptional activation. Accordingly, downregulation of several subunits or the SRCAP complex impairs muscle gene expression. These results identify SRCAP/H2A.Z-mediated chromatin remodelling as a key early event in muscle differentiation-specific gene expression. We also propose a mechanism by which p38 MAPK-mediated signals are converted into chromatin structural changes, thereby facilitating transcriptional activation during mammalian cell differentiation.
Repisalud
Publication Artículo científico (JournalArticle)

Regulation of CBP and Tip60 coordinates histone acetylation at local and global levels during Ras-induced transformation.

  • Sánchez-Molina, Sara
  • Estarás, Conchi
  • Oliva-Martinez, Jose Luis
  • Akizu, Naiara
  • Asensio-Juan, Elena
  • Rojas-Cabañeros, Jose Maria
  • Martínez-Balbás, Marian A
Cell transformation is clearly linked to epigenetic changes. However, the role of the histone-modifying enzymes in this process is still poorly understood. In this study, we investigated the contribution of the histone acetyltransferase (HAT) enzymes to Ras-mediated transformation. Our results demonstrated that lysine acetyltransferase 5, also known as Tip60, facilitates histone acetylation of bulk chromatin in Ras-transformed cells. As a consequence, global H4 acetylation (H4K8ac and H4K12ac) increases in Ras-transformed cells, rendering a more decompacted chromatin than in parental cells. Furthermore, low levels of CREB-binding protein (CBP) lead to hypoacetylation of retinoblastoma 1 (Rb1) and cyclin-dependent kinase inhibitor 1B (Cdkn1b or p27Kip1) tumour suppressor gene promoters to facilitate Ras-mediated transformation. In agreement with these data, overexpression of Cbp counteracts Ras transforming capability in a HAT-dependent manner. Altogether our results indicate that CBP and Tip60 coordinate histone acetylation at both local and global levels to facilitate Ras-induced transformation.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mechanisms of Fractionated Electrograms Formation in the Posterior Left Atrium During Paroxysmal Atrial Fibrillation in Humans

  • Atienza, Felipe
  • Calvo, David
  • Almendral, Jesús
  • Zlochiver, Sharon
  • Grzeda, Krzysztof R.
  • González-Torrecilla, Esteban
  • Arenal, Ángel
  • Fernández-Avilés, Francisco
  • Berenfeld, Omer
  • Martínez Alzamora, Mª Nieves|||0000-0002-8305-7963
Objectives: The aim of this paper was to study mechanisms of formation of fractionated electrograms on the posterior left atrial wall (PLAW) in human paroxysmal atrial fibrillation (AF). Background: The mechanisms responsible for complex fractionated atrial electrogram formation during AF are poorly understood. Methods: In 24 patients, we induced sustained AF by pacing from a pulmonary vein. We analyzed transitions between organized patterns and changes in electrogram morphology leading to fractionation in relation to interbeat interval duration (systolic interval [SI]) and dominant frequency. Computer simulations of rotors helped in the interpretation of the results. Results: Organized patterns were recorded 31 ± 18% of the time. In 47% of organized patterns, the electrograms and PLAW activation sequence were similar to those of incoming waves during pulmonary vein stimulation that induced AF. Transitions to fractionation were preceded by significant increases in electrogram duration, spike number, and SI shortening (R 2 = 0.94). Similarly, adenosine infusion during organized patterns caused significant SI shortening leading to fractionated electrograms formation. Activation maps during organization showed incoming wave patterns, with earliest activation located closest to the highest dominant frequency site. Activation maps during transitions to fragmentation showed areas of slowed conduction and unidirectional block. Simulations predicted that SI abbreviation that heralds fractionated electrograms formation might result from a Doppler effect on wave fronts preceding an approaching rotor or by acceleration of a stationary or meandering, remotely located source. Conclusions: During induced AF, SI shortening after either drift or acceleration of a source results in intermittent fibrillatory conduction and formation of fractionated electrograms at the PLAW, This work was supported in part by grants from the Spanish Society of Cardiology (to Dr. Calvo); National Heart, Lung, and Blood Institute Grants P01-HL039707, P01-HL87226, and R01-HL060843 (to Dr. Berenfeld); and the Ministerio de Ciencia e Innovacion, Red RECAVA (to Drs. Atienza, Gonzalez-Torrecilla, Arenal, and Fernandez-Aviles) and the Centro Nacional de Investigaciones Cardiovasculares (proyecto CNIC-13) (to Drs. Atienza, Almendral, Gonzalez-Torrecilla, and Berenfeld). Dr. Atienza has served on the advisory board of and received lecture fees from Medtronic; and has received research funding from St. Jude Medical Spain. Dr. Berenfeld has received a research grant from St. Jude Medical. All other authors have reported that they have no relationships to disclose. Drs. Atienza and Calvo contributed equally to this work.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

High-rate pacing-induced atrial fibrillation effectively reveals properties of spontaneously occurring paroxysmal atrial fibrillation in humans

  • Calvo, David
  • Atienza, Felipe
  • Jalife, José
  • Bravo, Loreto
  • Almendral Garrote, Jesús
  • González-Torrecilla, Esteban
  • Arenal, Ángel
  • Bermejo, Javier
  • Fernández-Avilés, Francisco
  • Berenfeld, Omer
  • Martínez Alzamora, Mª Nieves|||0000-0002-8305-7963
Aims Research on paroxysmal atrial fibrillation (AF) assumes that fibrillation induced by rapid pacing adequately reproduces spontaneously occurring paroxysmal AF in humans. We aimed to compare the spectral properties of spontaneous vs. induced AF episodes in paroxysmal AF patients. Methods and results Eighty-five paroxysmal AF patients arriving in sinus rhythm to the electrophysiology laboratory were evaluated prior to ablation. Atrial fibrillation was induced by rapid pacing from the pulmonary vein-left atrial junctions (PV-LAJ), the coronary sinus (CS), or the high right atrium (HRA). Simultaneous recordings were obtained using multipolar catheters. Off-line power spectral analysis of 5 s bipolar electrograms was used to determine dominant frequency (DF) at recording sites with regularity index 0.2. Sixty-eight episodes were analysed for DF. Comparisons were made between spontaneous (n = 23) and induced (n = 45) AF episodes at each recording site. No significant differences were observed between spontaneous and induced AF episodes in HRA (5.18 +/- 0.69 vs. 5.06 +/- 0.91 Hz; P = 0.64), CS (5.27 +/- 0.69 vs. 5.36 +/- 0.76 Hz; P = 0.69), or LA (5.72 +/- 0.88 vs. 5.64 +/- 0.75 Hz; P = 0.7) regardless of pacing site. Consistent with these results, paired analysis in seven patients with both spontaneous and induced AF episodes, showed no regional DFs differences. Moreover, a left-to-right DF gradient was also present in both spontaneous (PV-LAJ 5.71 +/- 0.81 vs. HRA 5.18 +/- 0.69 Hz; P = 0.005) and induced (PV-LAJ 5.62 +/- 0.72 vs. HRA 5.07 +/- 0.91 Hz; P = 0.002) AF episodes, with no differences between them (P = not specific). Conclusion In patients with paroxysmal AF, high-rate pacing-induced AF adequately mimics spontaneously initiated AF, regardless of induction site., This study was supported in part by grants from the Spanish Society of Cardiology (D. C. and F. A.); the Ministerio de Economia y Competitividad, Red RECAVA (F. A., J.A., E. G. T., A. A., J.B., and F. F. A.); the Centro Nacional de Investigaciones Cardiovasculares (proyecto CNIC-13) to (F. A., J.A., E. G. T., O.B., and J.J.); NIH P01 HL087226 and the Leducq Foundation (J.J. and O.B.); and the Gelman and the Coulter awards from the University of Michigan (O.B.).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer

  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Background There is a medical need for diagnostic biomarkers in lung cancer. We evaluated the diagnostic performance of complement activation fragments. Methods We assessed complement activation in four bronchial epithelial and seven lung cancer cell lines. C4d, a degradation product of complement activation, was determined in 90 primary lung tumors; bronchoalveolar lavage supernatants from patients with lung cancer (n = 50) and nonmalignant respiratory diseases (n = 22); and plasma samples from advanced (n = 50) and early lung cancer patients (n = 84) subjects with inflammatory lung diseases (n = 133), and asymptomatic individuals enrolled in a lung cancer computed tomography screening program (n = 190). Two-sided P values were calculated by Mann-Whitney U test. Results Lung cancer cells activated the classical complement pathway mediated by C1q binding that was inhibited by phosphomonoesters. Survival was decreased in patients with high C4d deposition in tumors (hazard ratio [HR] = 3.06; 95% confidence interval [CI] = 1.18 to 7.91). C4d levels were increased in bronchoalveolar lavage fluid from lung cancer patients compared with patients with nonmalignant respiratory diseases (0.61 +/- 0.87 vs 0.16 +/- 0.11 mu g/mL; P < .001). C4d levels in plasma samples from lung cancer patients at both advanced and early stages were also increased compared with control subjects (4.13 +/- 2.02 vs 1.86 +/- 0.95 mu g/mL, P < 0.001; 3.18 +/- 3.20 vs 1.13 +/- 0.69 mu g/mL, P < .001, respectively). C4d plasma levels were associated with shorter survival in patients at advanced (HR = 1.59; 95% CI = 0.97 to 2.60) and early stages (HR = 5.57; 95% CI = 1.60 to 19.39). Plasma C4d levels were reduced after surgical removal of lung tumors (P < .001) and were associated with increased lung cancer risk in asymptomatic individuals with (n = 32) or without lung cancer (n = 158) (odds ratio = 4.38; 95% CI = 1.61 to 11.93). Conclusions Complement fragment C4d may serve as a biomarker for early diagnosis and prognosis of lung cancer., This work was supported by UTE project CIMA; the Spanish Government (grant numbers ISCIII-RTICC RD06/0020/0066, RD06/0020/1024, RD12/0036/0025, RD12/0036/0040, RD12/0036/0062, PI08/0923, PI10/01652, PI10/00166, and PI11/00618); the European Regional Development Fund; the European Community’s Seventh Framework Programme (HEALTH-F2-2010-258677- CURELUNG); and the Early Detection Research Network from the National Cancer Institute (grant number U01 CA152662). This work was supported (in part) by a grant (RD12/0036/XXXX) from Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness & European Regional Development Fund “Una manera de hacer Europa”.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

CellBase, a comprehensive collection of RESTful web services for retrieving relevant biological information from heterogeneous sources

  • Bleda, Marta
  • Tarraga, Joaquín
  • De María, Alejandro
  • Salavert, Francisco
  • García-Alonso, Luz
  • Celma Giménez, Matilde
  • Martín Mayordomo, Ainoha
  • Dopazo, Joaquín
  • Medina, Ignacio
During the past years, the advances in high-throughput technologies have produced an unprecedented growth in the number and size of repositories and databases storing relevant biological data. Today, there is more biological information than ever but, unfortunately, the current status of many of these repositories is far from being optimal. Some of the most common problems are that the information is spread out in many small databases; frequently there are different standards among repositories and some databases are no longer supported or they contain too specific and unconnected information. In addition, data size is increasingly becoming an obstacle when accessing or storing biological data. All these issues make very difficult to extract and integrate information from different sources, to analyze experiments or to access and query this information in a programmatic way. CellBase provides a solution to the growing necessity of integration by easing the access to biological data. CellBase implements a set of RESTful web services that query a centralized database containing the most relevant biological data sources. The database is hosted in our servers and is regularly updated. CellBase documentation can be found at http://docs.bioinfo.cipf.es/projects/cellbase., The Spanish Ministry of Science and Innovation (MICINN) [BIO2011-27069]; the Conselleria de Educacio of the Valencian Community [PROMETEO/2010/001]; National Institute of Bioinformatics (www.inab.org); CIBER de Enfermedades Raras (CIBERER), ISCIII and MICINN; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/1019] ISCIII, MICINN and INNPACTO [IPT-010000-2010-43], MICINN. Funding for open access charge: MICINN [BIO2011-27069].
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

NeuPAT: an intranet database supporting translational research in neuroblastic tumors will be published in Computers in Biology and Medicine

  • Villamon Ribate, Eva
  • Piqueras, Marta
  • Meseguer Anastasio, Javier Enrique
  • Berbegall Beltrán, Ana Pilar
  • Tadeo Cervera, Irene
  • Hernández García, Vicente
  • Navarro Fos, Samuel
  • Noguera Salvá, Rosa
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
Translational research in oncology is directed mainly towards establishing a better risk stratification and searching for appropriate therapeutic targets. This research generates a tremendous amount of complex clinical and biological data needing speedy and effective management. The authors describe the design, implementation and early experiences of a computer-aided system for the integration and management of data for neuroblastoma patients. NeuPAT facilitates clinical and translational research, minimizes the workload in consolidating the information, reduces errors and increases correlation of data through extensive coding. This design can also be applied to other tumor types., This work was supported by RD06/0020/0102 and PI10/0015 (ISCIII & ERDF); 396/2009 (FAECC).We are grateful to Mr.D. Harrison for assistance with English language editing.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer

  • Sanmartín, Elena
  • Usó, Marta
  • Blasco, Ana
  • Gallach, Sandra
  • Figueroa, Santiago
  • Martínez, Nieves
  • Hernando, Cristina
  • Honguero, Antonio
  • Martorell, Miguel
  • Guijarro, Ricardo
  • Rosell, Rafael
  • Jantus-Lewintre, Eloisa
  • Camps, Carlos
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Background. Angiogenesis and lymphangiogenesis are key mechanisms for tumor growth and dissemination. They are mainly regulated by the vascular endothelial growth factor (VEGF) family of ligands and receptors. The aim of this study was to analyze relative expression levels of angiogenic markers in resectable non-small cell lung cancer patients in order to asses a prognostic signature that could improve characterization of patients with worse clinical outcomes. Methods. RNA was obtained from tumor and normal lung specimens from 175 patients. Quantitative polymerase chain reaction was performed to analyze the relative expression of HIF1A, PlGF, VEGFA, VEGFA(165b), VEGFB, VEGFC, VEGFD, VEGFR1, VEGFR2, VEGFR3, NRP1 and NRP2. Results. Univariate analysis showed that tumor size and ECOG-PS are prognostic factors for time to progression (TTP) and overall survival (OS). This analysis in the case of angiogenic factors also revealed that PlGF, VEGFA, VEGFB and VEGFD distinguish patients with different outcomes. Taking into account the complex interplay between the different ligands of the VEGF family and to more precisely predict the outcome of the patients, we considered a new analysis combining several VEGF ligands. In order to find independent prognostic variables, we performed a multivariate Cox analysis, which showed that the subgroup of patients with higher relative expression of VEGFA plus lower VEGFB and VEGFD presented the poorest outcome for both TTP and OS. Conclusions. The relative expression of these three genes can be considered as an angiogenic gene signature whose applicability for the selection of candidates for targeted therapies needs to be further validated., This study was partially supported by a grant from the Instituto de Salud Carlos III (FIS PI06/1041 and PS09/1149), Red Tematica de Investigacion Cooperativa en Cancer (RD06/0020/1024), and FEDER.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC

  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
  • Sanmartin, Elena
  • Blasco, Ana
  • Sanchez, Jose Javier
  • Taron, Miguel
  • Rosell, Rafael
  • Camps, Carlos
Introduction: The vascular endothelial growth factor (VEGF) family of ligands and receptors (VEGFR) play an important role in tumor angiogenesis. Increased expression of angiogenic factors in tumors or in blood is associated with poor prognosis. The aim of this study was to investigate the role of VEGF-A and soluble VEGFR-2 (sVEGFR-2) as biomarkers in advanced non-small-cell lung cancer (NSCLC). Methods: We studied 432 patients with advanced NSCLC (stages IIIB-IV) treated with cisplatin and docetaxel and 89 healthy age-matched controls. Blood samples were collected before chemotherapy, and VEGF-A and sVEGFR-2 levels were determined by ELISA. Results: VEGF-A and sVEGFR-2 levels were higher in NSCLC patients than in the controls, but VEGF-A behaves as a better diagnostic biomarker. There were no significant associations between VEGF-A and sVEGFR-2 concentrations and clinical characteristics, such as ECOG-PS, gender, stage, histology, metastases, and treatment response. A patient subgroup characterized by a combination of high VEGF-A and low sVEGFR-2 levels exhibited the worst patient prognoses in terms of TTP and OS. Conclusions: VEGF-A and sVEGFR-2 levels were significantly higher in patients than in the controls. A combination of VEGF-A and sVEGFR-2 can be used as an independent prognostic biomarker in advanced NSCLC. © 2011 Elsevier Ireland Ltd., This work was supported in part, by a grant [PI06/104] from Instituto de Salud Carlos III and a grant [RD06/0020/1024] from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation and European Regional Development Fund (ERDF) "Una manera de hacer Europa".
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Ventricular fibrillation conduction through an isthmus of preserved myocardium between radiofrequency lesions

  • CHORRO GASCO, FCO JAVIER
  • Ibañez Catala, Xavier
  • TRAPERO, ISABEL
  • SUCH-MIQUEL, LUIS M
  • PELECHANO, FRANCISCA
  • CÁNOVES, JOAQUÍN
  • MAINAR LATORRE, LUIS
  • CERDA, JOSE M.
  • ALBEROLA, ANTONIO
  • SUCH, L
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
[EN] Background: Selective local acceleration of myocardial activation during ventricular fibrillation (VF) contributes information on the interactions between neighboring zones during the arrhythmia. This study analyzes these interactions, centering the observations on an isthmus of myocardium between two radiofrequency (RF) lesions. Methods: In nine isolated rabbit hearts, a gap of preserved myocardium was established between two RF lesions in the anterolateral left ventricle (LV) wall. Before, during, and after increasing the spatial heterogeneity of VF by local myocardial stretching, VF epicardial recordings were obtained. Results: Local stretch in the anterior LV wall decreased the excitable window (17 ±7ms vs 26 ±7ms; P < 0.05) and increased the dominant frequency (DFr; 18.9 ± 5.0 Hz vs 15.2 ± 3.6 Hz; P < 0.05) in this zone, without changes in the non-stretched posterolateral zone (25 ±4ms vs 27 ± 6 ms, ns and 14.1 ± 2.7 Hz vs 14.3 ± 3.0 Hz, ns). The DFr ratio at both sides of the gap was inversely correlated to the excitable window ratio (R = ¿0.57; P = 0.002). Before (31% vs 26%), during (29% vs 22%), and after stretch suppression (35% vs 25%), the wavefronts passing through the gap from the posterolateral to the anterior LV wall were seen to predominate. The number of wavefronts that passed from the anterior to the posterolateral LV wall was related to the excitable window in this zone (R = 0.41; P = 0.03). Conclusions: The VF acceleration induced in the stretched zone does not increase the flow of wavefronts toward the non-stretched zone in the adjacent gap of preserved myocardium. The absence of significant changes in the electrophysiological parameters of the non-stretched myocardium limits the arrival of wavefronts in this zone. (PACE 2013; 36:286¿298), Grants: This work was supported by Spanish Ministry of Science "Instituto de Salud Carlos III" Grants FIS PS09/02417 and RETIC REDINSCOR RD06/0003/0010, and by "Generalitat Valenciana" Grant PROMETEO 2010/093.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Modifications in Ventricular Fibrillation and Capture Capacity Induced by a Linear Radiofrequency Lesion, Modificaciones de la fibrilación ventricular y de la capacidad de captura inducidas por una lesión lineal con radiofrecuencia

  • Chorro, Francisco J.
  • Pelechano Ribes, Francisca
  • Trapero, Isabel
  • Ibañez Catala, Xavier
  • Such-Miquel, Luis
  • Guerrero, Juan
  • Canoves, Joaquin
  • Mainar, Luis
  • Alberola, Antonio
  • Such, Luis
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
  • Millet Roig, José|||0000-0002-8879-003X
[EN] Introduction and objectives: An analysis was made of the effects of a radiofrequency-induced linear lesion during ventricular fibrillation and the capacity to capture myocardium through high-frequency pacing. Methods: Using multiple epicardial electrodes, ventricular fibrillation was recorded in 22 isolated perfused rabbit hearts, analyzing the activation maps upon applying trains of stimuli at 3 different frequencies close to that of the arrhythmia: a) at baseline; b) after radio-frequency ablation to induce a lesion of the left ventricular free wall (length=10 [1] mm), and c) after lengthening the lesion (length=23 [2] mm). Results: Following lesion induction, the regularity of the recorded signals decreased and significant variations in the direction of the activation fronts were observed. On lengthening the lesion, there was a slight increase in the episodes with at least 3 consecutive captures when pacing at cycles 10% longer than the arrhythmia (baseline: 0.6 [0.7]; initial lesion: 1 [1] no significant differences; lengthened lesion: 3 [2.8]; P<.001), while a decrease was observed in those obtained upon pacing at cycles 10% shorter than the arrhythmia. Conclusions: The radio-frequency -induced lesion increases the heterogeneity of myocardial activation during ventricular fibrillation and modifies arrival of the activation fronts in the adjacent zones. High-frequency pacing during ventricular fibrillation produces occasional captures during at least 3 consecutive stimuli. The lengthened lesion in turn slightly increases capture capacity when using cycles slightly longer than the arrhythmia. (C) 2011 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L. All rights reserved., [ES] Introducción y objetivos Analizar los efectos, en la fibrilación ventricular y en la capacidad de capturar al miocardio mediante estimulación a frecuencias rápidas, de una lesión lineal producida con radiofrecuencia. Métodos En 22 corazones de conejo aislados y perfundidos, se utilizaron electrodos múltiples epicárdicos para registrar la fibrilación ventricular. Se analizaron los mapas de activación al aplicar trenes de estímulos a tres frecuencias distintas, cercanas a las de la arritmia, en tres situaciones: a) basalmente, b) tras producir con radiofrecuencia una lesión en la pared libre del ventrículo izquierdo (longitud, 10 ± 1 mm), y c) tras ampliar su extensión (longitud, 23 ± 2 mm). Resultados Tras la lesión, se observó una disminución de la regularidad de las señales registradas y variaciones significativas en la dirección de los frentes de activación. Con la lesión ampliada, se incrementaron ligeramente los episodios con al menos tres capturas consecutivas al estimular con ciclos un 10% más largos que los de la arritmia (basal, 0,6 ± 0,7; lesión inicial, 1 ± 1, diferencias no significativas; lesión ampliada, 3 ± 2,8; p < 0,001), mientras que se redujeron los obtenidos al estimular con ciclos un 10% más cortos que los de la arritmia. Conclusiones La lesión efectuada con radiofrecuencia aumenta la heterogeneidad de la activación miocárdica durante la fibrilación ventricular y modifica la llegada de los frentes de activación a las zonas adyacentes. La estimulación durante la fibrilación ventricular a frecuencias rápidas provoca capturas ocasionales durante al menos tres estímulos consecutivos. La lesión ampliada incrementa ligeramente la capacidad de captura al utilizar ciclos ligeramente más largos que los de la fibrilación ventricular., This study was funded by research grants from the Instituto de Salud Carlos III FIS PI06/0758-PS09/02417 and RETIC REDINSCOR RD06/0003/0010, from the Generalitat Valenciana PROMETEO 2010/093, and from the Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Culture of human bone marrow-derived mesenchymal stem cells on of poly(L-lactic acid) scaffolds: potential application for the tissue engineering of cartilage

  • Izal, Iñigo
  • Aranda, Pablo
  • Sanz Ramos, Patricia
  • Ripalda, Purificacion
  • Mora, Gonzalo
  • Granero Molto, Froilan
  • Deplaine, Harmony
  • Acosta, Victor
  • Ochoa, Ignacio
  • García Aznar, Manuel
  • Andreu, Enrique J.
  • Doblare Castellano, Manuel
  • Prosper, Felipe
  • Gómez Ribelles, José Luís|||0000-0001-9099-0885
  • Gallego-Ferrer, Gloria|||0000-0002-2428-0903
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
Due to the attractive properties of poly(l-lactic acid) (PLLA) for tissue engineering, the aim was to determine the growth and differentiation capacity of mesenchymal stromal cells (MSCs) in PLLA scaffolds and their potential use in the treatment of cartilage diseases. MSCs were cultured in PLLA films and thin porous membranes to study adherence and proliferation. Permeability and porosity were determined for the different scaffolds employed. The optimal conditions for cell seeding were first determined, as well as cell density and distribution inside the PLLA. Scaffolds were then maintained in expansion or chondrogenic differentiation media for 21 days. Apoptosis, proliferation and chondrogenic differentiation was assessed after 21 days in culture by immunohistochemistry. Mechanical characteristics of scaffolds were determined before and after cell seeding. MSCs uniformly adhered to PLLA films as well as to porous membranes. Proliferation was detected only in monolayers of pure PLLA, but was no longer detected after 10 days. Mechanical characterization of PLLA scaffolds showed differences in the apparent compression elastic modulus for the two sizes used. After determining high efficiencies of seeding, the production of extracellular matrix (ECM) was determined and contained aggrecan and collagens type I and X. ECM produced by the cells induced a twofold increase in the apparent elastic modulus of the composite. Biocompatible PLLA scaffolds have been developed that can be efficiently loaded with MSCs. The scaffold supports chondrogenic differentiation and ECM deposition that improves the mechanics of the scaffold. Although this improvement does not met the expectations of a hyaline-like cartilage ECM, in part due to the lack of a mechanical stimulation, their potential use in the treatment of cartilage pathologies encourages to improve the mechanical component., This work has been supported by the Spanish Ministry of Science and Innovation DPI2010-20399-C04-00 project and Instituto de Salud Carlos III RETIC RD06/0014.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Noninvasive Localization of Maximal Frequency Sites of Atrial Fibrillation by Body Surface Potential Mapping

  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Millet Roig, José|||0000-0002-8879-003X
  • Climent, Andreu M.
  • Arenal, Ángel
  • Fernandez-Aviles, Francisco
  • Jalife, José
  • Atienza, Felipe
  • Berenfeld, Omer
Background—Ablation of high-frequency sources in patients with atrial fibrillation (AF) is an effective therapy to restore sinus rhythm. However, this strategy may be ineffective in patients without a significant dominant frequency (DF) gradient. The aim of this study was to investigate whether sites with high-frequency activity in human AF can be identified noninvasively, which should help intervention planning and therapy. Methods and Results—In 14 patients with a history of AF, 67-lead body surface recordings were simultaneously registered with 15 endocardial electrograms from both atria including the highest DF site, which was predetermined by atrial-wide real-time frequency electroanatomical mapping. Power spectra of surface leads and the body surface location of the highest DF site were compared with intracardiac information. Highest DFs found on specific sites of the torso showed a significant correlation with DFs found in the nearest atrium (ρ=0.96 for right atrium and ρ=0.92 for left atrium) and the DF gradient between them (ρ=0.93). The spatial distribution of power on the surface showed an inverse relationship between the frequencies versus the power spread area, consistent with localized fast sources as the AF mechanism with fibrillatory conduction elsewhere. Conclusions—Spectral analysis of body surface recordings during AF allows a noninvasive characterization of the global distribution of the atrial DFs and the identification of the atrium with the highest frequency, opening the possibility for improved noninvasive personalized diagnosis and treatment. (Circ Arrhythm Electrophysiol. 2013;6:294-301.), Dr Atienza served on the advisory board of Medtronic and has received research funding from St. Jude Medical Spain. Dr Jalife is a consultant for Topera, Inc., and for Rhythm Solutions, Inc. He is a coinvestigator in a research grant from Gilead, Inc. Dr Berenfeld is a cofounder and chief scientist of Rhythm Solutions, Inc. None of the companies disclosed financed the research described in this article. The other authors have no conflicts to report.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients

  • Camps, Carlos
  • Cabrera, Andrea
  • Blasco, Ana
  • Sanmartin, Elena
  • Gallach, Sandra
  • Caballero, Cristina
  • del Pozo, Nieves
  • Rosell, Rafael
  • Guijarro, Ricardo
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
Qualitative analysis of circulating DNA in the blood is a promising non-invasive diagnostic and prognostic tool. Our aim was to study the association between the presence of KRAS mutations at codon 12 and several clinical variables in advanced non-small cell lung cancer (NSCLC) patients. Methods: We examined 308 stage IIIB and IV NSCLC patients who were treated with cisplatin and docetaxel. Blood samples were collected before chemotherapy, and circulating DNA was extracted from the plasma using commercial adsorption columns. The KRAS mutational status was determined by an RT-PCR method that is based on allelic discrimination. Results: The median age of the patients was 60 years [31-80], 84% were male, 98% had a performance status of 0-1 and 84% of the patients were in stage IV. The histological subtypes were as follows: 30% squamous cell carcinoma (SCC), 51% adenocarcinoma (ADC) and 19% others. Of the 277 response-evaluated patients, 1% achieved a complete response (CR), 26% achieved a partial response (PR), 34% had stable disease (SD) and 39% had progressive disease (PD). Additionally, 27 (8.8%) patients had KRAS mutations; 26 had a KRAS codon 12 TGT mutation, and 1 had a codon 12 GTT mutation. Plasmatic KRAS mutations were found in patients presenting SCC or ADC. Patients with KRAS mutations in plasma DNA had a median progression free survival (PFS) of 5.77 months [3.39-8.14], whereas for patients with wild-type (wt) KRAS, the PFS was 5.43 months [4.65-6.22] (p = 0.277). The median overall survival (OS) in KRAS-mutated patients was 9.07 months [4.43-13.70] vs 10.03 months [8.80-11.26] in wt patients (p = 0.514). Conclusions: In advanced NSCLC patients, there were no significant differences between patients with or without KRAS mutations in plasma-free DNA with respect to the baseline characteristics, response rates, PFS or OS. © 2010 Elsevier Ireland Ltd., This work was sponsored in part by a grant from the Spanish Society of Medical Oncology (SEOM) and by a grant (RD06/0020/1024) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation & European Regional Development Fund (ERDF) "Una manera de hacer Europa". None of the funding agencies were involved in the design, data management, data analysis, manuscript preparation and review, or decision to submit.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients

  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
  • Cabrera, Andrea
  • Blasco, Ana
  • Caballero, Cristina
  • Iranzo, Vega
  • Rosell, Rafael
  • Camps, Carlos
[EN] Background: Epidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial malignancies including lung cancer. A soluble fragment of the EGFR extracellular domain (sEGFR) can be detected in the blood of patients who have Non-small-cell lung cancer (NSCLC), but its clinical/ prognostic role must be further elucidated. Methods: sEGFR concentration was retrospectively determined by enzyme-linked immunosorbent assay in plasma samples from 308 advanced NSCLC patients (before treatment) and 109 healthy controls and correlated with clinico-pathological variables. Results: The concentration of sEGFR was lower in NSCLC patients than in controls (P <.0001). sEGFR behaves as a sensitive but not specific screening biomarker. No significant associations were observed between sEGFR concentration and demographic/clinical characteristics such as gender, Eastern Cooperative Oncology Group performance status, stage, and number or location of the metastatic sites. sEGFR was lower in patients with progressive disease or in squamous cell carcinoma compared with adenocarcinoma, but these differences were not significant. Patients with sEGFR ¿ 34.56 ng/mL showed a shorter overall survival (median 9.1 versus 12.2 months, P =.019) than others. Moreover, in multivariate analysis, sEGFR remained a significant independent prognostic marker. Conclusion: Low baseline sEGFR is associated with reduced survival in advanced NSCLC. Therefore, our findings in this large cohort of patients suggest that the determination of sEGFR concentration provides valuable prognostic information. © 2011 Elsevier Inc. All rights reserved., This work was sponsored in part by a grant from the Spanish Society of Medical Oncology (SEOM) and by a grant (RD06/0020/1024) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), the Spanish Ministry of Science and Innovation and the European Regional Development Fund (ERDF) "Una manera de hacer Europa." The authors declare no conflicts of interest or any financial disclosure.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

OmpK26, a novel porin associated with carbapenem resistance in 'Klebsiella pneumoniae'

  • García-Sureda, Laura
  • Doménech-Sánchez, Aantonio
  • Barbier, M.
  • Juan, C.
  • Gascó, J.
  • Albertí, Sebastián
[eng] Clinical isolates of Klebsiella pneumoniae resistant to carbapenems are being isolated with increasing frequency. Loss of the expression of the major nonspecific porins OmpK35/36 is a frequent feature in these isolates. In this study, we looked for porins that could compensate for the loss of the major porins in carbapenem-resistant organisms. Comparison of the outer membrane proteins from two K. pneumoniae clinical isogenic isolates that are susceptible (KpCS-1) and resistant (KpCR-1) to carbapenems revealed the absence of OmpK35/36 and the presence of a new 26-kDa protein in the resistant isolate. An identical result was obtained when another pair of isogenic isolates that are homoresistant (Kpn-3) and heteroresistant (Kpn-17) to carbapenems were compared. Mass spectrometry and DNA sequencing analysis demonstrated that this new protein, designated OmpK26, is a small monomeric oligogalacturonate-specific porin that belongs to the KdgM family of porins. Insertion-duplication mutagenesis of the OmpK26 coding gene, yjhA, in the carbapenemresistant, porin-deficient isolate KpCR-1 caused the expression of OmpK36 and the reversion to the carbapenem-susceptible phenotype, suggesting that OmpK26 is indispensable for KpCR-1 to lose OmpK36 and become resistant to these antibiotics. Moreover, loss of the major porin and expression of OmpK26 reduced in vitro fitness and attenuated virulence in a murine model of acute systemic infection. Altogether, these results indicate that expression of the oligogalacturonate-specific porin OmpK26 compensates for the absence of OmpK35/36 and allows carbapenem resistance in K. pneumoniae but cannot restore the fitness of the microorganism.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

O6-Methylguanine-DNA Methyltransferase protein expresión by immunohistochemistry in brain and non-brain  systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction

  • Brell, Marta
  • Ibáñez, Javier
  • Tortosa, Avelina
[eng] Background: The DNA repair protein O6-Methylguanine-DNA methyltransferase (MGMT) confers resistance to alkylating agents. Several methods have been applied to its analysis, with methylation-specific polymerase chain reaction (MSP) the most commonly used for promoter methylation study, while immunohistochemistry (IHC) has become the most frequently used for the detection of MGMT protein expression. Agreement on the best and most reliable technique for evaluating MGMT status remains unsettled. The aim of this study was to perform a systematic review and meta-analysis of the correlation between IHC and MSP. Methods: A computer-aided search of MEDLINE (1950-October 2009), EBSCO (1966-October 2009) and EMBASE (1974-October 2009) was performed for relevant publications. Studies meeting inclusion criteria were those comparing MGMT protein expression by IHC with MGMT promoter methylation by MSP in the same cohort of patients. Methodological quality was assessed by using the QUADAS and STARD instruments. Previously published guidelines were followed for meta-analysis performance. Results: Of 254 studies identified as eligible for full-text review, 52 (20.5%) met the inclusion criteria. The review showed that results of MGMT protein expression by IHC are not in close agreement with those obtained with MSP. Moreover, type of tumour (primary brain tumour vs others) was an independent covariate of accuracy estimates in the meta-regression analysis beyond the cut-off value. Conclusions: Protein expression assessed by IHC alone fails to reflect the promoter methylation status of MGMT. Thus, in attempts at clinical diagnosis the two methods seem to select different groups of patients and should not be used interchangeably.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Effects of Millimolar Steady-State Hydrogen Peroxide Exposure on Inflammatory and Redox Gene Expression in Immune Cells from Humans with Metabolic Syndrome

  • Busquets-Cortés, Carla
  • Capó, Xavier
  • Argelich, Emma
  • Ferrer, Miquel D.
  • Mateos, David
  • Bouzas, Cristina
  • Abbate, Manuela
  • Tur, Josep A.
  • Sureda, Antoni
  • Pons, Antoni
[eng] Reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) can exert opposed effects depending on the dosage: low levels can be involved in signalling and adaptive processes, while higher levels can exert deleterious effects in cells and tissues. Our aim was to emulate a chronic ex vivo oxidative stress situation through a 2 h exposure of immune cells to sustained H2O2 produced by glucose oxidase (GOX), at high or low production rate, in order to determine dissimilar responses of peripheral blood mononuclear cells (PBMCs) and neutrophils on ROS and cytokine production, and mitochondrial dynamics-related proteins, pro/anti-inflammatory and anti-oxidant gene expression. Immune cells were obtained from subjects with metabolic syndrome. H2O2 at low concentrations can trigger a transient anti-inflammatory adiponectin secretion and reduced gene expression of toll-like receptors (TLRs) in PBMCs but may act as a stimulator of proinflammatory genes (IL6, IL8) and mitochondrial dynamics-related proteins (Mtf2, NRF2, Tfam). H2O2 at a high concentration enhances the expression of pro-inflammatory genes (TLR2 and IL1β) and diminishes the expression of mitochondrial dynamics-related proteins (Mtf1, Tfam) and antioxidant enzymes (Cu/Zn SOD) in PBMCs. The GOX treatments produce dissimilar changes in immune cells: Neutrophils were more resistant to H2O2 effects and exhibited a more constant response in terms of gene expression than PBMCs. We observe emerging roles of H2O2 in mitochondrial dynamics and redox and inflammation processes in immune cells.
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
Publication Artículo científico (JournalArticle)

Superinfection during treatment of nosocomial infections with tigecycline

  • García-Cabrera, Emilio
  • Jiménez-Mejías, Manuel E.
  • Gil-Navarro, María Victoria
  • Gómez-Gómez, M J
  • Ortiz-Leyba, C
  • Cordero, Elisa
  • Pachón, J
We performed a retrospective and observational study of 51 patients treated with tigecycline, as the treatment for nosocomial infections due to multidrug-resistant microorganisms, to evaluate the superinfection rate and their etiologies. Superinfections were diagnosed in 12 (23.5%) patients (seven due to Pseudomonas aeruginosa, 13.7%) and one patient had P. aeruginosa colonization. Five patients with superinfection died (41.6%), three due to superinfections and two to underlying diseases. The superinfection rate observed during tigecycline treatment is higher than that previously reported. Pseudomonas aeruginosa is the most frequent agent, being the cause of 58.5% of all superinfections., This study was supported by the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008, Instituto de Salud Carlos III-FEDER, Ministerio de Ciencia e Innovación)., Yes
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
Publication Artículo científico (JournalArticle)

Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment.

  • Garnacho-Montero, José
  • García-Cabrera, Emilio
  • Diaz-Martín, Ana
  • Lepe, José Antonio
  • Iraurgi-Arcarazo, Patricia
  • Jiménez-Alvarez, Rocio
  • Revuelto-Rey, Jaume
  • Aznar, Javier
We set out to determine the factors influencing mortality in 125 adult patients with bacteraemic pneumococcal community-acquired pneumonia (CAP), assessing the impact on outcomes of early adequate therapy in particular. Presumed prognostic factors with p < 0.1 in the unadjusted model were subjected to multivariate Cox regression analysis, with in-hospital and 90-day mortalities as the dependent variables. A time period of >4 h from admission to start of adequate antibiotic treatment (adjusted hazard ratio (aHR) 2.62, 95% confidence interval (CI) 1.06-6.45; p =0.037) and severe sepsis or septic shock (aHR 5.06, 95% CI 1.63-15.71; p = 0.005) were independently associated with in-hospital mortality. Variables associated with 90-day mortality were Charlson comorbidity index (aHR 1.17, 95% CI 1.02-1.34; p = 0.018), severe sepsis or septic shock (aHR 3.03, 95% CI 1.22-7.51; p = 0.016) and delay of adequate antibiotic therapy >4 h (aHR 2.21, 95% CI 1.01-4.86; p = 0.048). The use of combination therapy was not included in these models but was a protective factor for delayed adequate therapy (aHR 0.53, 95% CI 0.29-0.95; p = 0.033). Administration of adequate antimicrobial therapy within 4 h of arrival is a critical determinant of survival in patients with bacteraemic pneumococcal CAP., This study was supported by Consejería de Salud de la Junta de Andalucía. Exp. Num. 0185 (2006), and Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008)., Yes
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal

  • Villar, Macarena
  • Cano, María E.
  • Gato, Eva
  • Garnacho-Montero, José
  • Cisneros, José Miguel
  • Ruiz de Alegría-Puig, Carlos
  • Fernández-Cuenca, Felipe
  • Martínez-Martínez, Luis
  • Vila, Jordi
  • Pascual, Álvaro
  • Tomás, María
  • Bou, Germán
  • Rodríguez-Baño, Jesús
Observational study, [Abstract] Acinetobacter baumannii is one of the most important antibiotic-resistant nosocomial bacteria. We investigated changes in the clinical and molecular epidemiology of A. baumannii over a 10-year period. We compared the data from 2 prospective multicenter cohort studies in Spain, one performed in 2000 (183 patients) and one in 2010 (246 patients), which included consecutive patients infected or colonized by A. baumannii. Molecular typing was performed by repetitive extragenic palindromic polymerase chain reaction (REP-PCR), pulsed-field gel electrophoresis (PFGE), and multilocus sequence typing (MLST). The incidence density of A. baumannii colonization or infection increased significantly from 0.14 in 2000 to 0.52 in 2010 in medical services (p < 0.001). The number of non-nosocomial health care-associated cases increased from 1.2% to 14.2%, respectively (p < 0.001). Previous exposure to carbapenems increased in 2010 (16.9% in 2000 vs 27.3% in 2010, p = 0.03). The drugs most frequently used for definitive treatment of patients with infections were carbapenems in 2000 (45%) and colistin in 2010 (50.3%). There was molecular-typing evidence of an increase in the frequency of A. baumannii acquisition in non-intensive care unit wards in 2010 (7.6% in 2000 vs 19.2% in 2010, p = 0.01). By MSLT, the ST2 clonal group predominated and increased in 2010. This epidemic clonal group was more frequently resistant to imipenem and was associated with an increased risk of sepsis, although not with severe sepsis or mortality. Some significant changes were noted in the epidemiology of A. baumannii, which is increasingly affecting patients admitted to conventional wards and is also the cause of non-nosocomial health care-associated infections. Epidemic clones seem to combine antimicrobial resistance and the ability to spread, while maintaining their clinical virulence., The study was funded by the Ministerio de Ciencia e Innovaci on, Instituto de Salud Carlos III, cofinanced by European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008), and FIS (PI 10/00056 and PI 11/02046).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems

  • Papp-Wallace, Krisztina M.
  • Mallo Cancela, Susana
  • Bethel, Christopher R.
  • Taracila, Magdalena A.
  • Hujer, Andrea M.
  • Viña Fernández, Anabel María
  • Gatta, Julian A.
  • Smith, Kerri M.
  • Xu, Yan
  • Page, Malcolm G.P.
  • Desarbre, Eric
  • Bou, Germán
  • Bonomo, Robert
[Abstract] Objectives: Class C β-lactamases are prevalent among Enterobacteriaceae; however, these enzymes are resistant to inactivation by commercially available β-lactamase inhibitors. In order to find novel scaffolds to inhibit class C β-lactamases, the comparative efficacy of monocyclic β-lactam antibiotics (aztreonam and the siderophore monosulfactam BAL30072), the bridged monobactam β-lactamase inhibitor BAL29880, and carbapenems (imipenem, meropenem, doripenem and ertapenem) were tested in kinetic assays against FOX-4, a plasmid-mediated class C β-lactamase (pmAmpC). Methods: The FOX-4 β-lactamase was purified. Steady-state kinetics, electrospray ionization mass spectrometry (ESI-MS) and ultraviolet difference (UVD) spectroscopy were conducted using the β-lactam scaffolds described. Results: The K(i) values for the monocyclic β-lactams against FOX-4 β-lactamase were 0.04 ± 0.01 μM (aztreonam) and 0.66 ± 0.03 μM (BAL30072), and the Ki value for the bridged monobactam BAL29880 was 8.9 ± 0.5 μM. For carbapenems, the Ki values ranged from 0.27 ± 0.05 μM (ertapenem) to 2.3 ± 0.3 μM (imipenem). ESI-MS demonstrated the formation of stable covalent adducts when the monocyclic β-lactams and carbapenems were reacted with FOX-4 β-lactamase. UVD spectroscopy suggested the appearance of different chromophoric intermediates. Conclusions: Monocyclic β-lactam and carbapenem antibiotics are effective mechanism-based inhibitors of FOX-4 β-lactamase, a clinically important pmAmpC, and provide stimulus for the development of new inhibitors to inactivate plasmidic and chromosomal class C β-lactamases., G. B. was funded by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-FEDER, Spanish Network for Research in Infectious Diseases (REIPI RD06/0008). This work was also funded by FIS PI12/00552, PS09/00687 and PS07/90 from Xunta de Galicia. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01 AI100560 and R01 AI063517 to R. A. B.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism

  • Cabral, M. P.
  • Soares, Nelson C.
  • Aranda Rodríguez, Jesús
  • Parreira, José Ricardo
  • Rumbo, Carlos
  • Poza, Margarita
  • Valle, Jaione
  • Calamia, Valentina
  • Lasa, Íñigo
  • Bou, Germán
[Abstract] Biofilm formation is one of the main causes for the persistence of Acinetobacter baumannii, a pathogen associated with severe infections and outbreaks in hospitals. Here, we performed comparative proteomic analyses (2D-DIGE and MALDI-TOF/TOF and iTRAQ/SCX-LC-MS/MS) of cells at three different conditions: exponential, late stationary phase, and biofilms. These results were compared with alterations in the proteome resulting from exposure to a biofilm inhibitory compound (salicylate). Using this multiple-approach strategy, proteomic patterns showed a unique lifestyle for A. baumannii biofilms and novel associated proteins. Several cell surface proteins (such as CarO, OmpA, OprD-like, DcaP-like, PstS, LysM, and Omp33), as well as those involved in histidine metabolism (like Urocanase), were found to be implicated in biofilm formation, this being confirmed by gene disruption. Although l-His uptake triggered biofilms efficiently in wild-type A. baumannii, no effect was observed in Urocanase and OmpA mutants, while a slight increase was observed in a CarO deficient strain. We conclude that Urocanase plays a crucial role in histidine metabolism leading to biofilm formation and that OmpA and CarO can act as channels for L-His uptake. Finally, we propose a model in which novel proteins are suggested for the first time as targets for preventing the formation of A. baumannii biofilms., This work was funded by the Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008), FIS PI081613, PS09/00687, PS07/90, PS07/51, and 08CSA064916PR from Xunta de Galicia., Xunta de Galicia; 08CSA064916PR, SERGAS; PS07/90, SERGAS; PS07/51
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Expression of OXA-Type and SFO-1 β-Lactamases Induces Changes in Peptidoglycan Composition and Affects Bacterial Fitness

  • Fernández González, Ana
  • Pérez Gómez, Astrid
  • Ayala, Juan A.
  • Mallo Cancela, Susana
  • Rumbo-Feal, Soraya
  • Tomás, María
  • Poza, Margarita
  • Bou, Germán
[Abstract] β-Lactamases and penicillin-binding proteins (PBPs) have evolved from a common ancestor. β-Lactamases are enzymes that degrade β-lactam antibiotics, whereas PBPs are involved in the synthesis and processing of peptidoglycan, which forms an elastic network in the bacterial cell wall. This study analyzed the interaction between β-lactamases and peptidoglycan and the impact on fitness and biofilm production. A representative set of all classes of β-lactamases was cloned in the expression vector pBGS18 under the control of the CTX-M promoter and expressed in Escherichia coli MG1655. The peptidoglycan composition of all clones was evaluated, and quantitative changes were found in E. coli strains expressing OXA-24, OXA-10-like, and SFO-1 (with its upstream regulator AmpR) β-lactamases; the level of cross-linked muropeptides decreased, and their average length increased. These changes were associated with a statistically significant fitness cost, which was demonstrated in both in vitro and in vivo experiments. The observed changes in peptidoglycan may be explained by the presence of residual dd-endopeptidase activity in these β-lactamases, which may result in hydrolysis of the peptide cross bridge. The biological cost associated with these changes provides important data regarding the interaction between β-lactamases and the metabolism of peptidoglycan and may provide an explanation for the epidemiology of these β-lactamases in Enterobacteriaceae., This work was supported by REIPI, Spanish Network for Research in Infectious Diseases (Instituto de Salud Carlos III, RD06/0008/0025), Fondo de Investigaciones Sanitarias (PI061368, PI081368, and PS09/00687), and SERGAS (PS07/90) and grants from Xunta de Galicia (07CSA050916PR) to G.B. A.F. is in receipt of a Rio Hortega research support contract from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. This work was partly supported by a grant from the Spanish Society for Microbiology and Infectious Disease (SEIMC) and by grant BFU2009-09200 awarded by the Ministry of Science and Innovation (MICINN) to J.A.A., Xunta de Galicia; PS07/90, Xunta de Galicia (07CSA050916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A Rapid and Simple Method for Constructing Stable Mutants of Acinetobacter baumannii

  • Aranda Rodríguez, Jesús
  • Poza, Margarita
  • Gómez Pardo, M. Belén
  • Rumbo-Feal, Soraya
  • Rumbo, Carlos
  • Parreira, José Ricardo
  • Rodríguez-Velo, Patricia
  • Bou, Germán
[Abstract] Background: Acinetobacter baumannii is a multidrug-resistant bacterium responsible for nosocomial infections in hospitals worldwide. Study of mutant phenotypes is fundamental for understanding gene function. The methodologies developed to inactivate A. baumannii genes are complicated and time-consuming; sometimes result in unstable mutants, and do not enable construction of double (or more) gene knockout mutant strains of A. baumannii. Results: We describe here a rapid and simple method of obtaining A. baumannii mutants by gene replacement via double crossover recombination, by use of a PCR product that carries an antibiotic resistance cassette flanked by regions homologous to the target locus. To demonstrate the reproducibility of the approach, we produced mutants of three different chromosomal genes (omp33, oxyR, and soxR) by this method. In addition, we disrupted one of these genes (omp33) by integration of a plasmid into the chromosome by single crossover recombination, the most widely used method of obtaining A. baumannii mutants. Comparison of the different techniques revealed absolute stability when the gene was replaced by a double recombination event, whereas up to 40% of the population reverted to wild-type when the plasmid was disrupting the target gene after 10 passages in broth without selective pressure. Moreover, we demonstrate that the combination of both gene disruption and gene replacement techniques is an easy and useful procedure for obtaining double gene knockout mutants in A. baumannii. Conclusions: This study provides a rapid and simple method of obtaining stable mutants of A. baumannii free of foreign plasmidic DNA, which does not require cloning steps, and enables construction of multiple gene knockout mutants., The present study was supported by grants from SERGAS (PS08/24 and PS07/90) and INCITE 08CSA064916PR from the Xunta de Galicia, by the Spanish Network for Research in Infectious Diseases RD06/0008/0025, and by grants PI081613 and PS09/00687 from the Instituto de Salud Carlos III (Madrid). J. Aranda is in receipt of a Sara Borrell post-doctoral grant from the Instituto de Salud Carlos III (Madrid). M. Poza and B. Gómez are in receipt of Isidro Parga Pondal postdoctoral grants from the Xunta de Galicia. S. Rumbo and C. Rumbo are in receipt of pre-doctoral grants from the Instituto de Salud Carlos III (Madrid)., Xunta de Galicia; PS08/24, Xunta de Galicia; PS07/90, Xunta de Galicia; 08CSA064916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii

  • Méndez, José Antonio
  • Soares, Nelson C.
  • Mateos, Jesús
  • Gayoso Babío, Carmen María
  • Rumbo, Carlos
  • Aranda Rodríguez, Jesús
  • Tomás, María
  • Bou, Germán
[Abstract] The study of the extracellular proteomes of pathogenic bacteria is essential for gaining insights into the mechanisms of pathogenesis and for the identification of virulence factors. Through the use of different proteomic approaches, namely Nano-LC and 2DE combined with MALDI-TOF/TOF, we have characterized the extracellular proteome of a highly invasive, multidrug-resistant strain of A. baumannii (clone AbH12O-A2). This study focused on two main protein fractions of the extracellular proteome: proteins that are exported by outer membrane vesicles (OMVs) and freely soluble extracellular proteins (FSEPs) present in the culture medium of A. baumannii. Herein, a total of 179 nonredundant proteins were identified in the OMV protein fraction and a total of 148 nonredundant proteins were identified in FSEP fraction. Of the OMV proteins, 39 were associated with pathogenesis and virulence, including proteins associated with attachment to host cells (e.g., CsuE, CsuB, CsuA/B) and specialized secretion systems for delivery of virulence factors (e.g., P. pilus assembly and FilF), whereas the FSEP fraction possesses extracellular enzymes with degradative activity, such as alkaline metalloprotease. Furthermore, among the FSEP we have detected at least 18 proteins with a known role in oxidative stress response (e.g., catalase, thioredoxin, oxidoreductase, superoxide dismutase). Further assays demonstrated that in the presence of FSEPs, bacterial cells withstand much higher concentrations of H2O2 showing higher survival rate (approximately 2.5 fold) against macrophages. In this study we have identified an unprecedented number of novel extracellular proteins of A. baumannii and we provide insight into their potential role in relevant processes such as oxidative stress response and defense against macrophage attack., This work was funded by the Spanish Network for the Research in Infectious Diseases-REIPI-(Instituto de Salud Carlos III, RD06/0008/0025), FIS PI081613, PI10/00056, PS09/00687, PS07/90, PS07/51, and 08CSA064916PR from Xunta de Galicia. We thank Dr. Phil Jackson from ITQB/UNL for the useful comments on the manuscript. We acknowledge helpful advice from Dr. Cristina Ruiz-Romero and Dr. Patricia Fuentes (ProteoRed) and Ireneu Soares Costa for helping us with the table of contents graphic.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate

  • Pérez Gómez, Astrid
  • Canle, Delia
  • Latasa, Cristina
  • Poza, Margarita
  • Beceiro Casas, Alejandro
  • Tomás, María
  • Fernández González, Ana
  • Mallo Cancela, Susana
  • Pérez, S.
  • Molina, Francisca
  • Villanueva, Rosa
  • Lasa, Íñigo
  • Bou, Germán
[Abstract] Enterobacter cloacae is an emerging clinical pathogen that may be responsible for nosocomial infections. Management of these infections is often difficult, owing to the high frequency of strains that are resistant to disinfectants and antimicrobial agents in the clinical setting. Multidrug efflux pumps, especially those belonging to the resistance-nodulation-division family, play a major role as a mechanism of antimicrobial resistance in gram-negative pathogens. In the present study, we cloned and sequenced the genes encoding an AcrAcB-TolC-like efflux pump from an E. cloacae clinical isolate (isolate EcDC64) showing a broad antibiotic resistance profile. Sequence analysis showed that the acrR, acrA, acrB, and tolC genes encode proteins that display 79.8%, 84%, 88%, and 82% amino acid identities with the respective homologues of Enterobacter aerogenes and are arranged in a similar pattern. Deletion of the acrA gene to yield an AcrA-deficient EcDC64 mutant (EcΔacrA) showed the involvement of AcrAB-TolC in multidrug resistance in E. cloacae. However, experiments with an efflux pump inhibitor suggested that additional efflux systems also play a role in antibiotic resistance. Investigation of several unrelated isolates of E. cloacae by PCR analysis revealed that the AcrAB system is apparently ubiquitous in this species., Margarita Poza is a receipt of an Isidro Parga Pondal research contract, Alejandro Beceiro of a scholarship from SEIMC, and María del Mar Tomás of a postMIR research contract from the Instituto de Salud Carlos III. The study was partly financed by the Consellería de Innovación, Industria y Comercio, Xunta de Galicia (PGIDIT04BTF916028PR), Fondo de Investigaciones Sanitarias (PI040514 and PI061368), and also supported by Ministerio de Sanidad y Consumo, ISCIII, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008)., Xunta de Galicia; PGIDIT04BTF916028PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain

  • Acosta Barriga, Joshi
  • Merino Carballeira, María
  • Viedma Moreno, Esther
  • Poza, Margarita
  • Sanz, Francisca
  • Otero, Joaquín R.
  • Chaves Sánchez, Fernando
  • Bou, Germán
[Abstract] In February 2006, a patient colonized with a multidrug-resistant sequence type 56 Acinetobacter baumannii strain was admitted to a hospital in Madrid, Spain. This strain spread rapidly and caused a large outbreak in the hospital. Clinicians should be alert for this strain because its spread would have serious health consequences., This study was supported by the Spanish Network for Research in Infectious Diseases (grants RD06/0008/0011, RD06/0008/0025, PI081613, and PS09/00687) for the Instituto de Salud Carlos III.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Exploring Bacterial Diversity in Hospital Environments by GS-FLX Titanium Pyrosequencing

  • Poza, Margarita
  • Gayoso Babío, Carmen María
  • Gómez, Manuel J.
  • Rumbo-Feal, Soraya
  • Tomás, María
  • Aranda Rodríguez, Jesús
  • Fernández González, Ana
  • Bou, Germán
[Abstract] Understanding microbial populations in hospital environments is crucial for improving human health. Hospital-acquired infections are an increasing problem in intensive care units (ICU). In this work we present an exploration of bacterial diversity at inanimate surfaces of the ICU wards of the University Hospital A Coruña (Spain), as an example of confined hospital environment subjected to selective pressure, taking the entrance hall of the hospital, an open and crowded environment, as reference. Surface swab samples were collected from both locations and recovered DNA used as template to amplify a hypervariable region of the bacterial 16S rRNA gene. Sequencing of the amplicons was performed at the Roche 454 Sequencing Center using GS-FLX Titanium procedures. Reads were pre-processed and clustered into OTUs (operational taxonomic units), which were further classified. A total of 16 canonical bacterial phyla were detected in both locations. Members of the phyla Firmicutes (mainly Staphylococcus and Streptococcus) and Actinobacteria (mainly Micrococcaceae, Corynebacteriaceae and Brevibacteriaceae) were over-represented in the ICU with respect to the Hall. The phyllum Proteobacteria was also well represented in the ICU, mainly by members of the families Enterobacteriaceae, Methylobacteriaceae and Sphingomonadaceae. In the Hall sample, the phyla Proteobacteria, Bacteroidetes, Deinococcus-Thermus and Cyanobacteria were over-represented with respect to the ICU. Over-representation of Proteobacteria was mainly due to the high abundance of Enterobacteriaceae members. The presented results demonstrate that bacterial diversity differs at the ICU and entrance hall locations. Reduced diversity detected at ICU, relative to the entrance hall, can be explained by its confined character and by the existence of antimicrobial selective pressure. This is the first study using deep sequencing techniques made in hospital wards showing substantial hospital microbial diversity., This work was supported by the Spanish Network for Research in Infectious Diseases (REIPI, RD06/0008/0025), grants from Fondo de Investigaciones Sanitarias (PI081368 and PS09/00687), SERGAS (PS07/90) and Xunta de Galicia (07CSA050916PR) to GB and a grant from SERGAS (PS08/24, Galicia, Spain) to MP. MP was supported by the Isidro Parga Pondal Program (Xunta de Galicia, Spain), CG by the Spanish Network for Research in Infectious Diseases (REIPI, RD025/0008), MJG by the project Consolider INGENIO CSD2007-0005 and INTA-CSIC (Madrid, Spain) and SRF, MT, JA and AF by Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Xunta de Galicia; PS07/90, Xunta de Galicia; 07CSA050916PR, Xunta de Galicia; PS08/24
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate

  • Soares, Nelson C.
  • Spät, Philipp
  • Méndez Arredondo, José Antonio
  • Nakedi, Kehilwe
  • Aranda Rodríguez, Jesús
  • Bou, Germán
[Abstract] In the current study, the Ser/Thr/Tyr phosphoproteomes of two Acinetobacter baumannii strains, reference (ATCC17978) and highly invasive multidrug-resistant clinical isolate (Abh12O-A2) were analyzed using SCX and TiO2 chromatography followed by high resolution mass spectrometry. We detected a total of 201 unique phosphorylation sites (p-sites), and, after manual validation of peptide spectra, 91 high-confidence phosphorylation events (p-events) could be localized to a specific amino acid residue. The percentage distribution of Ser/Thr/Tyr phosphorylation was 68.9% on serine, 24.1% on threonine and 5.2% on tyrosine in ATCC17978, and 70.8% on serine, 25.2% on threonine and 3.8% on tyrosine in AbH12O-A2. Across all identified p-sites, 11 were identified in ATCC17978 only, while 43 were identified in Abh12O-A2 only, and 37 overlapped between the two strains. Here for the first time we describe the phosphoproteome of A. baumanii, and significance of selected phosphorylation sites is discussed in the context of stress/starvation, pathogenicity and drug resistance. Biological significance: It is now well established that protein phosphorylation on Ser/Thr/Tyr residues is an important post-translational modification in bacteria. Herein we employed SCX and TiO2 chromatographic phosphopeptide enrichment combined with LTQ-Orbitrap mass spectrometric analyses to characterize and establish a qualitative comparison between the Ser/Thr/Tyr phosphoproteomes of two Acinetobacter baumannii strains: a reference strain and a highly invasive multidrug-resistant clinical isolate. We highlight the identification of phosphoproteins with a role in pathogenicity and those involved in drug resistance., Xunta de Galicia; 08CSA06491PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

OXA-24 Carbapenemase Gene Flanked by XerC/XerD-Like Recombination Sites in Different Plasmids from Different Acinetobacter Species Isolated during a Nosocomial Outbreak

  • Merino Carballeira, María
  • Acosta Barriga, Joshi
  • Poza, Margarita
  • Sanz, Francisca
  • Beceiro Casas, Alejandro
  • Chaves Sánchez, Fernando
  • Bou, Germán
[Abstract] A clinical strain of Acinetobacter calcoaceticus resistant to carbapenems was isolated from a blood culture sample from an inpatient in a hospital in Madrid (Spain) during a large outbreak of infection (affecting more than 300 inpatients), caused by a multidrug-resistant Acinetobacter baumannii clone. The carbapenem resistance in both the A. calcoaceticus and A. baumannii clones was due to a blaOXA-24 gene harbored in different plasmids. The plasmids were fully sequenced, revealing the presence of site-specific recombination binding sites putatively involved in mobilization of the blaOXA-24 gene. Comparison of plasmids contained in the two strains revealed possible horizontal transmission of resistance genes between the Acinetobacter species., This study was supported by the Spanish Network for Research on Infectious Diseases—REIPI (Instituto de Salud Carlos III, RD06/0008/0025 and RD006/0008/0011), Fondo de Investigaciones Sanitarias (PI061368, PI081368, and PS09/00687), and SERGAS (PS07/90) and by grants from Xunta de Galicia (07CSA050916PR). Margarita Poza and Alejandro Beceiro are in receipt of Isidro Parga Pondal and Angeles Alvariño grants, respectively (research contracts from Xunta de Galicia)., Xunta de Galicia; PS07/90, Xunta de Galicia; 07CSA050916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Horizontal Transfer of the OXA-24 Carbapenemase Gene via Outer Membrane Vesicles: a New Mechanism of Dissemination of Carbapenem Resistance Genes in Acinetobacter baumannii

  • Rumbo, Carlos
  • Fernández-Moreira, Esteban
  • Merino Carballeira, María
  • Poza, Margarita
  • Méndez Arredondo, José Antonio
  • Soares, Nelson C.
  • Mosquera Rey, Alejandro
  • Chaves Sánchez, Fernando
  • Bou, Germán
[Abstract] The resistance of Acinetobacter baumannii strains to carbapenems is a worrying problem in hospital settings. The main mechanism of carbapenem resistance is the expression of β-lactamases (metalloenzymes or class D enzymes). The mechanisms of the dissemination of these genes among A. baumannii strains are not fully understood. In this study we used two carbapenem-resistant clinical strains of A. baumannii (AbH12O-A2 and AbH12O-CU3) expressing the plasmid-borne blaOXA-24 gene (plasmids pMMA2 and pMMCU3, respectively) to demonstrate that A. baumannii releases outer membrane vesicles (OMVs) during in vitro growth. The use of hybridization studies enabled us to show that these OMVs harbored the blaOXA-24 gene. The incubation of these OMVs with the carbapenem-susceptible A. baumannii ATCC 17978 host strain yielded full resistance to carbapenems. The presence of the original plasmids harboring the blaOXA-24 gene was detected in strain ATCC 17978 after the transformation of OMVs. New OMVs harboring blaOXA-24 were released by A. baumannii ATCC 17978 after it was transformed with the original OMV-mediated plasmids, indicating the universality of the process. We present the first experimental evidence that clinical isolates of A. baumannii may release OMVs as a mechanism of horizontal gene transfer whereby carbapenem resistance genes are delivered to surrounding A. baumannii bacterial isolates., This work was supported by SERGAS grants (PS07/51 and PS07/90) and INCITE grant 08CSA064916PR from Xunta de Galicia, by Spanish Network for Research in Infectious Diseases grants RD06/0008/0011 and RD06/0008/0025, and by grants PI081613 and PS09/00687 from the Instituto de Salud Carlos III. Margarita Poza and Carlos Rumbo are recipients of an Isidro Parga Pondal research contract (Xunta de Galicia) and a scholarship from the Instituto de Salud Carlos III, respectively. Nelson C. Soares is a recipient of an Angeles Alvariño research contract (Xunta de Galicia). Jose A. Mendez is supported by a Río Hortega research contract from the Instituto de Salud Carlos III., Xunta de Galicia; PS07/51, Xunta de Galicia; PS07/90, Xunta de Galicia; 08CSA064916PR
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Rapid detection of antibiotic resistance in gram-negative bacteria through assessment of changes in cellular morphology

  • Otero, Fátima
  • Santiso, Rebeca
  • Tamayo, María
  • Fernández, José Luis
  • Bou, Germán
  • Lepe, José Antonio
  • McConnell, Michael J.
  • Gosálvez, Jaime
  • Cisneros, José Miguel
[Abstract] Rapid antimicrobial susceptibility testing has the potential to improve patient outcomes and reduce healthcare-associated costs. In this study, a novel assay based on bacterial cell elongation after exposure to an antibiotic (ceftazidime) was evaluated for its ability to rapidly detect resistance in Gram-negative bacteria. The assay was used to detect resistance in a large collection of strains containing 320 clinical isolates of Acinetobacter baumannii, 171 clinical isolates of Klebsiella pneumoniae, and 212 clinical isolates of Pseudomonas aeruginosa, and the results were compared to those obtained using standard antimicrobial susceptibility testing methods. The assay identified ceftazidime-resistant strains with 100% sensitivity and 100% specificity for A. baumannii, 100% sensitivity and 97.2% specificity for K. pneumoniae, and with 82.3% sensitivity and 100% specificity for P. aeruginosa. Importantly, results were obtained in 1 hour 15 minutes from exponentially growing cultures. This study demonstrates that changes in cell length are highly correlated with phenotypic antibiotic susceptibility determined using standard susceptibility testing methods. This study therefore provides proof-of-concept that changes in cell morphology can be used as the basis for rapid detection of antibiotic resistance and provides the basis for the development of novel rapid diagnostics for the detection of antibiotic resistance., This work has been supported by MagicBullet, the Fondo de Investigaciones Sanitarias PI14/01346, and by REIPI: Spanish Network for Research in Infectious Diseases (Instituto de Salud Carlos III, RD06/0008/0025). M.J.M. is supported by the Subprograma Miguel Servet from the Ministerio de Economía y Competitividad of Spain (CP11/00314). MagicBullet is a project funded by the European Union-Directorate General for Research and Innovation through the Seventh Framework Program for Research and Development (grant agreement number 278232).
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial

  • Martínez-González, Miguel Ángel, 1957-
  • Montero, Pedro
  • Ruiz-Canela, Miguel
  • Toledo, Estefanía
  • Estruch Riba, Ramon
  • Gómez-Gracia, Enrique
  • Li, Jun
  • Ros Rahola, Emilio
  • Arós, Fernando
  • Hernáez, Álvaro
  • Corella Piquer, Dolores
  • Fiol, Miquel
  • Lapetra, José
  • Serra Majem, Lluís
  • Pintó Sala, Xavier
  • Cofán Pujol, Montserrat
  • Sorlí, José V.
  • Babio, Nancy
  • Márquez-Sandoval, Yolanda F.
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repeated measurements of dietary intake are able to improve subject classification and to increase the quality of the assessed relationships in nutritional epidemiology. Beyond observational studies, randomized trials provide stronger causal evidence. In the context of a randomized trial of primary cardiovascular prevention, we assessed type 2 diabetes incidence according to yearly repeated measures of compliance with a nutritional intervention based on the traditional Mediterranean diet. Methods PREDIMED (‘‘PREvención con DIeta MEDiterránea’’) was a Spanish trial including 7447 men and women at high cardiovascular risk. We assessed 3541 participants initially free of diabetes and originally randomized to 1 of 3 diets: low-fat diet (n = 1147, control group), Mediterranean diet supplemented with extra virgin olive (n = 1154) or Mediterranean diet supplemented with mixed nuts (n = 1240). As exposure we used actual adherence to Mediterranean diet (cumulative average), yearly assessed with the Mediterranean Diet Adherence Screener (scoring 0 to 14 points), and repeated up to 8 times (baseline and 7 consecutive follow-up years). This score was categorized into four groups: < 8, 8–< 10, 10– < 12, and 12–14 points. The outcome was new-onset type 2 diabetes. Results Multivariable-adjusted hazard ratios from time-varying Cox models were 0.80 (95% confidence interval, 0.70–0.92) per + 2 points in Mediterranean Diet Adherence Screener (linear trend p = .001), and 0.46 (0.25–0.83) for the highest (12–14 points) versus the lowest (< 8) adherence. This inverse association was maintained after additionally adjusting for the randomized arm. Age- and sex-adjusted analysis of a validated plasma metabolomic signature of the Mediterranean Diet Adherence Screener (constituted of 67 metabolites) in a subset of 889 participants also supported these results. Conclusions Dietary intervention trials should quantify actual dietary adherence throughout the trial period to enhance the benefits and to assist results interpretation. A rapid dietary assessment tool, yearly repeated as a screener, was able to capture a strong inverse linear relationship between Mediterranean diet and type 2 diabetes., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease

  • León, Rafael
  • García, Antonio G.
  • Marco-Contelles, José
With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations. Unless a new medicine capable to delay disease progression is found, the number of cases will reach 107 million in 2050. So far, the therapeutic paradigm one-compound-one-target has failed. This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, Ï„ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons. Approximately 100 compounds are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase. In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compound targeting two or more of the pathogenic mechanisms leading to neuronal death. This review summarizes the current therapeutic strategies based on the paradigm one-compound-various targets to treat AD. A treatment that delays disease onset and/or progression by 5 years could halve the number of people requiring institutionalization and/or dying from AD., Contract grant sponsor: Fundación CIEN; Contract grant number: PI 016/09; Contract grant sponsor: Agencia Laín Entralgo; Contract grant number: NDG07/9; Contract grant sponsor: MICINN; Contract grant numbers: SAF2006-08764-C02-01; SAF2009-07271; Contract grant sponsor: CSIC-GRICES; Contract grant number: 2007PT-13; Contract grant sponsors: ISCIII; MICINN; Contract grant number: RD06/0026/1002 Retic ‘‘RENEVAS’’; Contract grant sponsor: Comunidad de Madrid; Contract grant number: S/SAL-0275-2006, Peer reviewed, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma

  • García-Domínguez, D. J.
  • Hajji, Nabil
  • Sánchez-Molina, Sara
  • Figuerola-Bou, Elisabet
  • Martínez de Pablos, Rocío
  • Espinosa-Oliva, Ana M.
  • Andrés-León, Eduardo
  • Terrón-Camero, Laura Carmen
  • Flores-Campos, Rocío
  • Pascual-Pasto, Guillem
  • Robles-Frías, María José
  • Machado, Isidro
  • Llombart-Bosch, Antonio
  • Magagnoli, Giovanna
  • Scotlandi, Katia
  • Carcaboso, Ángel M.
  • Mora, Jaume
  • Álava, Enrique de
  • Hontecillas-Prieto, Lourdes
Ewing sarcoma (EWS) is an aggressive bone and soft tissue tumor of children and young adults in which the principal driver is a fusion gene, EWSR1-FLI1. Although the essential role of EWSR1-FLI1 protein in the regulation of oncogenesis, survival, and tumor progression processes has been described in-depth, little is known about the regulation of chimeric fusion-gene expression. Here, we demonstrate that the active nuclear HDAC6 in EWS modulates the acetylation status of specificity protein 1 (SP1), consequently regulating the SP1/P300 activator complex binding to EWSR1 and EWSR1-FLI1 promoters. Selective inhibition of HDAC6 impairs binding of the activator complex SP1/P300, thereby inducing EWSR1-FLI1 downregulation and significantly reducing its oncogenic functions. In addition, sensitivity of EWS cell lines to HDAC6 inhibition is higher than other tumor or non-tumor cell lines. High expression of HDAC6 in primary EWS tumor samples from patients correlates with a poor prognosis in two independent series accounting 279 patients. Notably, a combination treatment of a selective HDAC6 and doxorubicin (a DNA damage agent used as a standard therapy of EWS patients) dramatically inhibits tumor growth in two EWS murine xenograft models. These results could lead to suitable and promising therapeutic alternatives for patients with EWS., Research in the E.D.A. lab is supported by Asociación Española Contra el Cáncer (AECC), the Ministry of Science of Spain-FEDER (CIBERONC, PI1700464, PI2000003, RD06/0020/0059)S. D.G.D. and L.H.P. are supported by CIBERONC (CB16/12/00361). D.G.D., M.J.R. and L.H.P. are PhD researchers funded by the Consejería de Salud, Junta de Andalucía (PI-0197-2016, ECAI F2-0012-2018 and PI-0013-2018, respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma

  • Martín-Pérez, D.
  • Vargiu, P.
  • Montes-Moreno, Noemí
  • Andrés-León, Eduardo
  • Rodríguez-Pinilla, S. M.
  • Lisio, Lorena di
  • Martínez Martínez, Noelia
  • Rodríguez, R.
  • Mollejo, M.
  • Castellvi, J.
  • Pisano, David G.
  • Sánchez-Beato, M.
  • Piris, M. A.
We have studied the miRNA expression profile in 36 DLBCL samples using miRNA microarrays. Prevalence of EBV in this series (33 EBV-negative and 3 EBV-positive) was close to normal prevalence in DLBCL.1 Twenty-two out of thirty-two analysed viral miRNAs were significantly upregulated in EBV-positive samples (>two-fold change; t-test corrected P-value<0.05, Figure 1c, Supplementary table 2 and Supplementary table 3)., We would like to acknowledge all members of CNIOs Lymphoma Group for their thoughtful discussion. This study was funded with the following grants: from Ministerio de Educacio´n y Ciencia, Spain SAF2007-65957-C02-02, SAF2008-03871; from the Fondo de Investigaciones Sanitarias, RTICC RD06/0020/0107 and PI10/ 00621; from Fundacio´n Cientı´fica de la Asociacio´n Espan˜ola Contra el Ca´ncer (AECC). LDL is supported by a fellowship from Ministerio de Sanidad y Consumo (FI08/00038); NM is supported by a contract from Ministerio de Sanidad y Consumo (CP06/00002)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Imaging of plasmacytoid dendritic cell interactions with T cells

  • Mittelbrunn, María
  • Martínez del Hoyo, Gloria
  • López-Bravo, María
  • Martín-Cofreces, Noa B
  • Scholer, Alix
  • Hugues, Stéphanie
  • Fetler, Luc
  • Amigorena, Sebastián
  • Ardavín, Carlos
  • Sánchez-Madrid, Francisco
Plasmacytoid dendritic cells (pDCs) efficiently produce type I interferon and participate in adaptive immune responses, although the molecular interactions between pDCs and antigen-specific T cells remain unknown. This study examines immune synapse (IS) formation between murine pDCs and CD4(+) T cells. Mature pDCs formed canonical ISs, involving relocation to the contact site of the microtubule-organizing center, F-actin, protein kinase C-, and pVav, and activation of early signaling molecules in T cells. However, immature pDCs were less efficient at forming conjugates with T cells and inducing IS formation, microtubule-organizing center translocation, and T-cell signaling and activation. Time-lapse videomicroscopy and 2-photon in vivo imaging of pDC-T-cell interactions revealed that immature pDCs preferentially mediated transient interactions, whereas mature pDCs promoted more stable contacts. Our data indicate that, under steady-state conditions, pDCs preferentially establish transient contacts with naive T cells and show a very modest immunogenic capability, whereas on maturation, pDCs are able to form long-lived contacts with T cells and significantly enhance their capacity to activate these lymphocytes., This work was supported by grants BFU2005-08435/BMC from the Ministerio de Educación y Ciencia, Ayuda a la Investigación Básica 2002 from Juan March Foundation and European Network MAIN LSHG-CT-2003-502935 and Red Temática de Investigación cooperativa en Enfermedades Cardiovasculares RD06/0014-0030 (F.S.-M.). G.M.d.H. was supported by Instituto de Salud Carlos III. Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Health and Consumer Affairs and the Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

  • Mateo, F.
  • Arenas, E. J.
  • Aguilar, H.
  • Serra-Musach, J.
  • Ruiz de Garibay, G.
  • Boni, J.
  • Maicas, M.
  • Du, S.
  • Lorio, F.
  • Herranz-Ors, C.
  • Islam, A.
  • Prado, X.
  • Llorente, A.
  • Petit, A.
  • Vidal, A.
  • Catalá, I.
  • Soler, T.
  • Venturas, G.
  • Rojo-Sebastian, A.
  • Serra, H.
  • Cuadras, D.
  • Blanco, I.
  • Lozano, J.
  • Canals, F.
  • Sieuwerts, A. M.
  • Weerd, V. de
  • Look, M. P.
  • Puertas, S.
  • García, N.
  • Perkins, A. S.
  • Bonifaci, N.
  • Skowron, M.
  • Gómez-Baldó, L.
  • Hernández, V.
  • Martínez-Aranda, A.
  • Martínez-Iniesta, M.
  • Serrat, X.
  • Cerón, Julián
  • Brunet, J.
  • Barretina, M. P.
  • Gil, M.
  • Falo, C.
  • Fernández, A.
  • Morilla, I.
  • Pernas, S.
  • Plà, M. J.
  • Andreu, X.
  • Seguí, M. A.
  • Ballester, R.
  • Castellà, E.
  • Nellist. M.
  • Morales, S.
  • Valls, J.
  • Velasco, A.
  • Matias-Guiu, X.
  • Figueras, A.
  • Sánchez-Mut, José Vicente
  • Sánchez-Céspedes, M.
  • Cordero, A.
  • Gómez-Miragaya, J.
  • Palomero, L.
  • Gómez, A.
  • Gajewski, T. F.
  • Cohen, E. E. W.
  • Jesiotr, M.
  • Bodnar, L.
  • Quintela-Fandino, M.
  • López-Bigas, N.
  • Valdés-Mas, R.
  • Puente, X. S.
  • Viñals, F.
  • Casanovas, O.
  • Graupera, M.
  • Hernández-Losa, L.
  • Ramón y Cajal, S.
  • García-Alonso, L.
  • Sáez-Rodríguez, J.
  • Esteller, M.
  • Sierra, A.
  • Martín-Martín, N.
  • Matheu, A.
  • Carracedo, A.
  • González-Suárez, E.
  • Nanjundan, M.
  • Cortés, J.
  • Lázaro, C.
  • Odero, M. D.
  • Martens, J. W. M.
  • Moreno-Bueno, Gema
  • Barcellos-Hoff, M. H.
  • Villanueva, A.
  • Gomis, R. R.
  • Pujana, M. A.
13 páginas, 7 figuras, Inhibitors of the mechanistic target of rapamycin (mTOR) are currently used to treat advanced metastatic breast cancer. However, whether an aggressive phenotype is sustained through adaptation or resistance to mTOR inhibition remains unknown. Here, complementary studies in human tumors, cancer models and cell lines reveal transcriptional reprogramming that supports metastasis in response to mTOR inhibition. This cancer feature is driven by EVI1 and SOX9. EVI1 functionally cooperates with and positively regulates SOX9, and promotes the transcriptional upregulation of key mTOR pathway components (REHB and RAPTOR) and of lung metastasis mediators (FSCN1 and SPARC). The expression of EVI1 and SOX9 is associated with stem cell-like and metastasis signatures, and their depletion impairs the metastatic potential of breast cancer cells. These results establish the mechanistic link between resistance to mTOR inhibition and cancer metastatic potential, thus enhancing our understanding of mTOR targeting failure., This study was supported by the following bodies and grants: the Scientific Foundation ‘Asociación Española Contra el Cáncer’ (AECC, Stable Coordinated Group, Hereditary Cancer); the BBVA Foundation; the Eugenio Rodríguez Pascual Foundation grant 2012; Generalitat de Catalunya AGAUR SGR 2012 grants 283, 290 and 312, and SGR 2014 grants 364, 530, and 535; Spanish Ministry of Health ISCIII FIS grants PI10/00057, PI10/00222, PI10/01422, PI12/01528, PI13/00132, and PI14/00336. ISCIII RTICC grants RD06/0020/1051, RD12/0036/0007, RD12/0036/0008 and RD12/0036/0063; Spanish Ministry of Science and Innovation, ‘Fondo Europeo de Desarrollo Regional (FEDER), una manera de hacer Europa’, MINECO grants SAF2010- 20203 and SAF2013-46196; and the Telemaraton 2014 ‘Todos Somos Raros, Todos Somos Únicos’ grant P35. EJA was supported by ‘la Caixa’ PhD fellowship program, F Iorio was supported by a fellowship from the EMBL-EBI and the Wellcome Trust Sanger Institute Postdoctoral (ESPOD) program, and NL-B, ME and RRG were supported by ICREA., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Estimating mutation rates in low-replication experiments

  • Couce, Alejandro
  • Blázquez Gómez, Jesús
Since mutation rate is a key biological parameter, its proper estimation has received great attention for decades. However, instead of the mutation rate, many authors opt for reporting the average mutant frequency, a less meaningful quantity. This is because the standard methods to estimate the mutation rate, derived from the Luria and Delbrück's fluctuation analysis, ideally require high-replication experiments to be applied; a requirement often unattainable due to constraints of time, budget or sample availability. But the main problem with mutant frequency, apart from being less informative, is its poor reproducibility; an especially marked defect when the chosen average is the arithmetic mean. Several authors tried to avoid this by employing other averages (such as the median or the geometric mean) or discarding outliers, though as far as we know nobody has evaluated which method performs best under low-replication settings. Here we use computer simulations to compare the performance of different methods used in low-replication experiments (≤4 cultures). Besides the customary averages of mutant frequency, we also tested two well-known fluctuation methods. Contrary to common practice, our results support that fluctuation methods should be applied in such circumstances, as they perform as well as or better than any average of mutant frequency. In particular, experimentalists will benefit from using MSS maximum likelihood in low-replication experiments because it: (i) provides more reproducible results, (ii) allows for direct estimation of mutation rate and (iii) allows for the application of conventional statistics., This work was supported by grant PI070215 of Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008) and the PAR project (Ref. 241476) from EU 7th Framework Programme. We wish to thank J. Rodríguez-Beltrán, J.R. Guelfo and A. Rodríguez-Rojas for stimulating comments in the early steps of this work. We are also grateful to J.F. Poyatos and A. Rodríguez-Rojas for the helpful proofreading of the manuscript, and to J.W. Drake and an anonymous referee for their valuable suggestions to improve this article., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials

  • Thi, Thuy Do
  • López, Elena
  • Rodríguez-Rojas, Alexandro
  • Rodríguez-Beltrán, Jerónimo
  • Couce, Alejandro
  • Guelfo, Javier R
  • Castañeda-García, Alfredo
  • Blázquez, Jesús
Low concentrations of some antibiotics have been reported to stimulate mutagenesis and recombination, which may facilitate bacterial adaptation to different types of stress, including antibiotic pressure. However, the mutagenic effect of most of the currently used antibiotics remains untested. Furthermore, it is known that in many bacteria, including Escherichia coli, stimulation of mutagenesis is mediated by the SOS response. Thus, blockage or attenuation of this response through the inhibition of RecA has been proposed as a possible therapeutic adjuvant in combined therapy to reduce the ability to generate antibiotic-resistant mutants. The aim of this work was to study the capacity of sublethal concentrations of antimicrobials of different families with different molecular targets to increase the mutant frequency of E. coli, and the effect that inactivation of recA would have on antibiotic-mediated mutagenesis., This work was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (ISCIII) co-financed by the European Development Regional Fund ‘A way to achieve Europe’ ERDF, the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008) and grant PI070215 from ISCIII and the European Community (PAR, FP7-HEALTH-2009-241476). T. D. T. is the recipient of a JAE predoc fellowship from the CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study

  • García-Gutiérrez, María Salud
  • Torregrosa, Abraham B.
  • Navarrete, Francisco
  • Aracil-Fernández, Auxiliadora
  • Rubio, Gabriel
  • Manzanares, Jorge
[Aims] To describe differences in the expression of genes encoding cannabinoid receptors (CNR1, CNR2), the associated receptor GRP55 and the enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGLL) between individuals with alcohol use disorder (AUD) and controls in key mesocorticolimbic brain regions., [Design] Case-control, observational postmortem study comparing gene expression in brain tissue from individuals diagnosed with AUD and matched controls. The study was not pre-registered and should therefore be considered exploratory., [Setting] Brain collection from the New South Wales Tissue Resource Centre (NSWTRC) at the University of Sydney, Australia., [Participants/cases] Brain samples were obtained from 18 patients with AUD (mean alcohol use = 35.5 ± 8.7 drinking years) and 18 controls (C). Groups were matched for age (AUD: 55.8 ± 9; C: 56.3 ± 9.4) and postmortem interval (AUD: 39.7 ± 16.9 h; C: 31.8 ± 13.2 h)., [Measurements] Relative gene expression of CNR1, CNR2, GPR55, FAAH and MGLL was quantified using real-time polymerase chain reaction (qPCR) in the prefrontal cortex (PFC) and nucleus accumbens (NAc)., [Findings] Compared with controls, individuals with AUD showed higher CNR1 in the PFC (+125%) and NAc (+78%) and lower CNR2 expression in both regions (PFC: −50%; NAc: −49%). GPR55 was higher in the PFC (+19%) and lower in the NAc (−51%). FAAH expression was lower in the PFC (−15%) and higher in the NAc (+24%), whereas MGLL expression did not differ in the PFC and was lower in the NAc (−15%)., [Conclusions] This descriptive postmortem study identifying region-specific differences in endocannabinoid system gene expression between individuals with alcohol use disorder (AUD) and controls supports an involvement of the endocannabinoid system in the neuropathological features associated with AUD, although causal relationships cannot be inferred., Tissues were received from the New South Wales Brain Tissue Resource Centre at the University of Sydney, which the University of Sydney supports. Research reported in this publication was supported by the National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health under award number R28AA012725. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. We thank the Bioinformatics Service of the Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain, for providing statistical support., This research was supported by grants from the Ministry of Health, Spain (PNSD 2011/043), ‘Red Temática de Investigación Cooperativa en Salud’ (RETICS, Instituto de Salud Carlos III, MICINN and FEDER, Madrid, Spain, ‘Red Nacional de Trastornos Adictivos’, RD06/0001/1004) and Red de Investigación en Atención Primaria de Adicciones, Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, grant number RD21/0009/0008 and RD24/0003/0002 to J.M. and Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). The Instituto de Neurociencias is a ‘Centre of Excellence Severo Ochoa’ (CEX2021-001165-S). A.B.T. is a predoctoral fellow supported by Red de Investigación en Atención Primaria de Adicciones (Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, grant number RD21/0009/0008 and RD24/0003/0002)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Associations between frailty and serum N-terminal propeptide of type I procollagen and 25-hydroxyvitamin D in older Spanish women: The Toledo Study fo, Associations between frailty and serum N-terminal propeptide of type I procollagen and 25-hydroxyvitamin D in older Spanish women: The Toledo Study for Healthy Aging

  • Álvarez-Ríos, Ana Isabel
  • Guerrero Montávez, Juan Miguel
  • García-García, Francisco José
  • Rodríguez-Mañas, Leocadio
  • Medrano-Campillo, Pablo
  • Torre Lanza, María A. de la
  • Álvarez-Sánchez, Nuria
  • Carrillo-Vico, Antonio
Frail older people are at high risk for fractures and falls increasing the rates of institutionalization and mortality. Bone markers have been related to both aging and fractures. However, no previous reports have shown a potential relationship between serum bone markers such as N-terminal propeptide of type I procollagen (PINP), C-terminal telopeptide of type I collagen (β-CTX) and parathyroid hormone (PTH) with frailty in elderly female populations. This study is aimed at examining the associations of bone metabolism markers and frailty in older Spanish women through a descriptive cross-sectional analysis based on a cohort of the Toledo Study for Healthy Aging (TSHA). The levels of serum PINP, β-CTX, PTH and 25-hydroxyvitamin D (25(OH)D) were assessed in 592 participants (median age 74 years) who were defined as robust, prefrail and frail according to Fried's approach. Frail subjects had significantly high levels of PINP, β-CTX and PTH and low production of 25(OH)D. After adjustment for confounders, high PINP levels (defined by the upper quartile) and low levels of 25(OH)D (lower quartile) remained significantly associated to frailty [OR for PINP: 2.19 (95% CI, 1.15–4.18; P = 0.017); OR for 25(OH)D: 1.65 (95% CI, 1.02–2.67; P = 0.042)]. Women with both high PINP levels and low 25(OH)D levels presented a 5.85-fold increased frailty risk (95% CI, 1.64–20.93; P = 0.007). The main contribution of this paper is the novel definition of PINP and 25(OH)D markers as potential biomarkers of frailty and targets for intervention., This study was supported by the National Net RETICEF for Aging studies [Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad], grants PI07/90175, RD06/0013/0001, RD12/0043/0012 and RD12/0043, from the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion) and the PAIDI Program from the Andalusian Government (CTS160)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: A systematic review

  • Sanada, K.
  • Alda Díez, M.
  • Salas Valero, M.
  • Pérez-Yus, M.C.
  • Demarzo, M.M.P.
  • García-Toro, M.
  • García-Campayo, J.
Introduction: Fibromyalgia (FM) is a prevalent disorder. However, few studies have evaluated the effect of treatment interventions on biomarker expression. The aim of this review was to explore the efficacy of non-pharmacological interventions on inflammatory biomarker expression, specifically cytokines, neuropeptides and C-reactive protein (CRP), in FM patients. Method: A literature search using PubMed, EMBASE, PsycINFO and the Cochrane library was performed from January 1990 to March 2015. Randomized controlled trials (RCTs) and non-RCTs published in English, French or Spanish were eligible. Results: Twelve articles with a total of 536 participants were included. After exercise, multidisciplinary, or dietary interventions in FM patients, interleukin (IL) expression appeared reduced, specifically serum IL-8 and IL-6 (spontaneous, lipopolysaccharide (LPS)-induced, or serum). Furthermore, the changes to insulin-like growth factor 1 (IGF-1) levels might indicate a beneficial role for fatigue in obese FM patients. In contrast, evidence of changes in neuropeptide and CRP levels seemed inconsistent. Conclusion: Despite minimal evidence, our findings indicate that exercise interventions might act as an anti-inflammatory treatment in FM patients and ameliorate inflammatory status, especially for pro-inflammatory cytokines. Additional RCTs focused on the changes to inflammatory biomarker expression after non-pharmacological interventions in FM patients are needed.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Suicidality in primary care patients who present with sadness and anhedonia: A prospective European study

  • Moreno-Küstner, B.
  • Jones, R.
  • Švab, I.
  • Maaroos, H.
  • Xavier, M.
  • Geerlings, M.
  • Torres-González, F.
  • Nazareth, I.
  • Motrico-Martínez, E.
  • Montón-Franco, C.
  • Gil-de-Gómez, M.J.
  • Sánchez-Celaya, M.
  • Díaz-Barreiros, M.
  • Vicens-Caldentey, C.
  • King, M.
Background: Sadness and anhedonia (loss of interest in activities) are central symptoms of major depression. However, not all people with these symptoms meet diagnostic criteria for major depression. We aimed to assess the importance of suicidality in the outcomes for primary care patients who present with sadness and anhedonia. Method: Cohort study of 2, 599 unselected primary care attenders in six European countries followed up at 6 and 12 months. Results: 1) In patients with sadness and/or anhedonia who were not depressed at entry to the study, suicide plans (OR = 3.05; 95 % CI = 1.50-6.24; p = 0.0022) and suicide attempts (OR = 9.08; 95 % CI = 2.57-32.03; p = 0.0006) were significant predictors of developing new onset depression at 6 or 12 months. 2) In patients with sadness and/or anhedonia who met CIDI criteria for major depression at entry, suicidal ideation (OR = 2.93; 95 % CI = 1.70-5.07; p = 0.0001), suicide plans (OR = 3.70; 95 % CI = 2.08-6.57; p < 0.0001), and suicide attempts (OR = 3.33; 95 % CI = 1.47-7.54; p = 0.0040) were significant predictors of persistent depression at 6 or 12 months. Conclusions: Three questions on suicidality could help primary care professionals to assess such patients more closely without necessarily establishing whether they meet criteria for major depression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Low intensity vs. self-guided Internet-delivered psychotherapy for major depression: A multicenter, controlled, randomized study

  • López-del-Hoyo, Y.
  • Olivan, B.
  • Luciano, J.V.
  • Mayoral, F.
  • Roca, M.
  • Gili, M.
  • Andres, E.
  • Serrano-Blanco, A.
  • Collazo, F.
  • Araya, R.
  • Baños, R.
  • Botella, C.
  • Magallón, R.
  • García-Campayo, J.
Background: Major depression will become the second most important cause of disability in 2020. Computerized cognitive-behaviour therapy could be an efficacious and cost-effective option for its treatment. No studies on cost-effectiveness of low intensity vs self-guided psychotherapy has been carried out. The aim of this study is to assess the efficacy of low intensity vs self-guided psychotherapy for major depression in the Spanish health system. Methods: The study is made up of 3 phases: 1.- Development of a computerized cognitive-behaviour therapy for depression tailored to Spanish health system. 2.- Multicenter controlled, randomized study: A sample (N=450 patients) with mild/moderate depression recruited in primary care. They should have internet availability at home, not receive any previous psychological treatment, and not suffer from any other severe somatic or psychological disorder. They will be allocated to one of 3 treatments: a) Low intensity Internet-delivered psychotherapy + improved treatment as usual (ITAU) by GP, b) Self-guided Internet-delivered psychotherapy + ITAU or c) ITAU. Patients will be diagnosed with MINI psychiatric interview. Main outcome variable will be Beck Depression Inventory. It will be also administered EuroQol 5D (quality of life) and Client Service Receipt Inventory (consume of health and social services). Patients will be assessed at baseline, 3 and 12 months. An intention to treat and a per protocol analysis will be performed. Discussion: The comparisons between low intensity and self-guided are infrequent, and also a comparative economic evaluation between them and compared with usual treatment in primary. The strength of the study is that it is a multicenter, randomized, controlled trial of low intensity and self-guided Internet-delivered psychotherapy for depression in primary care, being the treatment completely integrated in primary care setting.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Variability in the performance of preventive services and in the degree of control of identified health problems: A primary care study protocol

  • Bolíbar, B.
  • Pareja, C.
  • Astier-Peña, M.P.
  • Morán, J.
  • Rodríguez-Blanco, T.
  • Rosell-Murphy, M.
  • Iglesias, M.
  • Juncosa, S.
  • Mascort, J.
  • Violan, C.
  • Magallón, R.
  • Apezteguia, J.
Background: Preventive activities carried out in primary care have important variability that makes necessary to know which factors have an impact in order to establish future strategies for improvement. The present study has three objectives: 1) To describe the variability in the implementation of 7 preventive services (screening for smoking status, alcohol abuse, hypertension, hypercholesterolemia, obesity, influenza and tetanus immunization) and to determine their related factors; 2) To describe the degree of control of 5 identified health problems (smoking, alcohol abuse, hypertension, hypercholesterolemia and obesity); 3) To calculate intraclass correlation coefficients. Design: Multi-centered cross-sectional study of a randomised sample of primary health care teams from 3 regions of Spain designed to analyse variability and related factors of 7 selected preventive services in years 2006 and 2007. At the end of 2008, we will perform a cross-sectional study of a cohort of patients attended in 2006 or 2007 to asses the degree of control of 5 identified health problems. All subjects older than16 years assigned to a randomised sample of 22 computerized primary health care teams and attended during the study period are included in each region providing a sample with more than 850.000 subjects. The main outcome measures will be implementation of 7 preventive services and control of 5 identified health problems. Furthermore, there will be 3 levels of data collection: 1) Patient level (age, gender, morbidity, preventive services, attendance); 2) Health-care professional level (professional characteristics, years working at the team, workload); 3) Team level (characteristics, electronic clinical record system). Data will be transferred from electronic clinical records to a central database with prior encryption and dissociation of subject, professional and team identity. Global and regional analysis will be performed including standard analysis for primary health care teams and health-care professional level. Linear and logistic regression multilevel analysis adjusted for individual and cluster variables will also be performed. Variability in the number of preventive services implemented will be calculated with Poisson multilevel models. Team and health-care professional will be considered random effects. Intraclass correlation coefficients, standard error and variance components for the different outcome measures will be calculated.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Perceived stress latent factors and the burnout subtypes: A structural model in dental students

  • Montero-Marín, J.
  • Piva Demarzo, M. M.
  • Stapinski, L.
  • Gili, M.
  • García-Campayo, J.
Background: Students of health-professions suffer high levels of stress and burnout. The aim of the present study was to evaluate the relationship between perceived stress latent factors (''tenseness'' and ''frustration'') and the features (''overload'', ''lack of development'' and ''neglect'') of the three burnout subtypes (''frenetic'', ''under-challenged'' and ''worn-out'', respectively), in a sample of Spanish dental students. Methods: The study employed a cross-sectional design. A sample of Spanish dental students (n = 314) completed the ''Perceived Stress Questionnaire'' and the ''Burnout Clinical Subtype Questionnaire Student Survey''. The associations among variables were observed by means of structural equation modelling using the unweighted least squares method from polychoric correlations. Results: Strong associations among perceived stress factors and the burnout characteristics were observed, although a distinct pattern of relations was observed for each burnout subtype. The ''overload'' was moderately and positively associated with both ''tenseness'' (0.45), and ''frustration'' (0.38) dimensions of perceived stress; the ''lack of development'' was positively associated with the ''frustration'' dimension (0.72), but negatively associated with ''tenseness'' (20.69); the ''neglect'' showed a weaker positive associated with ''frustration'' (0.41), and a small negative association with ''tenseness'' (20.20). The model was a very good fit to the data (GFI = 0.96; RSMR = 0.07; AGFI = 0.96; NFI = 0.95; RFI = 0.95). Conclusions: The stress factors of ''frustration'' and ''tenseness'' seems to be related in a distinct way to the burnout subtypes in Spanish dental students. This finding suggests that intervention programs specifically tailored to these subtypes may be a promising future direction.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Reassessment of the psychometric characteristics and factor structure of the 'Perceived Stress Questionnaire' (PSQ): Analysis in a sample of dental students

  • Montero-Marin, J.
  • Piva Demarzo, M. M.
  • Pereira, J. P.
  • Olea, M.
  • García-Campayo, J.
Background: The training to become a dentist can create psychological distress. The present study evaluates the structure of the ''Perceived Stress Questionnaire'' (PSQ), its internal consistency model and interrelatedness with burnout, anxiety, depression and resilience among dental students. Methods: The study employed a cross-sectional design. A sample of Spanish dental students (n = 314) completed the PSQ, the ''Goldberg Anxiety and Depression Scale'' (GADS), ''Connor-Davidson Resilience Scale'' (10-item CD-RISC) and ''Maslach Burnout Inventory-Student Survey'' (MBI-SS). The structure was estimated using Parallel Analysis from polychoric correlations. Unweighted Least Squares was the method for factor extraction, using the Item Response Theory to evaluate the discriminative power of items. Internal consistency was assessed by squaring the correlation between the latent true variable and the observed variable. The relationships between the PSQ and the other constructs were analysed using Spearman''s coefficient. Results: The results showed a PSQ structure through two sub-factors (''frustration'' and ''tenseness'') with regard to one general factor (''perceived stress''). Items that did not satisfy discriminative capacity were rejected. The model fit were acceptable (GFI = 0.98; RSMR = 0.06; AGFI = 0.98; NFI = 0.98; RFI = 0.98). All the factors showed adequate internal consistency as measured by the congeneric model (=0.91). High and significant associations were observed between perceived stress and burnout, anxiety, depression and resilience. Conclusions: The PSQ showed a hierarchical bi-factor structure among Spanish dental students. Using the questionnaire as a uni-dimensional scale may be useful in perceived stress level discrimination, while the sub-factors could help us to refine perceived stress analysis and improve therapeutic processes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Predicting the onset of anxiety syndromes at 12 months in primary care attendees. The predictA-Spain study

  • Moreno-Peral, P.
  • De Dios Luna, J.
  • Marston, L.
  • King, M.
  • Nazareth, I.
  • Motrico, E.
  • Gildegómez-Barragán, M. J.
  • Torres-González, F.
  • Montón-Franco, C.
  • Sánchez-Celaya, M.
  • Díaz-Barreiros, M. A.
  • Vicens, C.
  • Muñoz-Bravo, C.
  • Bellón, J. Á.
Background: There are no risk algorithms for the onset of anxiety syndromes at 12 months in primary care. We aimed to develop and validate internally a risk algorithm to predict the onset of anxiety syndromes at 12 months. Methods: A prospective cohort study with evaluations at baseline, 6 and 12 months. We measured 39 known risk factors and used multilevel logistic regression and inverse probability weighting to build the risk algorithm. Our main outcome was generalized anxiety, panic and other non-specific anxiety syndromes as measured by the Primary Care Evaluation of Mental Disorders, Patient Health Questionnaire (PRIME-MD-PHQ). We recruited 3, 564 adult primary care attendees without anxiety syndromes from 174 family physicians and 32 health centers in 6 Spanish provinces. Results: The cumulative 12-month incidence of anxiety syndromes was 12.2%. The predictA-Spain risk algorithm included the following predictors of anxiety syndromes: province; sex (female); younger age; taking medicines for anxiety, depression or stress; worse physical and mental quality of life (SF-12); dissatisfaction with paid and unpaid work; perception of financial strain; and the interactions sex*age, sex*perception of financial strain, and age*dissatisfaction with paid work. The C-index was 0.80 (95% confidence interval = 0.78-0.83) and the Hedges'' g = 1.17 (95% confidence interval = 1.04-1.29). The Copas shrinkage factor was 0.98 and calibration plots showed an accurate goodness of fit. Conclusions: The predictA-Spain risk algorithm is valid to predict anxiety syndromes at 12 months. Although external validation is required, the predictA-Spain is available for use as a predictive tool in the prevention of anxiety syndromes in primary care.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Coping with stress and types of burnout: Explanatory power of different coping strategies

  • Montero-Marin, J.
  • Prado-Abril, J.
  • Piva Demarzo, M. M.
  • Gascon, S.
  • García-Campayo, J.
Background: Burnout occurs when professionals use ineffective coping strategies to try to protect themselves from work-related stress. The dimensions of ''overload'', ''lack of development'' and ''neglect'', belonging to the ''frenetic'', ''underchallenged'' and ''worn-out'' subtypes, respectively, comprise a brief typological definition of burnout. The aim of the present study was to estimate the explanatory power of the different coping strategies on the development of burnout subtypes. Methods: This was a cross-sectional survey with a random sample of university employees, stratified by occupation (n = 429). Multivariate linear regression models were constructed between the ''Burnout Clinical Subtypes Questionnaire'', with its three dimensions -overload, lack of development and neglect- as dependent variables, and the ''Coping Orientation for Problem Experiences'', with its fifteen dimensions, as independent variables. Adjusted multiple determination coefficients and beta coefficients were calculated to evaluate and compare the explanatory capacity of the different coping strategies. Results: The ''Coping Orientation for Problem Experiences'' subscales together explained 15% of the ''overload'' (p<0.001), 9% of the ''lack of development'' (p<0.001), and 21% of the ''neglect'' (p<0.001). ''Overload'' was mainly explained by ''venting of emotions'' (Beta = 0.34; p<0.001); ''lack of development'' by ''cognitive avoidance'' (Beta = 0.21; p<0.001); and ''neglect'' by ''behavioural disengagement'' (Beta = 0.40; p<0.001). Other interesting associations were observed. Conclusions: These findings further our understanding of the way in which the effectiveness of interventions for burnout may be improved, by influencing new treatments and preventive programmes using features of the strategies for handling stress in the workplace.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A personalized intervention to prevent depression in primary care: cost-effectiveness study nested into a clustered randomized trial

  • Fernandez, A.
  • Mendive, J.M.
  • Conejo-Ceron, S.
  • Moreno-Peral, P.
  • King, M.
  • Nazareth, I.
  • Martin-Perez, C.
  • Fernandez-Alonso, C.
  • Rodriguez-Bayon, A.
  • Aiarzaguena, J.M.
  • Monton-Franco, C.
  • Serrano-Blanco, A.
  • Ibanez-Casas, I.
  • Rodriguez-Sanchez, E.
  • Salvador-Carulla, L.
  • Garay, P.B.
  • Ballesta-Rodriguez, M.I.
  • LaFuente, P.
  • Munoz-Garcia, M.D.
  • Minguez-Gonzalo, P.
  • Araujo, L.
  • Palao, D.
  • Gomez, M.C.
  • Zubiaga, F.
  • Navas-Campana, D.
  • Aranda-Regules, J.M.
  • Rodriguez-Morejon, A.
  • Luna, J.D.
  • Bellon, J.A.
Background: Depression is viewed as a major and increasing public health issue, as it causes high distress in the people experiencing it and considerable financial costs to society. Efforts are being made to reduce this burden by preventing depression. A critical component of this strategy is the ability to assess the individual level and profile of risk for the development of major depression. This paper presents the cost-effectiveness of a personalized intervention based on the risk of developing depression carried out in primary care, compared with usual care. Methods: Cost-effectiveness analyses are nested within a multicentre, clustered, randomized controlled trial of a personalized intervention to prevent depression. The study was carried out in 70 primary care centres from seven cities in Spain. Two general practitioners (GPs) were randomly sampled from those prepared to participate in each centre (i.e. 140 GPs), and 3326 participants consented and were eligible to participate. The intervention included the GP communicating to the patient his/her individual risk for depression and personal risk factors and the construction by both GPs and patients of a psychosocial programme tailored to prevent depression. In addition, GPs carried out measures to activate and empower the patients, who also received a leaflet about preventing depression. GPs were trained in a 10- to 15-h workshop. Costs were measured from a societal and National Health care perspective. Qualityadjustedlife years were assessed using the EuroQOL five dimensions questionnaire. The time horizon was 18 months. Results: With a willingness-to-pay threshold of (sic)10, 000 ((sic)8568) the probability of cost-effectiveness oscillated from 83% (societal perspective) to 89% (health perspective). If the threshold was increased to (sic)30, 000 ((sic)25, 704), the probability of being considered cost-effective was 94% (societal perspective) and 96%, respectively (health perspective). The sensitivity analysis confirmed these results. Conclusions: Compared with usual care, an intervention based on personal predictors of risk of depression implemented by GPs is a cost-effective strategy to prevent depression. This type of personalized intervention in primary care should be further developed and evaluated.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Emergency presentation of colorectal patients in Spain

  • Esteva, M.
  • [Ruidíaz], M.
  • Sanchez, M.A.
  • Pertega, S.
  • Pita-Fernandez, S.
  • Macia, F.
  • Posso, M.
  • Gonzalez-Lujan, L.
  • Bosca-Wats, M.M.
  • Leiva, A.
  • Ripoll, J.
Background Colorectal cancer (CRC) is the leading cause of cancer deaths in Europe. Survival is poorer in patients admitted to hospitals through the emergency department than in electively admitted patients. Knowledge of factors associated with a cancer diagnosis through presentation at an emergency department may reduce the likelihood of an emergency diagnosis. This study evaluated factors influencing the diagnosis of CRC in the emergency department. Methods and findings This is a cross-sectional study in 5 Spanish regions; subjects were incident cases of CRC diagnosed in 9 public hospitals, between 2006 and 2008. Data were obtained from patient interviews and primary care and hospital clinical records. We found that approximately 40% of CRC patients first contacted a hospital for CRC through an emergency service. Women were more likely than men to be emergency presenters. The type of symptom associated with emergency presentation differed between patients with colon cancer and those with rectal cancer, in that the frequency of "alarm symptoms" was significantly lower in colon than in rectal cancer patients who initially presented to emergency services. Soon after symptom onset, some patients went to a hospital emergency service, whereas others contacted their GP. Lack of contact with a GP for CRC-related symptoms was consistently related to emergency presentation. Among patients who contacted a GP, a higher number of consultations for CRC symptoms and any referral to outpatient consultations reduced the likelihood of emergency presentation. All diagnostic time intervals were shorter in emergency presenters than in elective patients. Conclusions Emergency presenters are not a uniform category and can be divided into categories according to their symptoms, help seeking behavior trajectory and interaction with their GPs. Time constraints for testing and delays in obtaining outpatient appointments led patients to visit a hospital service either on their own or after referral by their GP.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Reseña (Review)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies

  • Prieto-Torres, L.
  • Rodriguez-Pinilla, S.M.
  • Onaindia, A.
  • Ara, M.
  • Requena, L.
  • Piris, M.Á.
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders are the second most common subgroup of cutaneous T-cell lymphomas. They include two clinically different entities with some overlapping features and borderline cases: lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. Molecular studies of primary cutaneous anaplastic large cell lymphoma reveal an increasing level of heterogeneity that is associated with histological and immunophenotypic features of the cases and their response to specific therapies. Here, we review the most significant genetic, epigenetic and molecular alterations described to date in primary cutaneous CD30-positive T-cell lymphoproliferative disorders, and their potential as therapeutic targets.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Influencia de la obesidad y la ganancia de peso sobre la calidad de vida según el SF-36 en individuos de la cohorte dinámica Seguimiento Universidad de Navarra

  • Barcones-Molero, M.F.
  • Sánchez-Villegas, A.
  • Martínez-González, M.A.
  • Bes-Rastrollo, M.
  • Martínez-Urbistondo, M.
  • Santabárbara, J.
  • Martínez, J.A.
Antecedentes La calidad de vida relacionada con la salud es un elemento importante en la valoración integral del sobrepeso y la obesidad. Objetivo Evaluar el impacto de la obesidad y la ganancia de peso sobre la calidad de vida relacionada con la salud en la cohorte dinámica Seguimiento Universidad de Navarra. Materiales y métodos Los análisis incluyeron a 10.033 participantes de la cohorte dinámica prospectiva del Proyecto Seguimiento Universidad de Navarra, con una tasa de respuesta de aproximadamente el 90%. La calidad de vida fue medida con la versión abreviada de la Encuesta de Salud (SF-36) (0: peor calidad de vida, 100: mejor calidad de vida). El análisis estadístico se realizó con modelos lineales generalizados (media de cada dominio del SF-36 e IC al 95%). Una diferencia de 3 puntos fue considerada como clínicamente relevante. Resultados El análisis del SF-36 mostró que la función física, la salud general y la variable física sumario fueron inferiores en las personas con sobrepeso y obesidad al inicio del estudio que en los individuos con normopeso. La población a estudio con sobrepeso u obesidad sin cambios tras 2 años de seguimiento presentó peores puntuaciones en los dominios del SF-36 correspondientes a la función física, dolor corporal, variable física sumario y salud general que los individuos que mantuvieron la categoría del normopeso según el IMC (kg/m2). Conclusiones La obesidad parece asociarse a un impacto negativo sobre la calidad de vida relacionada con la salud, que afecta más significativamente al área física que a la psicosocial. Background: The health-related quality of life is an important element for the comprehensive assessment of overweight and obesity. Objective: To assess the impact of obesity and weight gain on the health-related quality of life of the dynamic cohort of the Follow-up Program of the University of Navarra. Material and methods: The analysis included 10, 033 participants of the prospective dynamic cohort of the Follow-up Project of the University of Navarra, with a response rate of approximately 90%. The quality of life was measured with the Short Form 36 Health Survey (SF-36) (0, worst quality of life; 100, best quality of life). The statistical analysis was performed with generalized lineal models (mean of each SF-36 domain and 95% CI). A difference of 3 points was considered clinically relevant. Results: The SF-36 analysis showed that physical function, general health and the physical component summary were inferior in individuals with excess weight and obesity at the start of the study, compared with individuals with normal weight. The study population with unchanged excess weight or obesity after 2 years of follow-up presented lower scores on the SF-36 domains corresponding to physical function, body pain, physical component summary and general health than individuals who maintained the normal weight category according to BMI (kg/m2). Conclusions: Obesity appears to be associated with a negative impact on health-related quality of life, affecting the physical area more significantly than the psychosocial.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effects of attachment-based compassion therapy (ABCT) on brain-derived neurotrophic factor and low-grade inflammation among fibromyalgia patients: A randomized controlled trial

  • Montero-Marin, Jesús
  • Andrés-Rodríguez, Laura
  • Tops, Mattie
  • Luciano, Juan V.
  • Navarro-Gil, Mayte
  • Feliu-Soler, Albert
  • López-del-Hoyo, Yolanda
  • Garcia-Campayo, Javier
Fibromyalgia (FM) is a disabling syndrome characterized by chronic pain associated with fatigue. Its pathogenesis is unknown, but alterations in central sensitization, involving an imbalance of brain-derived neurotrophic factor (BDNF) and inflammatory biomarkers, appear to be implicated. The aim of this study was to evaluate the impact of attachment-based compassion therapy (ABCT) on levels of BDNF, the inflammatory markers TNF-a, IL-6, IL-10, and the C-reactive protein (CRP), analysing whether biomarkers play a mediating/moderating role in improvements in FM functional status. Thirty-four female patients with FM participated in a RCT and were assigned to ABCT or relaxation therapy. Blood extractions were conducted at baseline and post-intervention, with self-report assessments of functional status (FIQ) at baseline, post-intervention and 3-month follow-up. A pro-inflammatory composite was obtained by summing up IL-6, TNF-a and CRP normalized values. Non-parametric tests, analysis of variance and regression models were used to evaluate treatment and mediation/moderation. Compared to relaxation therapy, ABCT showed significant improvements in FIQ and decreases in BDNF, CRP, and pro-inflammatory composite. Changes in BDNF had a mediating role in FIQ. ABCT seems to reduce BDNF and appears to have anti-inflammatory effects in FM patients. Reductions in BDNF could be a mechanism of FM functional status improvement.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

  • Fernandez-Berges, D.
  • Degano, I.R.
  • Fernandez, R.G.
  • Subirana, I.
  • Vila, J.
  • Jimenez-Navarro, M.
  • Perez-Fernandez, S.
  • Roque, M.
  • Bayes-Genis, A.
  • Fernandez-Aviles, F.
  • Mayorga, A.
  • Bertomeu-Gonzalez, V.
  • Sanchis, J.
  • Esteban, M.R.
  • Sanchez-Hidalgo, A.
  • Sanchez-Insa, E.
  • Elorriaga, A.
  • Abu Assi, E.
  • Nunez, A.
  • Ruiz, J.M.G.
  • Valdeolmillos, P.M.
  • Bosch-Portell, D.
  • Lekuona, I.
  • Carrillo-Lopez, A.
  • Zamora, A.
  • Vega-Hernandez, B.
  • Serrano, J.A.
  • Rubert, C.
  • Ruiz-Valdepenas, L.
  • Quintas, L.
  • Rodriguez-Padial, L.
  • Vaquero, J.
  • Martinez Dolz, L.
  • Barrabes, J.A.
  • Sanchez, P.L.
  • Sionis, A.
  • Marti-Almor, J.
  • Elosua, R.
  • Lidon, R.M.
  • Garcia-Dorado, D.
  • Marrugat, J.
Objective: Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI >= 75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. The objective of this analysis was to determine the effectiveness of P-PCI in patients with STEMI >= 75 years. Methods: We included 979 patients with STEMI >= 75 years, from the ATencion HOspitalaria del Sindrome coronario study, a registry of 8142 consecutive patients with acute coronary syndrome admitted at 31 Spanish hospitals in 2014-2016. We calculated a propensity score (PS) for the indication of P-PCI. Patients that received or not P-PCI were matched by PS. Using logistic regression, we compared the effectiveness of performing P-PCI versus non-performance for the composite primary event, which included death, reinfarction, acute pulmonary oedema or cardiogenic shock during hospitalisation. Results: Of the included patients, 81.5 % received P-PCI. The matching provided two groups of 169 patients with and without P-PCI. Compared with its non-performance, P-PCI presented a composite event OR adjusted by PS of 0.55 (95% CI 0.34 to 0.89). Conclusions: Receiving a P-PCI was significantly associated with a reduced risk of major intrahospital complications in patients with STEMI aged 75 years or older.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

  • Beltrán-Pavez, C.
  • Gutiérrez-López, M.
  • Rubio-Garrido, M.
  • Valadés-Alcaraz, A.
  • Prieto, L.
  • Ramos, J.T.
  • Jiménez De Ory, S.
  • Navarro, M.
  • Díez-Romero, C.
  • Pulido, F.
  • Valencia, E.
  • Holguín, Á.
  • Mellado, M.J.
  • Escosa, L.
  • García Hortelano, M.
  • Sainz, T.
  • González-Tomé, M.I.
  • Rojo, P.
  • Blázquez, D.
  • Prieto-Tato, L.
  • Epalza, C.
  • Ramos, J.T.
  • Guillén, S.
  • Navarro, M.L.
  • Saavedra, J.
  • Santos, M.
  • Santiago, B.
  • Aguilera-Alonso, D.
  • Jiménez De Ory, S.
  • Carrasco, I.
  • Roa, M.Á.
  • Penín, M.
  • Martínez, J.
  • Badillo, K.
  • Oñate, E.
  • Pocheville, I.
  • Garrote, E.
  • Colino, E.
  • Gómez Sirvent, J.
  • Garzón, M.
  • Román, V.
  • Angulo, R.
  • Neth, O.
  • Falcón, L.
  • Terol, P.
  • Santos, J.L.
  • Moreno, D.
  • Lendínez, F.
  • Peromingo, E.
  • Uberos, J.
  • Ruiz, B.
  • Grande, A.
  • Romero, F.J.
  • Pérez, C.
  • Lillo, M.
  • Losada, B.
  • Herranz, M.
  • Bustillo, M.
  • Collado, P.
  • Couceiro, J.A.
  • Vila, L.
  • Calviño, C.
  • Piqueras, A.I.
  • Oltra, M.
  • Gavilán, C.
  • Montesinos, E.
  • Dapena, M.
  • Álvarez, C.
  • Jiménez, B.
  • Andrés, A.G.
  • Marugán, V.
  • Ochoa, C.
  • Alfayate, S.
  • Menasalvas, A.I.
  • Ruiz Del Prado, Y.
  • Soler-Palacín, P.
  • Frick, M.A.
  • Mur, A.
  • López, N.
  • Méndez, M.
  • Mayol, L.
  • Vallmanya, T.
  • Calavia, O.
  • García, L.
  • Coll, M.T.
  • Pineda, V.
  • Rius, N.
  • Dueñas, J.
  • Fortuny, C.
  • Noguera-Julián, A.
  • Bernardino, I.
  • Montes, M.L.
  • Valencia, E.
  • Rubio, R.
  • Pulido, F.
  • Bisbal, O.
  • Gaspar Alonso, G.
  • Berenguer, J.
  • Díez, C.
  • Aldamiz, T.
  • Montilla, P.
  • Bermúdez, E.
  • Valerio, M.
  • Sanz, J.
  • Arponen, S.
  • Gimeno, A.
  • Cervero, M.
  • Torres, R.
  • Moreno, S.
  • Pérez, M.ªJ.
  • Ryan, P.
  • Troya, J.
  • Sanz, J.
  • Losa, J.
  • Gómez, R.
  • Iribarren, J.A.
  • Rodríguez, F.
  • Pascual, L.
  • Aramburu, M.J.
  • Goikoetxea, A.J.
  • Aguirrebengoa, L.
  • Muñoz, J.
  • Ibarra, S.
  • Hernández, M.
  • Gómez Sirvent, J.L.
  • Rodríguez, J.
  • Cárdenes, M.Á.
  • López-Cortés, L.F.
  • Roca, C.
  • Llaves, S.
  • Ríos, M.J.
  • Rodríguez, J.
  • Palomo, V.
  • Pasquau, J.
  • García, C.
  • Hernández, J.
  • Martínez, C.
  • Rivero, A.
  • Camacho, Á.
  • Merino, D.
  • Martínez, E.
  • Mateos, F.
  • Blanch, J.J.
  • Torralba, M.
  • Arazo, P.
  • Samperiz, G.
  • Crusells, M.J.
  • San Joaquín, I.
  • Miralles, C.
  • Ocampo, A.
  • Pousada, G.
  • Mena, Á.
  • Montero, M.
  • Salavert, M.
  • Cuéllar, S.
  • Galindo, M.J.
  • Ferrando, R.
  • Portilla, J.
  • Portilla, I.
  • Gutiérrez, F.
  • Masiá, M.
  • Robledano, C.
  • Adsuar, A.
  • Hinojosa, C.
  • Bachiller, P.
  • Abadía, J.
  • Mostaza, J.L.
  • Pérez, R.
  • Galera, C.
  • Albendín, H.
  • Pérez, A.
  • Blanco, J.R.
  • Burgos, J.
  • Torres, B.
  • Lazzari, E.
The aim of this transversal study was to describe the virological and immunological features of HIV-infected youths transferred from pediatric to adult care units since 1997 vs. the non-transferred patients from the Madrid Cohort of HIV-infected children and adolescents in Spain. We included 106 non-transferred and 184 transferred patients under clinical follow-up in 17 public hospitals in Madrid by the end of December 2017. Virological and immunological outcomes were compared in transferred vs. non-transferred patients. ART drug resistance mutations and HIV-variants were analyzed in all subjects with available resistance pol genotypes and/or genotypic resistance profiles. Among the study cohort, 133 (72.3%) of 184 transferred and 75 (70.7%) of 106 non-transferred patients had available resistance genotypes. Most (88.9%) of transferred had ART experience at sampling. A third (33.3%) had had a triple-class experience. Acquired drug resistance (ADR) prevalence was significantly higher in pretreated transferred than non-transferred patients (71.8% vs. 44%; p = 0.0009), mainly to NRTI (72.8% vs. 31.1%; p < 0.0001) and PI (29.1% vs. 12%; p = 0.0262). HIV-1 non-B variants were less frequent in transferred vs. non-transferred (6.9% vs. 32%; p < 0.0001). In conclusion, the frequent resistant genotypes found in transferred youths justifies the reinforcement of HIV resistance monitoring after the transition to avoid future therapeutic failures.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand

  • Crichton, S.
  • Belfrage, E.
  • Collins, I.J.
  • Doerholt, K.
  • Judd, A.
  • Le Coeur, S.
  • Spoulou, V.
  • Goodall, R.
  • Scherpbier, H.
  • Smit, C.
  • Goetghebuer, T.
  • Gibb, D.M.
  • Noguera, A.
  • Navarro, M.L.
  • Ramos, J.T.
  • Galli, L.
  • Giaquinto, C.
  • Thorne, C.
  • Santa Ansone.
  • Marczynska, M.
  • Okhonskaia, L.
  • de Tejada, BM.
  • Jourdain, G.
  • Decker, L.
  • Ene, L.
  • Hainaut, M.
  • Van der Kelen, E.
  • Delforge, M.
  • de Martino, M.
  • Tovo, PA.
  • Patrizia, O.
  • Larovere, D.
  • Ruggeri, M.
  • Faldella, G.
  • Baldi, F.
  • Badolato, R.
  • Montagnani, C.
  • Venturini, E.
  • Lisi, C.
  • Di Biagio, A.
  • Taramasso, L.
  • Giacomet, V.
  • Erba, P.
  • Esposito, S.
  • Lipreri, R.
  • Salvini, F.
  • Tagliabue, C.
  • Cellini, M.
  • Bruzzese, E.
  • Lo Vecchio, A.
  • Rampon, O.
  • Dona, D.
  • Romano, A.
  • Dodi, I.
  • Maccabruni, A.
  • Consolini, R.
  • Bernardi, S.
  • Kuekou, HT.
  • Genovese, O.
  • Olmeo, P.
  • Cristiano, L.
  • Mazza, A.
  • Gabiano, C.
  • Garazzino, S.
  • Pellegatta, A.
  • Pajkrt, D.
  • Scherpbier, HJ.
  • Weijsenfeld, AM.
  • de Boer, CG.
  • Jurriaans, S.
  • Back, NKT.
  • Zaaijer, HL.
  • Berkhout, B.
  • Cornelissen, MTE.
  • Schinkel, CJ.
  • Wolthers, KC.
  • Fraaij, PLA.
  • van Rossum, AMC.
  • Vermont, CL.
  • van der Knaap, LC.
  • Visser, EG.
  • Boucher, CAB.
  • Koopmans, MPG.
  • van Kampen, JJA.
  • Pas, SD.
  • Henriet, SSV.
  • van de Flier, M.
  • van Aerde, K.
  • Strik-Albers, R.
  • Rahamat-Langendoen, J.
  • Stelma, FF.
  • Scholvinck, EH.
  • de Groot-de Jonge, H.
  • Niesters, HGM.
  • van Leer-Buter, CC.
  • Knoester, M.
  • Bont, LJ.
  • Geelen, SPM.
  • Wolfs, TFW.
  • Nauta, N.
  • Schuurman, R.
  • Verduyn-Lunel, F.
  • Wensing, AMJ.
  • Reiss, P.
  • Zaheri, S.
  • Bezemer, DO.
  • van Sighem, AI.
  • Smit, C.
  • Wit, FWMN.
  • Hillebregt, M.
  • de Jong, A.
  • Woudstra, T.
  • Bergsma, D.
  • Grivell, S.
  • Meijering, R.
  • Raethke, M.
  • Rutkens, T.
  • de Groot, L.
  • van den Akker, M.
  • Bakker, Y.
  • Bezemer, M.
  • El Berkaoui, A.
  • Geerlinks, J.
  • Koops, J.
  • Kruijne, E.
  • Lodewijk, C.
  • Lucas, E.
  • van der Meer, R.
  • Munjishvili, L.
  • Paling, E.
  • Peeck, B.
  • Ree, C.
  • Regtop, R.
  • Ruijs, Y.
  • van de Sande, L.
  • Schoorl, M.
  • Schnorr, P.
  • Tuijn, E.
  • Veenenberg, L.
  • van der Vliet, S.
  • Wisse, A.
  • Witte, EC.
  • Tuk, B.
  • Popielska, J.
  • Pokorska-Spiewak, M.
  • Oldakowska, A.
  • Zawadka, K.
  • Coupland, U.
  • Doroba, M.
  • Voronin, E.
  • Miloenko, M.
  • Labutina, S.
  • Soler-Palacin, P.
  • Frick, MA.
  • Perez-Hoyos, S.
  • Mur, A.
  • Lopez, N.
  • Mendez, M.
  • Mayol, L.
  • Vallmanya, T.
  • Calavia, O.
  • Garcia, L.
  • Coll, M.
  • Pineda, V.
  • Rius, N.
  • Rovira, N.
  • Duenas, J.
  • Gamell, A.
  • Fortuny, C.
  • Noguera-Julian, A.
  • Mellado, MJ.
  • Escosa, L.
  • Hortelano, MG.
  • Sainz, T.
  • Gonzalez-Tome, MI.
  • Rojo, P.
  • Blazquez, D.
  • Prieto, L.
  • Guillen, S.
  • Saavedra, J.
  • Santos, M.
  • Munoz, MA.
  • Ruiz, B.
  • Mc Phee, CF.
  • de Ory, SJ.
  • Alvarez, S.
  • Roa, MA.
  • Beceiro, J.
  • Martinez, J.
  • Badillo, K.
  • Apilanez, M.
  • Pocheville, I.
  • Garrote, E.
  • Colino, E.
  • Sirvent, JG.
  • Garzon, M.
  • Roman, V.
  • Montesdeoca, A.
  • Mateo, M.
  • Munoz, MJ.
  • Angulo, R.
  • Neth, O.
  • Falcon, L.
  • Terol, P.
  • Santos, JL.
  • Moreno, D.
  • Lendinez, F.
  • Grande, A.
  • Romero, FJ.
  • Perez, C.
  • Lillo, M.
  • Losada, B.
  • Herranz, M.
  • Bustillo, M.
  • Guerrero, C.
  • Collado, P.
  • Couceiro, JA.
  • Perez, A.
Objective: The aim of this study was to describe growth during puberty in young people with vertically acquired HIV. Design: Pooled data from 12 paediatric HIV cohorts in Europe and Thailand. Methods: One thousand and ninety-four children initiating a nonnucleoside reverse transcriptase inhibitor or boosted protease inhibitor based regimen aged 1-10 years were included. Super Imposition by Translation And Rotation (SITAR) models described growth from age 8 years using three parameters (average height, timing and shape of the growth spurt), dependent on age and height-for-age z-score (HAZ) (WHO references) at antiretroviral therapy (ART) initiation. Multivariate regression explored characteristics associated with these three parameters. Results: At ART initiation, median age and HAZ was 6.4 [interquartile range (IQR): 2.8, 9.0] years and -1.2 (IQR: -2.3 to -0.2), respectively. Median follow-up was 9.1 (IQR: 6.9, 11.4) years. In girls, older age and lower HAZ at ART initiation were independently associated with a growth spurt which occurred 0.41 (95% confidence interval 0.20-0.62) years later in children starting ART age 6 to 10 years compared with 1 to 2 years and 1.50 (1.21-1.78) years later in those starting with HAZ less than -3 compared with HAZ at least -1. Later growth spurts in girls resulted in continued height growth into later adolescence. In boys starting ART with HAZ less than -1, growth spurts were later in children starting ART in the oldest age group, but for HAZ at least -1, there was no association with age. Girls and boys who initiated ART with HAZ at least -1 maintained a similar height to the WHO reference mean. Conclusion: Stunting at ART initiation was associated with later growth spurts in girls. Children with HAZ at least -1 at ART initiation grew in height at the level expected in HIV negative children of a comparable age.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Neuroinflammatory and behavioral susceptibility profile of mice exposed to social stress towards cocaine effects

  • Ballestín, Raúl
  • Alegre-Zurano, Laia
  • Ferrer-Pérez, Carmen
  • Cantacorps, Lídia
  • Miñarro, José
  • Valverde, Olga
  • Rodríguez-Arias, Marta
Using the social defeat (SD) model, numerous studies have shown that stressed mice display an enhanced response to the motivational effects of cocaine in the self-administration (SA) and conditioned-place preference (CPP) paradigms. However, not all subjects exposed to stress express its harmful effects. Some are particularly susceptible to the deleterious effects of repeated SD, while resilient mice successfully cope with stressful experiences and display adjusted psychological functioning after stress. Vulnerability to develop stress-related disorders, such as depression, has been linked to coping strategies and more recently to individual differences in the immune system. However, no studies have evaluated if coping strategies and immune system reactivity to social stress experiences can also predict susceptibility to stress-induced enhancement of the cocaine response. We evaluated cocaine response in socially defeated mice in the CPP and SA paradigms. To evaluate neuroimmune reactivity to stress the pro-inflammatory cytokine IL-6 and the chemokine CX3CL1 were measured in the striatum and hippocampus. Behavioral phenotype during and after SD episodes was also evaluated. Our results showed that susceptible mice to the depressive-like behaviors effects of stress showed increased conditioned rewarding effects of cocaine in the CPP. In addition, susceptible mice displayed passive-reactive coping behavior during social stress episodes and more pronounced changes in neuroinflammatory markers after the last SD episode, which lasted for one month. Although the complex mechanisms underlying susceptibility or resilience to social stress are still unclear, our results point to multiple adaptive stress responses expressed at different phenotypic levels.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals

  • Anguita-Ruiz, Augusto
  • Zarza-Rebollo, Juan Antonio
  • Pérez-Gutiérrez, Ana M.
  • Molina, Esther
  • Gutiérrez, Blanca
  • Bellón, Juan Ángel
  • Moreno-Peral, Patricia
  • Conejo-Cerón, Sonia
  • Aiarzagüena, Jose María
  • Ballesta-Rodríguez, M. Isabel
  • Fernández, Anna
  • Fernández-Alonso, Carmen
  • Martín-Pérez, Carlos
  • Montón-Franco, Carmen
  • Rodríguez-Bayón, Antonina
  • Torres-Martos, Álvaro
  • López-Isac, Elena
  • Cervilla, Jorge
  • Rivera, Margarita
Depression is strongly associated with obesity among other chronic physical diseases. The latest mega- and meta-analysis of genome-wide association studies have identified multiple risk loci robustly associated with depression. In this study, we aimed to investigate whether a genetic-risk score (GRS) combining multiple depression risk single nucleotide polymorphisms (SNPs) might have utility in the prediction of this disorder in individuals with obesity. A total of 30 depression-associated SNPs were included in a GRS to predict the risk of depression in a large case-control sample from the Spanish PredictD-CCRT study, a national multicentre, randomized controlled trial, which included 104 cases of depression and 1546 controls. An unweighted GRS was calculated as a summation of the number of risk alleles for depression and incorporated into several logistic regression models with depression status as the main outcome. Constructed models were trained and evaluated in the whole recruited sample. Non-genetic-risk factors were combined with the GRS in several ways across the five predictive models in order to improve predictive ability. An enrichment functional analysis was finally conducted with the aim of providing a general understanding of the biological pathways mapped by analyzed SNPs. We found that an unweighted GRS based on 30 risk loci was significantly associated with a higher risk of depression. Although the GRS itself explained a small amount of variance of depression, we found a significant improvement in the prediction of depression after including some non-genetic-risk factors into the models. The highest predictive ability for depression was achieved when the model included an interaction term between the GRS and the body mass index (BMI), apart from the inclusion of classical demographic information as marginal terms (AUC = 0.71, 95% CI = [0.65, 0.76]). Functional analyses on the 30 SNPs composing the GRS revealed an over-representation of the mapped genes in signaling pathways involved in processes such as extracellular remodeling, proinflammatory regulatory mechanisms, and circadian rhythm alterations. Although the GRS on its own explained a small amount of variance of depression, a significant novel feature of this study is that including non-genetic-risk factors such as BMI together with a GRS came close to the conventional threshold for clinical utility used in ROC analysis and improves the prediction of depression. In this study, the highest predictive ability was achieved by the model combining the GRS and the BMI under an interaction term. Particularly, BMI was identified as a trigger-like risk factor for depression acting in a concerted way with the GRS component. This is an interesting finding since it suggests the existence of a risk overlap between both diseases, and the need for individual depression genetics-risk evaluation in subjects with obesity. This research has therefore potential clinical implications and set the basis for future research directions in exploring the link between depression and obesity-associated disorders. While it is likely that future genome-wide studies with large samples will detect novel genetic variants associated with depression, it seems clear that a combination of genetics and non-genetic information (such is the case of obesity status and other depression comorbidities) will still be needed for the optimization prediction of depression in high-susceptibility individuals.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

La Red de Investigación en Actividades Preventivas y Promoción de la Salud (redIAPP): una red de referencia e impulsora de la investigación en atención primaria

  • Bolibar Ribas, Bonaventura
  • Llobera-Cànaves, Joan
  • García-Ortiz, Luis
  • Bellón, Juan-Ángel
  • Ramos, Rafel
  • García-Campayo, Javier
  • Sánchez-Pérez, Álvaro
  • Claveria, Ana
  • Martínez, Vicente
  • Vicens, Enric
  • Minué, César
  • Gil-Guillen, Vicente
  • Berenguera, Anna
  • Moleras-Serra, Anna
La Red de Investigación en Actividades Preventivas y Promoción de la Salud (redIAPP), una red de referencia e impulsora de la investigación en atención primaria fue creada en 2003 gracias al programa Redes Temáticas de Investigación Cooperativa en Salud (RETICS) del Instituto de Salud Carlos III (ISCIII). Su creación ha supuesto un cambio radical en la situación de la investigación en atención primaria. A lo largo de sus 19 años (2003-2021) han participado distintos grupos de investigación y comunidades autónomas, y se han desarrollado distintas líneas de investigación con numerosos proyectos y publicaciones. A pesar de las dificultades sufridas, ha creado una experiencia de investigación colaborativa entre distintas comunidades autónomas con gran vitalidad y con importantes resultados para la atención primaria. La redIAPP, por tanto, ha sido un gran referente para la investigación en atención primaria y para la profundización de su área de conocimiento. Se sugieren varias líneas de mejora para el futuro de la investigación en atención primaria.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Evaluation of Institut Georges Lopez-1 preservation solution in pig pancreas transplantation: a pilot study

  • García-Gil, Francisco A
  • Fuentes-Broto, Lorena
  • Albendea, Carlos D.
  • Serrano, María Trinidad
  • Roselló-Catafau, Joan
  • Lampreave, Fermín
  • López-Pingarrón, Laura
  • Escartín, Jorge
  • Soria, Joaquín
  • Garcia, ,Joaquín J
  • Fernández-Cruz, Laureano
Background. Institut Georges Lopez-1 preservation solution (IGL-1) is an emerging extracellular-type electrolyte solution, low in viscosity, containing polyethylene glycol 35 as a colloid. Although IGL-1 has shown beneficial outcomes in kidney and liver preservation, this pilot study is the first to evaluate the efficacy of IGL-1 in pancreas transplantation (PT) compared with the University of Wisconsin solution (UW) Methods. Sixteen Landrace pigs underwent allogeneic PT with 16 hr of cold ischemia. Grafts were preserved with IGL-1 (n=8) or UW (n=8). No immunosuppression was administered. We analyzed graft function, the acute-phase response, and oxidative stress in the pancreatic graft monitoring membrane fluidity and lipid peroxidation@@@Results. All eight grafts with IGL-1, but only six with UW, were functioning. Graft failures with UW resulted from graft thrombosis. There were no differences between the two solutions in the number of normoglycemic days (IGL-1: 11.5T6.2 versus UW: 8.5T4.4 days, P=0.1357), nor in lipid peroxidation during 16-hr cold ischemia (P=0.672), or reperfusion (P=0.185), but IGL-1 prevented changes in membrane fluidity after reperfusion when compared with UW (P=0.026) Conclusion. IGL-1 offered the same degree of safety and effectiveness as UW in our model of pig PT with 16 hr of cold ischemia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Prognosis of 2009 a(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy

  • Paño-Pardo, José Ramón
  • Rodríguez-Baño, Jesús
  • Martínez-Sánchez, Nuria
  • Viasus, Diego
  • Fariñas, M Carmen
  • Leyes, María
  • López-Medrano, Francisco
  • Pachón, Jerónimo
  • Torre-Cisneros, Julián
  • Oteo, José Antonio
  • Pumarola, Tomás
  • García-Gasalla, Mercedes
  • Ortega, Lucía
  • Segura, Ferrán
  • Carratalá, Jordi
Initial reports suggested that novel A(H1N1) influenza virus (2009 A[H1N1]v) infection was significantly more severe in pregnant than in non-pregnant women. In Spain, antiviral therapy was recommended for pregnant women from the beginning of the 2009 pandemic. Methods The prospective cohort study included consecutive pregnant and non-pregnant women of reproductive age with a proven diagnosis of 2009 A(H1N1)v admitted to any of the 13 participating Spanish hospitals between 12 June and 10 November 2009. Results In total, 98 pregnant and 112 non-pregnant women with proven 2009 A(H1N1)v hospitalized during the study period were included. Influenza was more severe among non-pregnant patients than pregnant patients with respect to outcomes of both intensive care unit admission (18% versus 2%; P<0.001) and death (5 versus 0; P=0.06). Pregnant women had fewer associated comorbid conditions other than pregnancy (18% versus 44%; P<0.001); they were also admitted earlier than non-pregnant women (median days since onset of symptoms: 2 versus 3; P<0.001) and a higher percentage received early antiviral therapy (41% versus 28%; P=0.03). Neither a multivariate nor a matched cohort analysis found pregnancy to be associated with greater severity than that associated with hospitalized, seriously ill non-pregnant women. Conclusions 2009 A(H1N1)v influenza was not associated with worse outcomes in hospitalized pregnant women compared with non-pregnant ones of reproductive age in a context of early diagnosis and antiviral therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Age differences in presentation, diagnosis pathway and management of colorectal cancer

  • Esteva, M.
  • Ruiz, A.
  • Ramos, M.
  • Casamitjana, M.
  • Sánchez-Calavera, M.A.
  • González-Luján, L.
  • Pita-Fernández, S.
  • Leiva, A.
  • Pértega-Díaz, S.
  • Costa-Alcaraz, A.
  • Macià, F.
  • Espí, A.
  • Segura, J.M.
  • Lafita, S.
  • Novella, M.T.
  • Yus, C.
  • Oliván, B.
  • Cabeza, E.
  • Seoane-Pillado, T.
  • López-Calviño, B.
  • Llobera, J.
  • Martín-Rabadán, M. Maria
  • Teresa Novella, M.
  • Ripoll, J.
  • Manzano, H.
  • Amengual, I.
  • Forteza, A.
  • Company, M.
  • Lluch Bennassar, Maria de
  • Sánchez, M.A.
  • Magallón, R.
  • Olivan, B.
  • Maciá, F.
  • Pita, S.
  • Pertega-Díaz, S.
  • Louro, A.
  • Serrano, J.
  • Arnal, F.
  • González-Santamaría, P.
  • Seoane, T.
  • González-Lujan, L.
  • Costa-Alcaraz, A.
  • Espí, I.
  • Bosca, M.M.
  • Balza, N.
  • Villagrasa, R.A.
  • Vázquez,J. F.
  • González-Timoneda, Y.A.
BACKGROUND: The gap in survival between older and younger European cancer patients is getting wider. It is possible that cancer in the elderly is being managed or treated differently than in their younger counterparts. This study aims to explore age disparities with respect to the clinical characteristics of the tumour, diagnostic pathway and treatment of colorectal cancer patients. METHODS: We conducted a multicenter cross sectional study in 5 Spanish regions. Consecutive incident cases of CRC were identified from pathology services. MEASUREMENTS: From patient interviews, hospital and primary care clinical records, we collected data on symptoms, stage, doctors investigations, time duration to diagnosis/treatment, quality of care and treatment. RESULTS: 777 symptomatic cases, 154 were older than 80 years. Stage was similar by age group. General symptoms were more frequent in the eldest and abdominal symptoms in the youngest. No differences were found regarding perception of symptom seriousness and symptom disclosure between age groups as no longer duration to diagnosis or treatment was observed in the oldest groups. In primary care, only ultrasound is more frequently ordered in those <65 years. Those >80 years had a significantly higher proportion of iron testing and abdominal XR requested in hospital. We observed a high resection rate independently of age but less adjuvant chemotherapy in Stage III colon cancer, and of radiotherapy in stage II and III rectal cancer as age increases. CONCLUSION: There are no relevant age disparities in the CRC diagnosis process with similar stage, duration to diagnosis, investigations and surgery. However, further improvements have to be made with respect to adjuvant therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer

  • Esteva, M.
  • Leiva, A.
  • Ramos, M.
  • Pita-Fernández, S.
  • González-Luján, L.
  • Casamitjana, M.
  • Sánchez, M. A.
  • Pértega-Díaz, S.
  • Ruiz, A.
  • Gonzalez-Santamaría, P.
  • Martín-Rabadán, M.
  • Costa-Alcaraz, A.
  • Espí, A.
  • Macià, F.
  • Segura, J. M.
  • Lafita, S.
  • Arnal-Monreal, F.
  • Amengual, I.
  • Boscá-Watts, M. M.
  • Hospital, A.
  • Manzano, H.
  • Magallón, R.
  • Novella, M. T.
  • Cabeza, E.
  • Ripoll, J.
  • Forteza, A.
  • Company, M.
  • de Lluch Bennassar
  • Llobera, J.
  • Olivan, B.
  • Yus, C.
  • Casamitjana, M.
  • Pita, S.
  • Pertega, S.
  • Louro, A.
  • Serrano, J.
  • Arnal, F.
  • González-Santamaria, P.
  • González-Lujan, L.
  • Balza, N.
  • Villagrasa, R. A.
  • Vázquez, J. F.
  • González-Timoneda, A.
Background Colorectal cancer (CRC) survival depends mostly on stage at the time of diagnosis. However, symptom duration at diagnosis or treatment have also been considered as predictors of stage and survival. This study was designed to: 1) establish the distinct time-symptom duration intervals; 2) identify factors associated with symptom duration until diagnosis and treatment. Methods This is a cross-sectional study of all incident cases of symptomatic CRC during 2006–2009 (795 incident cases) in 5 Spanish regions. Data were obtained from patients’ interviews and reviews of primary care and hospital clinical records. Measurements: CRC symptoms, symptom perception, trust in the general practitioner (GP), primary care and hospital examinations/visits before diagnosis, type of referral and tumor characteristics at diagnosis. Symptom Diagnosis Interval (SDI) was calculated as time from first CRC symptoms to date of diagnosis. Symptom Treatment Interval (STI) was defined as time from first CRC symptoms until start of treatment. Nonparametric tests were used to compare SDI and STI according to different variables. Results Symptom to diagnosis interval for CRC was 128 days and symptom treatment interval was 155. No statistically significant differences were observed between colon and rectum cancers. Women experienced longer intervals than men. Symptom presentation such as vomiting or abdominal pain and the presence of obstruction led to shorter diagnostic or treatment intervals. Time elapsed was also shorter in those patients that perceived their first symptom/s as serious, disclosed it to their acquaintances, contacted emergencies services or had trust in their GPs. Primary care and hospital doctor examinations and investigations appeared to be related to time elapsed to diagnosis or treatment. Conclusions Results show that gender, symptom perception and help-seeking behaviour are the main patient factors related to interval duration. Health service performance also has a very important role in symptom to diagnosis and treatment interval. If time to diagnosis is to be reduced, interventions and guidelines must be developed to ensure appropriate examination and diagnosis during both primary and hospital care.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement

  • Prieto-Torres, L
  • Trascasa, A
  • Manso, R
  • Machan, S
  • Cieza-Diaz, D
  • Olmedilla, G
  • Garcia-Garcia, M
  • Ara-Martin, M
  • Requena, L
  • Piris, MA
  • Rodriguez-Pinilla, SM
Several studies have provided evidence of the presence of lymphoma stem cells by showing the apparent transmission of premalignant lymphoid cells in allogeneic bone marrow transplantation, where the donor and recipient develop the same lymphoid disease.1-6 The lymphoid neoplasms do not develop at the same time, and in some cases, a different immunoglobulin heavy chain (IgH) rearrangement occurs in the two tumours. These data support the theory of a common lymphoma precursor cell (CPC) and make it less likely that it is due to a circulating donor tumour cell. Recently, Hattori et al.7 published genetic evidence of CPC in primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL), suggesting that intra- and extra-CNS tumours in the same patient are derived from CPC with myeloid differentiation factor 88 (MYD88) L265P gene mutations, which arise before or after the IgH rearrangement. They suggested that CPC maps to different positions during B-lineage differentiation. The position after IgH rearrangement and even after hypermutation at the variable region could explain the appearance of clonally related lymphomas, whereas the emergence of CPC before IgH rearrangement might account for the presence of clonally unrelated B-cell lymphomas in the same patient because divergence may occur before the Variable-Diversity-Junctional (VDJ) rearrangements.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

FK506 affects mitochondrial protein synthesis and oxygen consumption in human cells

  • Palacín, M.
  • Coto, E.
  • Llobet, L.
  • Pacheu-Grau, D.
  • Montoya, J.
  • Ruiz-Pesini, E.
FK506 is an important immunosuppressive medication. However, it can provoke neurotoxicity, nephrotoxicity, and diabetes as adverse side effects. The decrease in oxygen consumption of rat cells treated with pharmacologically relevant concentrations of FK506, along with other evidences, has insinuated that some of the toxic effects are probably caused by drug-induced mitochondrial dysfunction at the level of gene expression. To confirm this suggestion, we have analyzed cell respiration and mitochondrial protein synthesis in human cell lines treated with FK506. This drug provokes an important decrease in oxygen consumption, accompanied by a slight reduction in the synthesis of mitochondria DNA-encoded proteins. These results are similar to those triggered by rapamycin, another macrolide with immunosuppressive properties, therefore insinuating a common toxic pathway.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial

  • Martínez-González, Miguel Ángel, 1957-
  • Montero, Pedro
  • Ruiz-Canela, Miguel
  • Toledo, Estefanía
  • Estruch Riba, Ramon
  • Gómez-Gracia, Enrique
  • Li, Jun
  • Ros Rahola, Emilio
  • Arós, Fernando
  • Hernáez, Álvaro
  • Corella Piquer, Dolores
  • Fiol, Miquel
  • Lapetra, José
  • Serra Majem, Lluís
  • Pintó Sala, Xavier
  • Cofán Pujol, Montserrat
  • Sorlí, José V.
  • Babio, Nancy
  • Márquez-Sandoval, Yolanda F.
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repeated measurements of dietary intake are able to improve subject classification and to increase the quality of the assessed relationships in nutritional epidemiology. Beyond observational studies, randomized trials provide stronger causal evidence. In the context of a randomized trial of primary cardiovascular prevention, we assessed type 2 diabetes incidence according to yearly repeated measures of compliance with a nutritional intervention based on the traditional Mediterranean diet. Methods PREDIMED (‘‘PREvención con DIeta MEDiterránea’’) was a Spanish trial including 7447 men and women at high cardiovascular risk. We assessed 3541 participants initially free of diabetes and originally randomized to 1 of 3 diets: low-fat diet (n = 1147, control group), Mediterranean diet supplemented with extra virgin olive (n = 1154) or Mediterranean diet supplemented with mixed nuts (n = 1240). As exposure we used actual adherence to Mediterranean diet (cumulative average), yearly assessed with the Mediterranean Diet Adherence Screener (scoring 0 to 14 points), and repeated up to 8 times (baseline and 7 consecutive follow-up years). This score was categorized into four groups: < 8, 8–< 10, 10– < 12, and 12–14 points. The outcome was new-onset type 2 diabetes. Results Multivariable-adjusted hazard ratios from time-varying Cox models were 0.80 (95% confidence interval, 0.70–0.92) per + 2 points in Mediterranean Diet Adherence Screener (linear trend p = .001), and 0.46 (0.25–0.83) for the highest (12–14 points) versus the lowest (< 8) adherence. This inverse association was maintained after additionally adjusting for the randomized arm. Age- and sex-adjusted analysis of a validated plasma metabolomic signature of the Mediterranean Diet Adherence Screener (constituted of 67 metabolites) in a subset of 889 participants also supported these results. Conclusions Dietary intervention trials should quantify actual dietary adherence throughout the trial period to enhance the benefits and to assist results interpretation. A rapid dietary assessment tool, yearly repeated as a screener, was able to capture a strong inverse linear relationship between Mediterranean diet and type 2 diabetes., info:eu-repo/semantics/publishedVersion
Docta Complutense
Publication Artículo científico (JournalArticle)

Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin

  • Xavier, Fabiano
  • Aras López, Rosa
  • Arroyo Villa, Irene
  • Del Campo Milán, Lara
  • Salaices, Mercedes
  • Rossoni, Luciana
  • Ferrer, Mercedes
  • Balfagón, Gloria
Background and purpose: The present study was designed to assess whether cyclooxygenase-2 (COX-2) activation is involved in the effects of chronic aldosterone treatment on endothelial function of mesenteric resistance arteries (MRA) from Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR). Experimental approach: Relaxation to acetylcholine was measured in MRA from both untreated and aldosterone-treated strains. Vasomotor responses to prostacyclin and U46619 were also analysed. Release of 6-oxo-prostaglandin (PG)F1alpha and thromboxane B2 (TxB2) was determined by enzyme immunoassay. COX-2 protein expression was measured by western blot. Key results: Aldosterone reduced acetylcholine relaxation in MRA from both strains. In MRA from both aldosterone-treated strains the COX-1/2 or COX-2 inhibitor (indomethacin and NS-398, respectively), TxA2 synthesis inhibitor (furegrelate), prostacyclin synthesis inhibitor (tranylcypromine) or TxA2/ PGH2 receptor antagonist (SQ 29 548), but not COX-1 inhibitor SC-560, increased acetylcholine relaxation. In untreated rats this response was increased only in SHR. Prostacyclin elicited a biphasic vasomotor response: lower concentrations elicited relaxation, whereas higher concentrations elicited contraction that was reduced by SQ 29 548. Aldosterone increased the acetylcholine-stimulated production of 6-oxo-PGF(1alpha) and TxB2 in MRA from both strains. COX-2 expression was higher in both strains of rats treated with aldosterone. Conclusions and implications: Chronic treatment with aldosterone impaired endothelial function in MRA under normotensive and hypertensive conditions by increasing COX-2-derived prostacyclin and thromboxane A2. As endothelial dysfunction participates in the pathogenesis of many cardiovascular disorders we hypothesize that anti-inflammatory drugs, specifically COX-2 inhibitors, could ameliorate vascular damage in patients with elevated aldosterone production.
Docta Complutense
Publication Artículo científico (JournalArticle)

Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy

  • Álvarez Prats, Alejandro
  • Hernández Perera, Octavio
  • Díaz Herrera, Pilar
  • Ucero Herrería, Álvaro Conrado
  • Anabitarte Prieto, Aránzazu
  • Losada Cabrera, Antonio
  • Ortiz, Alberto
  • Rodríguez Pérez, José C.
Background Angiotensin receptor 1 blockers (ARB) are standard nephroprotective drugs in chronic kidney disease. There is less evidence for a nephroprotective effect of HMG-CoA reductase inhibitors (statins) and much less is known about potential benefits of combination therapy. We evaluated the therapeutic potential of a statin alone or in combination with an ARB in experimental chronic kidney disease. Methods Subtotally nephrectomized (5/6 Nx) rats were treated early with vehicle, losartan, cerivastatin or losartan/cerivastatin. Expression of messenger RNA (mRNA) was assessed by real-time reverse transcription–polymerase chain reaction. Tissue proteins were localized by immunohistochemistry. Nuclear factor-κB (NF-κB) activation was measured in whole kidneys. Results In contrast to the sham group, at 6 weeks, vehicle-treated 5/6 Nx rats displayed renal lesions, albuminuria and increased blood pressure, serum creatinine and total kidney NF-κB p65 DNA-binding activity and preproendothelin-1, fibronectin and type I and III collagen mRNA. NF-κB activation correlated with albuminuria and histological renal injury. Losartan or combination therapy preserved renal function, abrogated albuminuria and improved glomerular and interstitial histology. Cerivastatin alone preserved renal function and improved interstitial injury but did not influence albuminuria, glomerular histology or NF-κB activation. Losartan/cerivastatin normalized kidney NF-κB activation and extracellular matrix mRNA expression pattern. The effect of losartan alone on these parameters was less intense. All treatments decreased preproendothelin-1 mRNA and preserved interstitial capillaries. Conclusions In a chronic kidney disease model, early treatment with either an ARB or a statin preserved renal function although the mechanisms differed. Combination therapy with an ARB and a statin did not confer clear-cut advantages on biochemical and histological parameters over ARB alone, although it further improved the kidney NF-κB and gene expression profile.
Docta Complutense
Publication Artículo científico (JournalArticle)

NF-κB-Inducing Kinase Is Essential for Effective c-Rel Transactivation and Binding to the Il12b Promoter in Macrophages

  • Cuesta Rubio, Natalia
  • Staniszewska, Anna D.
  • Moreno, Cristóbal
  • Punzón, Carmen
  • Fresno, Manuel
This study investigates the role of NIK in activating specific inflammatory genes in macrophages, focusing on the effect of a mutation in NIK found in alymphoplasia (aly/aly) mice. Mouse peritoneal macrophages from aly/aly mice showed a severe defect in the production of some pro-inflammatory cytokines, such as IL-12. This effect seemed to take place at the transcriptional level, as shown by the reduced transcription of Il12b and Il12a in aly/aly macrophages after exposure to the TLR4 agonist LPS. Immunoprecipitation studies showed that the binding of NIK to c-Rel was not efficient in RAW 264.7 cells over-expressing the aly/aly mutation. In addition, the shuttling of c-Rel to the nucleus was shown to be impaired in aly/aly macrophages in response to LPS. When looking more specifically at the regulation of the Il12b promoter, we found that c-Rel bound to the NF-kB consensus sequence in macrophages from WT mice 1 hr. after LPS challenge, whereas in aly/aly macrophages, the transcription factor bound to the promoter was p65. These findings indicate that NIK is essential for efficient c-Rel activation and proper inflammatory responses. NIK dysfunction could lead to weakened immune responses, and targeting this pathway may help in developing therapies for immune-related conditions.
Docta Complutense
Publication Artículo científico (JournalArticle)

Cannabinoid type 1 receptors transiently silence glutamatergic nerve terminals of cultured cerebellar granule cells

  • Ramírez Franco, José Jorge
  • Bartolomé-Martín, David
  • Alonso, Beatris
  • Torres Molina, Magdalena Isabel
  • Sánchez-Prieto Borja, José
Cannabinoid receptors are the most abundant G protein-coupled receptors in the brain and they mediate retrograde short-term inhibition of neurotransmitter release, as well as long-term depression of synaptic transmission at many excitatory synapses. The induction of presynaptically silent synapses is a means of modulating synaptic strength, which is important for synaptic plasticity. Persistent activation of cannabinoid type 1 receptors (CB1Rs) mutes GABAergic terminals, although it is unclear if CB1Rs can also induce silencing at glutamatergic synapses. Cerebellar granule cells were transfected with VGLUT1-pHluorin to visualise the exo-endocytotic cycle. We found that prolonged stimulation (10 min) of cannabinoid receptors with the agonist HU-210 induces the silencing of previously active synapses. However, the presynaptic silencing induced by HU-210 is transient as it reverses after 20 min. cAMP with forskolin prevented CB1R-induced synaptic silencing, via activation of the Exchange Protein directly Activated by cAMP (Epac). Furthermore, Epac activation accelerated awakening of already silent boutons. Electron microscopy revealed that silencing was associated with synaptic vesicle (SV) redistribution within the nerve terminal, which diminished the number of vesicles close to the active zone of the plasma membrane. Finally, by combining functional and immunocytochemical approaches, we observed a strong correlation between the release capacity of the nerve terminals and RIM1α protein content, but not that of Munc13-1 protein. These results suggest that prolonged stimulation of cannabinoid receptors can transiently silence glutamatergic nerve terminals.